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LETTER FROM THE PROFESSOR
Preparation, not luck.
Dear Class of 2022,
What a journey this has been! Significant upheavals in world events occurred during your four years at Kenyon College. A global pandemic,
mass protests and political uncertainty in the United States, a European
war in the twenty-first century that recapitulates the worst nation-state
behaviors of the twentieth century. And as you leave college, these
events continue to unfold and you are called upon to participate in the
world and do your part in shaping the yet to be determined outcomes.
As is often the case, many people will wish you well as you transition
from college to your post-college life, and you will probably hear the
phrase “good luck” quite often. Those who wish you good luck are
doing so with the best of intentions, but luck, by definition, emphasizes random chance and minimizes intentional action. And although we cannot deny that some random chance plays a role in all of our lives, we know
that to achieve the outcomes for which we strive, we must engage in intentional behaviors and sustained
effort. This is how we prepare to meet challenges. To be prepared is to tilt the outcomes in life in favor of the
intentional and away from random chance. You wanted your future success to depend less on luck and more
on preparation and so you have spent the last four years engaged in sustained, intentional actions in preparing for your future. The paths you have chosen to follow after Kenyon varies, but what cannot be denied
is your preparation to walk those paths. That preparation made graduate school possible; it made medical
school possible; it made law school possible; preparation made you successful in your job search; preparation
gave you the mental clarity to know that you need to take a break between college and your next adventure;
and it gave you the confidence to act on that realization. You understood that preparation is more than the
acquisition of knowledge in your specific discipline; that true preparation for global citizenship requires a
broad, liberal education. And so even as you became experts in neuroscience, you remained or became artists and athletes, and participated in a variety of activities both on and off campus that speaks to that broader
engagement. This magazine is a tangible testament to your expertise in neuroscience as well as your ability
to communicate complex ideas to anyone interested in hearing those ideas. We, your faculty, were honored
to be part of your journey of preparation. Our role was to pushed you to grow and excel; you responded by
growing and excelling. You are successful. We too wish you good luck as you leave us; it is our way acknowledging that random chance plays a role in all of our lives. But we know that your success is not due to chance;
it is the outcome of focused and sustained effort. It came from persistence; a willingness to try harder, work
longer, take the smarter approach. You are successful because you have prepared to be successful. And so,
we have no doubt that you will meet and overcome the challenges of the future. Whatever path(s) you take,
we are confident that you will represent yourselves, the Neuroscience Department, and Kenyon College with
grace and distinction. We wish you well.
Sincerely,

Hewlet G. McFarlane
Professor and Chair
Department of Neuroscience
Kenyon College

Editor-In-Chief
Hewlet G. McFarlane
Art Director
Selam Habtemariam

Current Topics in Neuroscience

Copy Editors & Fact Checkers
Lucy Friedberg, Madde Hyland,
and Sierra Smith

Dr. Hewlet G. McFarlane and
The Class of 2022

Table of Contents

1
11
21
31
39

A Racing Mind

How Time Perception Impacts Athletic Endurance
Sierra Smith

How the Bacteria in Your Gut May Calm the Butterflies
in Your Somach
Hailey Napier

A Controversial New Hope

Exploring Recent Advancements in Alzheimer’s Disease Treatment
Lauren Limbach

Your Mind’s Eye: Metaphor or Reality?

An Exploration of the Varieties of Visual Imagery
Alia Korot

I Feel Your Pain: Do You Feel Mine?
Lucy Friedberg

51

High Performing Athletes

59

1 in 5

69

Short Term Cravings, Long Term Effects

77

Exercise Can Give Us Brain-boosting Superpowers?

85

In 500 Feet, Turn Right Onto Memory Lane

95

Are You Depressed?

107

Does Cannibis Use Enhance Performance?
Racine Ross

Why Women Are More Likely to Develop Migraines
Karolina Edlund

A Call for More Comprehensive Alcohol Education
Madde Hyland

Selam Habtemariam

How Our Brains Create Maps of Our Memories
Sofia Alonso

Or Are You Just on Birth Control...
Olive Cowan

Consciousness

Our Most Basic State is More Complicated Than You Think!
Alyssa Dowling

SCIENTIFIC KENYON

A Racing Mind
How Time Perception Impacts Athletic Endurance
By Sierra Smith
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Take out a stopwatch, hit
“start”, and immediately close
your eyes. Without counting, open
your eyes once exactly 20 seconds have passed. What does the
watch say? How accurate was your
timing? Try this again, this time,
for 60 seconds. Were you closer
or further away from being correct? How accurate do you think
you’d be if you tried this for an
hour — 24 hours, even? While this
exercise may feel bizarre, there are
many ways we replicate this process of internally measuring time
throughout the day. From determining exactly how much time is
necessary to wash our hands, to
anticipating when the red light our
car is stopped at will turn green,
our ability to conceptualize time
guides many of our actions. Can
you also think of instances when
losing track of time isn’t necessarily a bad thing? Watching the clock
during a 3 hour college lecture, or
even a 30 minute jog, has a unique
capacity for wearing someone out.
While it is easy enough to train
yourself to ignore the clock on
the wall during a lengthy activity,
what would happen if you were
also able to ignore your internal
clock? There is one woman who
potentially holds the answer to this
question: Diane Van Deren.

The Ultrarunner
Diane Van Deren, a 61
year-old from Omaha, Nebraska,
began her professional athletic
career as a tennis player. However,
in 2006 at 46 years-old, Diane was
the runner-up to Lance Armstrong
for outdoor person of the year for
ultramarathon running (a race exceeding 26 miles and 385 yards).
WNYC studios reporter Mark Phillips highlighted how Diane did not
compete in her first ultramarathon
until the age of 42, when she entered a 50-mile ultramarathon on

“Snow Mountains” by Susan Drury, https://www.flickr.com/photos/yukonlife/12514293385 Available under CC BY 2.0

a whim, and subsequently won (1).
Testing her luck, she entered a second ultramarathon (a 100-mile race
through the Bighorn Mountains in
Wyoming), and managed to place.
Diane was just getting started.
A non-exhaustive list of her running victories includes: the Alfred
Packer 50 mile race, second place.
The Bear 100-miler, first place.
The Tahoe Rim 100-mile race, first
place. First in “Dances with the
Dirt,” a 50-mile race in Hell, Michigan. First place in the “24 hours in
Frisco” trial run. Upping the ante
by adding the challenge of extreme cold to these races, she won
first place in the Canadian Death
Race, a 78-miler in Edmonton,
Canada (1). One of her craziest
accomplishments, however, was
when she became the first woman
to complete the Yukon Arctic Ultra
300 race — a race where she ran
430 miles in -48 degree weather in
the Yukon territory while dragging
a 50-pound sled behind her. The
race lasted about 10 days, with

Diane averaging 1 hour of sleep
per night, and trekking onward
with frozen shoes. What makes
someone wake up one day at 42
years old and become an elite endurance athlete? In Diane’s case,
it involved literally losing her mind
— to be precise, the removal of a
kiwi-sized portion of her brain (1).
While Diane had always
been an athlete, (playing professional tennis, winning a marathon,
and competing in other athletic
competitions) it was not until she
had a brain surgery to remove a
portion of her temporal lobe as a
treatment for epilepsy that she became an ultra-runner. To first provide some background on Diane’s
condition: at 28-years old she experienced her first seizure. In an interview with WNYC studios, Diane
describes feeling a peculiar sensation, blacking out while in the car
with her mother, and waking up
in the hospital (1). This “peculiar
sensation”, which many epileptics
describe feeling before a seizure,
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“Lobes of the brain” by Anwinkle at English Wikibooks,
https://commons.wikimedia.org/wiki/File:Lobes_of_the_brain.svg Available under CC BY 3.0

is known as a “premonition” or
“aura”, and can serve as a warning
sign for the onset of a seizure. The
sensation can differ from person
to person, but has been described
by some as a rising feeling in the
stomach — similar to that experienced when riding a roller coaster.
For Diane (who began to regularly
experience seizures after this initial
incident), the seizure premonition
was also accompanied by the urge
to run. Every time Diane would
experience a seizure premonition,
she would throw on running shoes,
and dash onto the trails in the
woods behind her home in Colorado (1). Though this habit frightened her family, it was surprisingly
successful at preventing seizure
onset. Running potentially “reset”
her brain activity to normal levels,
and prevented the electrical activity from becoming erratic (which
occurs during a seizure) (1, 2).

3

Diane continued this seizure-preventing strategy, but eventually
the time from seizure premonition
to the occurrence of the seizure
became too short for her to take
off running. The seizures became
increasingly disruptive to her life
at this point, and Diane worried
about her ability to care for her 3
children, and perform simple tasks
such as safely bathing and driving.
After exhausting other potential
treatment methods such as special
diets and medication, Diane’s doctors proposed a more aggressive
procedure: lobectomy.

How to Lose Your
Mind
A lobectomy is a procedure
involving the targeted removal
of a small portion of the brain. To
conduct a lobectomy procedure

(1, 2) in epileptic patients, doctors
use an EEG determine if there
is a discrete region of the brain
where a patient’s epileptic seizures
are originating (1, 2). This device
measures the electrical activity of
different brain regions by pasting
dozens of electrodes to the head
of the patient. While the patient
is hooked up to an EEG, doctors
measure the activity in different
regions of their brain when they
experience a seizure. If there is
erratic electrical activity in a specific brain region during the patient’s seizure, this portion of their
brain can potentially be removed
to prevent further seizing. While
removing a segment of the brain
comes with its own risk, for people
like Diane with persistent seizures
disrupting their daily activities, a
lobectomy has the potential to restore some normalcy to their lives.
At 37-years old, Diane entered the
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Schematic of process of localizing brain region of seizure origin with EEG device, and undergoing brain surgery to this
region. Hippocampal region of the brain removed from Diane Van Deren highlighted in blue. Original image by Sierra
Smith. Created in BioRender

hospital to have dozens of EEG
electrodes glued to her head, and
await the arrival of a seizure for the
EEG to record. Doctors cheered
at the success of the procedure:
a discrete seizure-initiating region
of her brain was found. Diane
underwent surgery to remove this
section of her brain, and never
experienced a seizure again (1, 2).
The chunk of brain removed from Diane was pretty significant; a human brain is roughly
the size of two clenched fists, and
the piece of brain removed from
Diane was about the size of a kiwi
(3). The damaged brain segment
was on the right side of her head
in a region known as the temporal
lobe, and included a portion of a
sea-horse shaped structure known
as the hippocampus. The hippocampus is a structure with a variety
of functions, including imagining
the past and future, learning,
memory, spatial navigation, and
the temporal organization of
memories (which may allow us to
register the passing of time) (4, 5,
6). What about the removal of this
brain region caused Diane’s seizure
to stop, and her ultra-running career to begin? Some theorize that
by removing part of Diane’s hippocampus, doctors disrupted her

“internal clock” and inadvertently
enhanced her endurance (1).
During an interview with
WNYC radio reporter Mark Phillips,
when asked to describe how she
conceptualizes time while she runs
by, Diane simply replied, “I stay
in the moment.” Diane described
her thought processes during a
grueling endurance race, emphasizing her focus on the rhythm of
her strides rather than the passage

of time (1). This ability to “stay in
the moment” is potentially a result
of her brain processing individual
moments of the race, but due to
the missing portion of her hippocampus, being unable to stitch
these moments into a coherent
timeline. If this is the phenomenon
Diane is experiencing, it would
prevent her from recognizing how
much time has elapsed. A lack
of time recognition could be the

EEG device attached to human subject “Eeg registration” by Baburov, https://
commons.wikimedia.org/wiki/File:Eeg_registration.jpg Available under CC BY
4.0
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Temporal organization of memories. If events can be remembered in the order in which they occurred over time, it could
be easier to distinguish how much time has passed (as the sum of the time it’s taken to experience each event). Original
image by Sierra Smith. Created in BioRender.

key to understanding the mental
processes behind endurance — if
you do not know how long you
have been running, and therefore
cannot determine how tired you
think you should be, this could
delay feelings of exhaustion. In a
much simpler example, think of
the exercise from the beginning of
this paper. If every second you had
your eyes closed felt like the first
second, do you think it would be
easier to keep your eyes closed for
longer?

Feeding Fatigue

5

When you consider the
feeling of exhaustion, there are
two distinct forms that come to
mind: physical exhaustion, and
mental exhaustion. While physical exhaustion can be easier to
identify through sore muscles and
achy joints, mental exhaustion
can be slightly harder to define.
However, it’s likely we’ve all experienced mental exhaustion in some

form or another; picture how you
feel taking your last exam during
finals week, or how ready you
are to leave a very long, boring
meeting. If mental exhaustion has
a profound ability to affect our
motivation to continue a task, for
someone on the 30th mile of an
ultramarathon race, a combination
of their level of physical exhaustion
(how willing/able their body is to
continue), and mental exhaustion
(how willing/able their mind is to
continue) could shape their ability
to run onward. If we consider the
development of mental exhaustion
in a similar vein to the development of physical exhaustion, we
can think of it as operating in a
“feedback loop” system.
Many systems in our body
operate in a “feedback loop”,
where the output of the system
has the ability to alter future
outputs from this same system.
Feedback loops have the potential
to be either positive or negative
(which does not refer to the connotation of the effects of these

loops). Outputs from a positive
feedback loop induce the system
to produce even more outputs,
while outputs from a negative
feedback loop inhibit the production of future outputs. While this
concept may seem abstract, it is
how our body automatically regulates many functions; feedback
loops are why we naturally feel
more awake during the day than at
night, why our heart rate doesn’t
forever remain elevated after exercise, and why we can maintain a
steady body temperature (7). Let’s
focus now on how physical exhaustion operates in a feedback loop.
Picture this: you wake up
early, and decide to start your day
with a long run. Your plan is to run
for about an hour. The weather is
nice, and you’re feeling well-rested, so you start at a fast pace.
The first 10 minutes of your run
feel great — your legs feel strong,
your breathing is even — and you
feel like you could run forever. You
begin to slow your pace around
20 minutes into the run, and each
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As oxygen levels in muscles decrease during exercise, a new method of energy production is used that increases lactic
acid levels. Rising lactic acid levels eventually cause muscle fatigue and physical exhaustion. Original image by Sierra
Smith. Created in BioRender.

footfall on the running path feels
a little harder. By 30 minutes the
muscles in your thighs and calves
are beginning to feel sore. Over
the course of the rest of your run,
your muscles grow increasingly
sore, and when you finally stop
running after an hour, you’re ready
to sit and rest. How can you start
the run feeling so energetic and
strong, but feel so sore and tired
by the end? Throughout exercising, your muscles need a source
of energy, which is supplied to
them in the form of the molecule
“ATP”. During the early stages of
exercise, your body easily supplies your muscles with ATP; there
are high levels of oxygen in your
muscles, which react with glucose
stores to create ATP. However,
as exercise continues, your body
needs to produce more ATP, but
oxygen levels in your body have
dropped (8). Your body can no
longer directly react glucose with

oxygen to create ATP, so glucose
is converted to a molecule called
“lactic acid”, and the process of
this conversion sets off a chain of
events that eventually results in the
production of more ATP. However,
there’s a catch. When lactic acid is
formed during energy generation
in prolonged exercise, this molecule accumulates in your muscles
and causes them to feel pain and
fatigue. This is where physical
exhaustion becomes a feedback
loop; as ATP (energy) input into
your muscles increases, lactic acid
will eventually increase, inhibiting
your muscles from continuing to
work and stopping the production
of more lactic acid (8). To decrease
the rate at which this physical
fatigue advances, athletic training
over time can increase oxygen
availability in muscles to reduce
the type of ATP generation that
produces lactic acid as a byproduct (9).

If we now turn our attention back to the development of
mental exhaustion, how could this
too operate in the feedback loop?
When you think of instances in
which you feel mentally exhausted,
you’ll usually notice a common
denominator: time. A boring five
minute meeting is more tolerable
than a boring five hour meeting.

When the
Clock Stops
Considering mental exhaustion as a feedback loop of
its own, it’s important now to
consider, like any feedback loop,
what the inputs and outputs are.
If we consider time as an input in
this system, mental exhaustion
(involving decreased motivation,
and decreased motor output from
the body) could be the output.
Even something as intangible as
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In a normal brain, the hippocampus sends signals to the motor cortex with increased duration of an activity (such as
running). These signals tell the motor cortex to signal the body to stop performing the activity. Original image by Sierra
Smith. Created in BioRender

time can reasonably be an input
into a functional system due to
the hippocampus (the structure
that Diane lost), which allows us
to register and remember time
passage. If we think of the hippocampus as “consuming,” or “taking in” time as an input, how does
mental exhaustion manifest as an
output? A recent study performed
functional brain imaging on people given tasks that induce mental
exhaustion, which allowed them
to examine the participants’ brain
activity during these tasks (10). The
authors found that with increasing
duration of mentally exhausting
tasks, there was a decrease in the
activation of the motor cortex
of the brain (among many other
structures) (10). The motor cortex
allows us to execute movements,
and forms connections with the
hippocampus (11). This suggests
that as time is “input” into the
hippocampus, the hippocampus
could be sending signals to decrease the activity of the motor
cortex and cause the feelings and
impulses we associate with mental
exhaustion. This correlates mental
exhaustion with decreased physical ability, and could explain the
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feeling of “I’ve been doing homework for 4 hours, and I now feel
physically incapable of writing the
answer to another question.”
What happens then, if your
body cannot intake time into this
feedback loop — if your internal
clock essentially “stops?” A method through which the perception
of time could be disrupted is
through changes to the hippocampus. The hippocampus helps
us determine the amount of time
that has elapsed while performing
a task. It is often credited with (at
least in part) regulating our perception of time due to its ability
to store memories in sequential
order. This is where we turn our attention back to Diane Van Deren.

Time Warp
Time loosely exists in Diane’s universe ever since she lost
a portion of her hippocampus. To
Diane, hour 8 of a run feels like
minute 8, and in interviews, she
describes never knowing how long
she’s been running during an ultramarathon (1). If Diane is unable to
receive the input of time into her

hippocampus, this could reduce,
or even eliminate her ability to feel
mental exhaustion. In an endurance event like an ultramarathon,
this is wildly beneficial. Given that
Diane has always been a high-level
athlete (even prior to her brain surgery), she likely has so much physical training that she experiences
less physical exhaustion during a
long run than the average person.
Similar to other ultramarathon runners, Diane’s endurance training
limits the amount of lactic acid that
accumulates in her muscles and
slows her down. On top of this, if
she does not have the barrier of
mental exhaustion to deter her
from completing a time-intensive
activity, she now has the ultimate
combination of features to elevate
her ability to run long distances.
This could uncover the mystery of
Diane’s superhuman running ability.
While Diane’s running ability seems to be enhanced by her
lack of hippocampus, this severely
contradicts findings from studies of
other ultramarathoners. There are
challenges in studying what exactly makes an elite athlete an elite
athlete (it is hard to discern what is
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Your Brain
on Running

Highlighted regions of brain images show areas of increased gray
matter volume (neuron volume) in endurance runners compared to
healthy control subjects. The left hippocampus in endurance runners
was found to have greater gray matter volume, which is correlated
with greater use of this brain region. Figure adapted from ‘Structural
and functional brain signatures of endurance runners,’ from Cao, L.
et al. (2021). Brain Struct and Funct, licensed under CC BY 4.0

an innate ability vs what has been
acquired through years of training). However, numerous studies
have attempted to find neurological commonalities between elite
athletes that could potentially
explain their distinction. Over the
past several years, research groups
have examined brain morphology
differences (differences in the sizes
of certain brain regions) between
marathon runners and healthy,
non-runners (12). These studies
have found that the hippocampi
of the ultramarathon runners have
a greater volume — which can
indicate an increase in neurons
(and potentially use) of this portion
of the brain (12). Additionally, in
a study of a type of mouse bred

to have higher running capacity
than a standard mouse, scientists also found greater activation
of the hippocampus of the high
running capacity mice while they
were running compared to normal
mice (13). Numerous other studies
demonstrate a correlation between endurance aerobic exercise
and an increase in neuron growth
in the hippocampus, positively
associating the hippocampus with
endurance activities (14). However,
this makes Diane Van Deren’s case
even more puzzling — how can
the hippocampus be a prominent
feature in the brains of endurance athletes if one of the most
competitive endurance athletes is
missing it?

This link between increased
hippocampal size, increased
hippocampal activation, and
increased hippocampal neurogenesis from endurance athletic
activities may say more about
what running is doing to the brains
of endurance athletes, rather
than what their brains are doing
for their running. For endurance
events — especially those like outdoor running and cycling that involve navigation — it is logical that
the hippocampus would be highly
activated throughout the competition. Since the hippocampus plays
a large role in spatial memory and
navigation, activation of this brain
region to have a strong grasp of
the course of the race would likely
occur. If you’re running up the
side of a mountain, it’s helpful to
know what direction you should
be heading in. In short, the hippocampus plays an important role
in the brain, and thus its presence has persisted in the brains
of athletes and non-athletes alike
over the course of evolution. This
being said, while the hippocampus is intensely utilized by people
performing tasks where it could be
of aid, this does not mean that the
hippocampus causes someone to
become a better runner. Becoming
a better endurance athlete can
increase the size and activation
level of the hippocampus, but this
doesn’t mean that this state of the
hippocampus greatly influences
their athletic performance(12).

Lost
When asked in an interview if she believed her hippocampal loss gives her a leg up in
ultra-running, Diane replied that
she doesn’t believe having a brain

8
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“Trail Running Forest” by natachagagnekinesiolog, https://pixabay.com/photos/trail-running-forest-woods-6497875/
Available under CC0

injury gives her an edge on her
competitors(1). While it is easy to
hear about all of her athletic accomplishments and focus on how
hippocampal loss could increase
Diane’s running capacity, Diane
is forced to confront the other
consequences of missing a region
of her brain. Given how intricately
involved the hippocampus is with
memory, Diane reports struggling
with remembering the names of
people she has met, or remembering to pick her children up from
school. Maps appear like gibberish
to her, as her brain can no longer
interpret spatial directions and information correctly. Looking even
at how her brain surgery has negatively impacted her running, Diane
talks in interviews about getting
horribly lost during dangerous
ultra-marathons (1). She laughs,
saying that her competitors know
better than to follow her on trails
now (1). In the Yukon 300 race (the
430-mile race she finished in the
Yukon territory), Diane describes
getting lost for over an hour in the
frozen tundra. She found strate-
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gies to combat this issue, such
as bringing pink ribbons to drop
along her path during a race so
she can retrace her steps in case
she gets lost, but this impedes her
running, and daily life (1). While
hippocampal removal could have
greatly increased Diane’s mental
endurance, the effects are not
purely beneficial. Diane has simply
learned to work around her injury.

What’s on your
mind?
Stories like Diane van
Deren’s offer a better understanding of the intricacies of the brain,
and cause us to reflect on how we
view extreme endurance or athletic ability. It raises the question of
whether we are emphasizing the
correct strategies when training
endurance athletes. You can easily
call to mind what is associated
with athletic training — fast-paced
running workouts, weight lifting,
etc., all of which have an empha-

sis on increasing physical fitness,
and ultimately physical endurance.
Less emphasis is explicitly placed,
however, on how to increase mental endurance. If Diane van Deren’s
incredible athletic ability is the
result of a combination of superior
physical AND mental endurance,
this makes the argument that increasing mental endurance should
be focused on just as much as
physical endurance when training
for competition. Disclaimer: this
is not advocating in any way for
anyone to have their hippocampus
carved out of their brain to improve their athletic performance.
However, if people could learn
strategies that disrupt their ability to perceive time during long
activities, this could be beneficial
for athletes and non-athletes alike!
Whether you’re running 50 miles,
or simply trying to remain attentive
throughout a long conference call,
developing strategies to make
yourself neglect the passage of
time could improve your ability to
persist through monotonous daily
activities.
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How the Bacteria in Your
Gut May Calm the
Butterflies in Your Stomach
By Hailey Naiper

T

his weekend I attended a wedding. On the
morning of the ceremony I ate breakfast with the bride
and some of her family members.
She was so nervous that all she
could stomach was a piece of
toast and a few nibbles of bacon.
To help calm her down, we decided to go around the table listing
other stressful things she’d done
that went well. She’d performed in
multiple musical theater productions, she’d made presentations
to critical audiences of powerful
people, she’d taken many difficult
tests, she was even once dragged
across a lake by a runaway capsized sailboat. Comforted by the
reminder that she had succeeded
before, she finished her breakfast.
A few hours later she walked down
the aisle, and she looked beautiful,
despite her fears that she’d trip
and fall over or appear disheveled.
Whether or not you’ve
gone through the nerve-wracking
process of planning a wedding,
you’ve probably experienced a
similarly stressful event in your life.
Perhaps you were in the spelling
bee as a child, or you climbed up
a tall tree to rescue a cat. Maybe
you’ve had to complete a project on a tight deadline or you’ve
experienced meeting a significant
other’s family. Recently, we’ve all
been experiencing sustained levels
of high stress, apart from these
isolated stressful incidents. In the
past two years, stress has become
increasingly present in day-to-day
life, be it from the COVID-19 pandemic, increased racially-targeted
violence, economic hardship, or
growing political partisanship. Last
year, the American Psychological Association deemed stress in
America a “national mental health
crisis”. In a survey conducted in
August 2020, 67% of adult respondents said they had experienced
increased stress during the course
of the pandemic (1). Increased
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stress seems to be impacting
younger generations more. From
2018 to 2020, Gen Z adults (born
between 1995 and 2001) have
consistently reported higher
average levels of stress than the
average stress levels reported by
adults as a whole (1). This concerning fact indicates a possible upward trend in stress overall as we
move into the future, suggesting
that stress is a health concern that
will necessitate increasing attention in coming years. Furthermore,
long term stress, such as that
Gen Z adults appear to be facing,
can result in more severe mental
health issues such as depression
and anxiety, which can negatively
affect them for the rest of their
lives. Indeed, Gen Z adults also
report higher rates of stress than
the general adult population. This
worrying trend means that stress
and anxiety will likely become a
more significant problem among
the general population, and this
doesn’t show signs of slowing.

Anxiety vs. Stress:
What’s the
Difference?
Although they are related,
stress and anxiety are two distinct phenomena. While stress is
your body’s response to a present
threat, anxiety is a response to a
threat that isn’t actually there. For
example: if you see a tiger in the
woods, your heart rate will increase and you will experience the
“fight or flight” response associated with stress. Prolonged stress
oftentimes leads to anxiety, particularly after the threat ceases to be
an active danger. If you’ve been in
a jungle filled with tigers for many
years, you may still have anxiety
about tiger attacks if you move to
New York City.
According to the Anxiety
and Depression Association of

America, anxiety affects about 40
million adults in America alone
each year. That’s 18.1% of the
adult US population (2). Anxiety
can develop as a result of many
interacting factors including genetics, life events, and brain chemistry.
In the body, anxiety and
stress are most closely linked to
the hypothalamic-pituitary-adrenal
axis, or the HPA axis. The HPA axis
is a communication system between the hypothalamus (a region
of the brain that is involved in
integrating body information and
producing broad responses), the
pituitary gland (a small structure
that kind of looks like a pea sitting
on the bottom of the brain, which
is involved in hormone secretion),
and the adrenal glands (small
organs located on top of the kidneys that also produce hormones)
(3). The HPA-axis is in charge of
assessing threats and producing
hormones like cortisol, the primary
stress hormone, which speeds up
your heart rate and prepares that
“fight or flight” response (3, 4).
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Stress Specifics
A system called the HPA axis controls the stress
response, also known as the fight or flight
response. When you experience a stressful
situation, a part of your brain called the hypothalamus secretes a hormone called CRH. CRH
causes a gland in your brain, the anterior pituitary gland, to secrete another hormone called
ACTH. ACTH then travels through your blood
and prompts the adrenal gland to secrete cortisol, which produces the effects we associate
with stress.

The Gut-Brain Axis and the
Gut Microbiota
Long term, or chronic, stress signaling
from the HPA-axis can have many negative effects throughout your body, including increased
risk of heart disease, memory impairments,
depression, and gastrointestinal distress….
yes, you read that right, stress in your brain can
affect your gut (3, 4, 5)! Recent studies have
shown that the brain and gut communicate with
each other via a pathway known as the gutbrain axis (6–8). Chronic stress signaling from
your brain can lead to imbalances in the bacteria in your gut, as well as increased inflammation and dysfunction of gut tissues, which can
promote gastrointestinal diseases like irritable
bowel syndrome (5).
Gut-brain communication is a two way
street though, so your gut is also able to signal
to your brain (9). Many hormones and neurotransmitters that are used in your body are
produced in your gut. Tryptophan, for example,
is an essential amino acid that we use to make
proteins and neurotransmitters. Our bodies,
however, are unable to produce tryptophan, so
we can only get it from foods that we eat. Eggs,
cheese, and nuts, for example, are all foods
that contain high levels of tryptophan (7). After
we consume these foods, they are broken down
by enzymes in our stomachs and filtered into
the small intestine. Many microorganisms reside within the small intestine, making up what
is known as the gut microbiota. The microbiota
aids in the digestion of proteins like those in
eggs, cheese, and nuts, producing tryptophan.
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HPA Axis. Original image by Hailey Naiper.
Created in BioRender
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The Gut-Brain
Axis and the Gut
Microbiota
Gut-produced tryptophan
is then either shuttled into the
bloodstream or used to make other molecules, such as melatonin
and serotonin. Serotonin is an
important neurotransmitter involved in mood, sleep, and eating.
Low levels of serotonin are closely
connected to anxiety, and drugs
that increase the amount of available serotonin in the brain, such
as selective serotonin reuptake
inhibitors (SSRIs), are frequently
used to treat anxiety (7). Cells and
bacteria within the gut make up to
95% of your body’s serotonin, but
since serotonin is unable to cross
the blood-brain barrier, the brain
has to produce its own supply
using tryptophan transported in
the blood (9). The brain is therefore dependent on gut supplies
of tryptophan which it needs to
generate serotonin. If you were to
stop eating tryptophan-containing foods, for example, your brain
would no longer be able to produce any serotonin, which would
certainly be very harmful to your
mental health.

fiber is plant material that can’t
be digested by human stomach
enzymes. You may have heard that
fiber is important for regulating
bowel movements, that’s because
it increases the size and weight of
stool, but also softens stool so it’s
able to move smoothly through
the large intestine. Dietary fiber is
important for more than just poop
though! It also lowers blood sugar
and cholesterol, and helps prevent/combat stroke, heart disease,
diabetes, and obesity (11).
Since dietary fiber can’t be
digested in the stomach, it continues along through the small intestine with the other non-digestible
foods and some waste products.
The next stop of the journey is the
large intestine. Like the small intes-

tine, the large intestine is home to
many different types of bacteria
that feed on the pieces of food
we’re unable to digest.
Some of these bacteria
break down dietary fiber, producing short chain fatty acids, which
are relatively small molecules with
many very important functions.
Although we still don’t understand
everything they do, studies have
shown that short chain fatty acids
decrease inflammation, mediate
brain development, and have the
potential to alleviate the symptoms of many illnesses, from depression to Alzheimer’s to Parkinson’s disease (8, 12, 13).
From the gut, many short
chain fatty acids diffuse into the
bloodstream where they have

The Relaxing
Journey of Dietary
Fiber
Let’s follow another nutrient to
get a better understanding of how
the gut can influence stress in the
brain specifically. We’ll begin the
journey with a snack: hummus
with carrots and whole grain pita
bread. Each of these foods contains dietary fiber, which is another
important nutrient we can only get
from the things we eat. Dietary

From Peanuts to Serotonin
After you eat peanuts, the protein is extracted by enzymes in your stomach. This protein is then converted to tryptophan by bacteria in your small
intestine. The tryptophan travels to your brain, where enzymes make it
into serotonin.
14
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broad effects on many organs
throughout the body (8). In the
nervous system, short chain fatty
acids have been shown to decrease stress signaling in the HPA
axis (14). These discoveries are
still very new, and it’s unclear how
SCFAs are able to lower stress
signaling. The authors of one
study suggested that short chain
fatty acids might activate receptors
in the nervous system that send
signals to decrease HPA axis activity (14). Recent studies have also
demonstrated that increasing short
chain fatty acids levels (which can
be accomplished by eating more
dietary fiber-rich foods) can decrease levels of the stress-related
hormone, corticosterone (14). They
can also reduce some of the other
effects of chronic stress, including
heart disease (16).

Depression in the Gut
Depression is a mental
health disorder that may result
from a combination of gut bacteria
imbalances, short chain fatty acid
deficits, and prior experiences
with chronic stress. Depression is
characterized by feelings of hopelessness and lack of motivation.
You likely know someone who
suffers from depression. About
21.0 million people experienced a
major depressive episode in 2020,
as reported by a survey of the US
population conducted by the National Institute of Mental Health in
2020 (15).
A prominent physiological
feature of depression is a higher
level of full-body inflammation
than non-depressed individuals.
Some scientists speculate that this
inflammation may at least in part,
be driven by the gut. Imbalances
in gut bacteria in depression tend
to favor inflammatory pathways.
At the same time, gut dysregulation can lead to a ‘leaky’ gut
wall, where the cells that line your
intestines become less tightly
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regulated, letting some molecules
that would normally remain in the
gut sneak into the body. Cytokines
are immune system molecules that
tend to increase inflammation. The
combination of increased inflammatory signaling and increased
gut ‘leakiness’ means that cytokines can infiltrate the rest of the
body, increasing general levels of
inflammation, particularly in the
brain (8, 13).
A high-fiber diet offers a
possible treatment in this situation
as well. Short chain fatty acids are
known to be beneficial for targeting some of the effects of depression on the brain, again in ways we
don’t yet fully understand. They
also seem to decrease the ‘leakiness’ of the gut, keeping cytokines
and other gut-molecules from
reaching other parts of the body
(8, 13). Short chain fatty acids may
even act to decrease the production of cytokines, limiting inflam-

mation at the source (8, 13).

The American Health
Crisis
Maintaining a healthy level
of fiber in your diet is possibly
an important tool for combating
stress, anxiety, and depression,
but adults in America still fail to
consume even half of the recommended amount of dietary fiber
per day. Adult women should eat
about 25 grams of dietary fiber per
day, while adult men should eat 3
grams (15). To put that into perspective, you’d be getting about
36 grams of dietary fiber if you ate
whole grain toast with peanut butter for breakfast, veggie chili for
lunch, a granola bar for a snack,
and a burrito bowl with spinach
and brown rice for dinner.
When we think of eating
healthy, we tend to associate it
with physical strength and well-

The Mediterranean Diet vs. the Western Diet
The Mediterranean diet is primarily made up of fruits, vegetables, and
whole grains, with small amounts of meat and other animal products. The
Western diet is composed primarily of high-fat and high-sugar foods as well
as animal products, with little focus on fruits and vegetables.
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being. Similarly, when we think
of sugary, high fat foods, we link
them to negative impacts of cholesterol and diabetes. While it’s
true that these are also impacts of
poor dietary health, it’s becoming
clear that the modern western diet
is detrimental to our brains as well
as our hearts, bridging the gap between mental and physical health.
Over the past century, food
in the United States had experienced a precipitous decline in
fiber content while simultaneously
becoming exceedingly sugary. At
least partly due to this dramatic
decrease in general nutritional
value, America has seen increases in obesity, diabetes, and heart
disease, coupled with a hidden
depression, stress and anxiety
epidemic. It has taken the onset
of multiple traumatic stressors
including social isolation during
pandemic lockdowns, a polarizing presidential election, and
increased racially and politically
motivated violence, for the impacts of our poor health practices
to be realized. The American Psychological Association is missing
the full picture when they refer to
America’s “mental health crisis”.
Separating mental health into its
own bucket (as something that is
not treatable in the same ways one
might combat high blood pressure) is simplistic and dangerously
impacts the ways we assign blame
when discussing mental health, as
well as the tools that we use to fix
it.
As our cultural understanding of mental health stands currently, the blame for mental health
disorders is placed on the person
experiencing them, instead of the
culture that has worked to foster
poor mental health practices. Shifting our consideration of mental
health towards the way we view
physical health will give people
experiencing mental health difficulties agency for treatment, while

simultaneously shifting the burden
of responsibility off of them. That
said, it’s important to remember
that, just as some physical diseases
are genetic and therefore cannot
always be cured with simple methods like changing diet, mental
health illness is often complicated
and driven by more nuanced factors than diet and exercise alone,
although both are contributors to
overall health.

The Mediterranean
Diet Fix
With this caveat in mind,
the Mediterranean diet may present a solution to the health crisis
brought on by the Western diet. In
order to follow the Mediterranean
diet, consider adding these tips to
your meal planning:
Eat Frequently: fruits, vegetables,
legumes, whole grains, nuts, and
seafood
Eat in Moderation: poultry, eggs,
and dairy products
Eat Rarely: red meat, candy, soda,
processed foods, and added sugars
Focusing on consumption
of fruits, vegetables, and legumes
as opposed to red meat and
processed sugar, the Mediterranean diet provides a framework
for increased dietary fiber intake
relative to the Western diet. The
constant availability and relatively
low cost of vegetables and beans
furthermore makes the Mediterranean diet easy to integrate into
your lifestyle. High in fiber and
nutrients that support gut microbiome health, the Mediterranean
diet therefore also supports brain
health. It is furthermore low in
refined sugars and saturated fats,
decreasing risk of diabetes and
heart disease. Example meals
include:

Chickpea pasta
with sweet
potatoes,
cauliflower, olive
oil, and garlic
Preheat the oven to 425
degrees Fahrenheit. Cube
the sweet potatoes and
cut or break the cauliflower into small pieces. Toss
the veggies with olive oil
and roast until tender.
Meanwhile, cook the pasta
according to the directions
on the package. Mince the
garlic while the pasta and
sweet potatoes are cooking, then combine with a
few tablespoons of olive
oil and salt. When the pasta and veggies are finished
cooking, toss the veggies
with the pasta and add the
garlic/olive oil mixture. Finally, add salt and pepper
to taste. Serve hot.

“Pasta with Chickpeas” by Pug Grill.
Flickr.
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Caprese sandwich
on whole wheat
bread
Cover one side of one slice
of whole wheat bread with a
thin spread of pesto or pesto mayonnaise. Layer sliced
tomato, arugula, mozzarella
cheese on top of the bread
and close with another slice
of whole wheat bread. Grill
on the stove or panini press.
Serve hot.

“Caprese sandwich” by Dana McMahan. 2009. Flickr

Salmon with
brown rice and
asparagus
Cook rice according to
package directions. Preheat the oven to 450
degrees Fahrenheit. Season the salmon with salt
and pepper. Roast until
cooked, approximately
12-15 minutes. Coat the
bottom of a frying pan and
warm it on the stove. Prep
the asparagus by snapping
the ends off. Toss in salt,
pepper, rosemary, and
olive oil. Saute until soft.
Serve hot.

“Planked Alaskan salmon and asparagus” by WordRidden. 2010. Flickr.
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All recipes developed by Hailey
Napier.
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Making simple changes,
like incorporating more plantbased foods in your diet can
potentially have positive effects
on your health, even if you don’t
make a full conversion to a Mediterranean diet or similar meal
planning structure. Changing just
a small part of your diet has the
potential to dramatically improve
the balance of bacteria in your gut,
resulting in broad health impacts,
including increased serotonin
production and decreased stress
signaling. These alterations can
do more than just make you feel
happy, they can also help you to
maintain regular sleep patterns,
strong memory, low cholesterol,
low blood pressure, and can lower
your chances of developing obesity or diabetes. All of these factors
likely work together to lower your

body’s overall stress, and improve
your general quality of life.
As life returns to a version of normal, it’s important to
remember that the effects of the
COVID-19 pandemic on the collective mental health of our world will
continue to impact us going forward. The chronic stress we have
all experienced over the past two
years has changed us in ways that
will continue to affect our mental
and physical health for the rest of
our lives. In coming years we may
see higher rates of depression
and anxiety, and we need to pay
attention to these mental health
difficulties. We have learned to be
particularly cautious about spreading disease to others, we sanitize
our hands and take days off work
if we get sick with the flu, and
it’s important to remember to be

kind and understanding of mental
health in the same way, both towards others and ourselves. Many
people have developed tools to
maintain mental health during the
pandemic. Some of these include
regular outdoor exercise, new hobbies, therapy, meditation, or cooking healthy meals. It’s important to
continue integrating these tools
after we return to a more normal
life in order to continue caring for
ourselves in the aftermath of a
chronically stressful event.
If you or a loved one are experiencing stress, anxiety, or depression, seek professional help.
The National Suicide Prevention
Hotline is 800-273-8255 if you find
yourself in immediate distress.

“Brain for everybody” by Ars Electronica. 2013. Flickr.
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A Controversial New Hope
Exploring recent advancements in Alzheimer’s disease treatment
By Lauren Limbach
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The Aduhelm
Controversy

M

ost people would
probably acknowledge that they’ve
made a mistake at work from time
to time. This is what happened
to *Joe, a successful industrial
researcher, who one day noticed
that he had made a calculation
error while at work. But this wasn’t
an isolated incident, these types
of calculation errors kept happening with increasing frequency.
Eventually the repeated mistakes
forced him to step away from a
job in which he used to thrive. This
trend continued for several years,
causing him to bounce from job
to job, before he was eventually
fired and became unemployed.
But the changes that Joe experienced weren’t limited to mistakes
at work. Joe began having difficulty navigating places he had been
many times before, and eventually
he lost the ability to perform many
basic tasks such as maintaining
personal hygiene [1]. Based on
these symptoms, you may not be
surprised to learn that Joe was
eventually diagnosed with Alzheimer’s disease (AD). However what
may be surprising is Joe’s age: he
was diagnosed with AD at the age
of 37 [1].
Alzheimer’s disease (AD) is
a neurodegenerative disease characterized by drastic deteriorations
in a patient’s cognition, memory
and overall function — all of which
were observed in Joe’s case [2].
AD also imposes large financial
and emotional burdens on families
and caregivers, and often necessitates entry into a nursing home [3].
The vast majority of AD diagnoses
are made in elderly individuals,
while a smaller number of cases
like Joe’s are diagnosed early in
life [2]. Over 6 million Americans
are currently living with AD, yet AD
is not often a topic of daily conversation despite the widespread and

devastating effects imposed by the
disease [3].
However, in the summer of
2021, AD was frequently featured
in media headlines because of
the US Food and Drug Association’s (FDA) decision to approve
Aduhelm: an innovative new drug
designed to treat AD. Despite being the first AD drug approved in
twenty years, the media coverage
of Aduhelm’s approval was largely negative. Confusion over the
drug’s efficacy and the basis for
the FDA’s decision overshadowed
what could have been a victory
for everyone involved in the fight
against AD. Shortly following
the approval of Aduhelm, stories
detailing the departure of several
members of the FDA’s advisory
board began circulating in the
news. These individuals cited their
disagreement with Aduhelm’s
approval as the motivating factor
behind their departure from the
FDA, stirring public intrigue as to
whether or not the FDA’s decision
was a sound one [4]. After the
board members’ departure, the
acting FDA commissioner initiated
an external investigation into the
proceedings that led to Aduhelm’s
approval [5]. The acting commissioner stated that the primary
motivation for launching the investigation was to reestablish public
confidence in the FDA approval
process [5]. However, launching
the external investigation fueled
the fire of public speculation that
something was amiss in regards
to Aduhelm’s approval. What
followed over the next several
weeks was an onslaught of attention-grabbing headlines such as:

“New Alzheimer’s drug could
cost the government as much as
it spends on NASA”
- New York Times
Overall, the media coverage of Aduhelm painted the drug
as an uninspiring advancement
in AD treatment, and a potential misstep by the FDA. Many
articles questioned the efficacy
of Aduhelm [6], [7], and others
highlighted the high price tag
associated with the drug [8], [9].
Some characterized the rollout of
the drug as unsuccessful and cited
numerous reputable hospitals and
insurance companies who were
choosing not to prescribe or cover
Aduhelm [10], [11].
Additionally, in October of
2021 the biotechnology company Eli Lilly filed for FDA approval
of their new Alzheimer’s drug,
Donanemab, which is mechanistically quite similar to the controversial Aduhelm drug [12], [13], [14].
This raises the question of whether
or not the FDA will grant approval
to an AD drug similar to Aduhelm
after the backlash that resulted
from their original approval. The
Aduhelm controversy and recent
developments with Donanemab
highlight the importance of investigating the biological basis of AD,
as well as how these treatments fit
into our current understanding of
AD.

“How Aduhelm, an unproven
Alzheimer’s drug, got approved”
- New York Times
“FDA Approved Biogen Alzheimer’s Drug Despite Some Staff
Concerns”
- Wall Street Journal
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Are amyloid-β
proteins the
underlying cause of
AD?
For the last several decades, the most commonly accepted explanation for AD has been
the amyloid-β hypothesis: AD
symptoms arise due to aggregations of amyloid-β proteins in the
brain [15]. According to the biological definition of AD, the buildup of amyloid-β proteins is a necessary precursor for an individual
to be diagnosed with AD [16]. Amyloid-β proteins are derived from
the breakdown of the amyloid precursor protein (APP): a protein that
is found in neurons and that plays
an unknown role in their growth
and survival [17]. APP is normally
broken down by an enzyme called

the α-secretase (Figure 1), [17]. The
breakdown of APP by α-secretase
produces benign byproducts that
do not contribute to AD pathology [17]. However APP can also
be broken down by two different
enzymes, β-secretase and γ-secretase, which yield slightly different
products than those produced by
the normal pathway (Figure 1),
[2]. Among those products are
amyloid-β proteins [2]. The physical properties of these amyloid-β
proteins make it easy for them to
combine into clumps, referred to
as insoluble plaques or fibrils [17].
Amyloid-β plaques are arguably
the most prominent feature of
AD pathology, and are thought to
underlie the cognitive and behavioral abnormalities associated with
AD [2]. Research has suggested
that the balance between the two
pathways for breaking down APP is
different in AD patients compared
to non-AD patients, leading to

increased production of amyloid-β
in AD patients [2].
If there is so much evidence that amyloid-β is the underlying cause of AD, then why have
the collective efforts of researchers
around the globe not resulted
in an amyloid-β-clearing treatment capable of curing AD? And
why are there studies circulating
saying that the severity of amyloid-β plaque buildup isn’t even
predictive of the severity of AD
symptoms [2]? There are several
viable theories for why this is the
case. Some scientists think that the
initial presence of amyloid-β proteins, rather than the quantitative
buildup of amyloid-β over time,
triggers a chain of events that
leads to the clinical symptoms of
AD [2]. In this scenario the quantitative extent of amyloid-β buildup
would not predict symptom severity because the symptoms would
not result from amyloid-β aggrega-

Figure 1. Possible pathways for APP breakdown. Original image by Lauren Limbach. Created in BioRender.
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Figure 2. “Biogenesis of types 1 and 2 Aβ oligomers in the brain” by Karen Hsiao Ashe is available under CC
BY-NC 4.0. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984270/)
tion, but would instead result from
meree amyloid-β presence [2].
Should this theory be true, amyloid-β-clearing drugs would likely
prove ineffective in alleviating the
symptoms of AD once the initial
presence of amyloid-β triggered
the ensuing downstream effects
[2]. A second theory suggests that
only a subset of amyloid-β proteins
are AD-causing agents, and that
the clinical symptoms of AD are associated with the quantity of these
particular amyloid-β subtypes, as
opposed to amyloid-β aggregation
as a whole [2]. If this is the case,
amyloid-β-based treatments for
AD would only be effective if they
target the specific disease-causing
subtypes of amyloid-β [2].
In fact, recent developments in AD research support the
hypothesis that not all amyloid-β
buildup plays an equal role in AD

pathology. Most AD pharmaceutical trials target insoluble amyloid-β: clusters of amyloid-β oligomers that form a plaque or fiber
[18]. However another form of amyloid-β, soluble amyloid-β oligomers, may be wreaking the most
havoc in the brains of AD patients
[18], (Figure 2). Soluble amyloid-β
oligomers are smaller and more
mobile than amyloid-β plaques,
and appear to be more toxic than
insoluble amyloid-β oligomers [2].
If this is the case, the many unsuccessful attempts to treat AD by
dissolving amyloid-β plaques may
be due to the fact that the soluble amyloid-β oligomers, rather
than the insoluble plaques, are to
blame for AD symptoms [18].
So what do scientists think
are the effects of soluble oligomers and how do they lead to the
devastating clinical symptoms of

AD? They are perhaps implicated
in the ability to form memories.
Memory formation is a complex
process, and its loss is perhaps
the most commonly recognized
symptom of AD. Memory formation relies on a complex molecular
process called long-term potentiation in which the connections between certain neurons in the brain
are strengthened over time [19].
Soluble amyloid-β oligomers are
capable of altering the proteins
on the exterior of neurons, which
can prevent long-term potentiation from taking place (Figure
3), [19]. The hindrance of longterm potentiation in AD patients
by soluble amyloid-β oligomers
would provide a powerful explanation for the memory loss and
cognitive deficits experienced by
AD patients. Furthermore, overall
cognitive functioning is dependent
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Figure 3. Downstream effects of amyloid-β proteins. Original image by Lauren Limbach. Created in BioRender.
on timely and accurate communication between neurons. This
occurs via the release of small
biological containers called synaptic vesicles that contain messenger
molecules called neurotransmitters
[19]. Soluble amyloid-β oligomers have been demonstrated to
interact with many of the proteins
involved in synaptic vesicle generation and release, providing a
potential pathway through which
amyloid-β oligomers may interfere
with neuronal communication and
as a result, cognitive functioning
(Figure 3), [19].

Neuroinflammation
in AD
Recently there has been
an increased focus on the link
between amyloid-β aggregation
and neuroinflammation, as well as
what role this relationship plays in
AD pathology. Neuroinflammation
occurs when the brain’s immune
system is activated in response to
a threatening stimulus such as a
foreign pathogen [17]. Neuroinflammation is mediated by microglia: a group of cells within the
central nervous system (CNS) that
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are responsible for defending the
brain and spinal cord from exterior
threats [17]. Microglia are essential
for maintaining stability within the
CNS, and as such, microglial and
neural immune dysfunction have
been speculated to play a role in
AD [17].
Microglia are responsible
for clearing amyloid-β following
its secretion from neurons [17]. It
is important for amyloid-β to be
broken down soon after its release
because its molecular makeup
makes it easy for it to assemble
into oligomers and plaques [17].
The delicate balance of amyloid-β secretion and removal can
be upset and result in amyloid-β
accumulation if neurons increase
their production of amyloid-β to
the point where the microglia can’t
keep up [17].
When microglia detect a
threat in the environment, they
enter a distinct activated state and
release molecules called proinflammatory cytokines that promote
inflammation and other immune
responses [17]. Microglia contain
receptors capable of identifying
amyloid-β in their environment,
meaning that microglia become
chronically activated following

amyloid-β accumulation [17]. This
chronic activation causes microglia
to release copious amounts of the
proinflammatory cytokines TNF-α
and Il-1β, which have been found
in higher levels in the brains of
AD patients [17]. While microglial
activation and proinflammatory
cytokine release may be helpful
following exposure to an isolated
pathogen, the long-term continuation of these responses is damaging to the brain [17]. Elevated
TNF-α and Il-1β levels have been
associated with declining cognitive
abilities, suggesting a direct role
for neuroinflammation in a hallmark characteristic of AD clinical
pathology [17]. Neuroinflammation
may also increase the severity of
AD pathology in patients because
there is a positive feedback loop
between neuroinflammation and
amyloid-β production: neuroinflammation activates the enzymes
that generate amyloid-β, increasing its accumulation in the brain
over time [17]. However, the
precise role that neuroinflammation plays in AD pathology remains
unclear, making it a promising area
of future research — particularly as
the search continues for effective
treatments for AD.
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Current treatments
for AD
The Alzheimer’s Association website breaks down the
currently available pharmaceutical treatments for AD into two
broad categories: “Drugs that may
change disease progression” and
“Drugs that treat symptoms” [20].
Aduhelm is the only drug that is
acknowledged to potentially possess the ability to change disease
progression of AD. The other
drugs may be effective at addressing the symptoms of AD, but have
no effect on the eventual advancement of the disease. These symptom-oriented drugs fall into four
classes: cholinesterase inhibitors,
glutamate regulators, cholinesterase inhibitor + glutamate regulator
combinations and orexin receptor
antagonists [20]. The drugs in each
category mitigate AD symptoms
by targeting neurotransmitter
systems that are disrupted in the
brains of AD patients. Therefore,
these drugs attempt to remedy the
downstream effects of amyloid-β
aggregation, rather than directly
addressing amyloid-β aggregation
itself.

Cholinesterase inhibitors,
one class of symptom-oriented AD
drugs, prevent the breakdown of
the neurotransmitter acetylcholine
[21]. The acetylcholinergic system
is integral to memory formation,
and AD-associated memory loss
likely partially results from decreased acetylcholine production
due amyloid-β aggregation [22].
Furthermore, decreased acetylcholine activity may increase the
formation of amyloid-β plaques
[22]. Cholinesterase inhibitors
that increase acetylcholine activity therefore not only address the
shortage of acetylcholine that results from amyloid-β formation, but
may slow the pace of amyloid-β
accumulation by elevating acetylcholine activity. Clinical trials have
demonstrated that cholinesterase
inhibitors are capable of improving
the cognitive abilities and overall
functioning levels of AD patients,
albeit to a limited extent [22], [21].
In addition to the acetylcholine system, another neurotransmitter system associated
with AD pathology is the glutamate system. Amyloid-β affects
glutamate activity in an opposite
manner than it does acetylcholine. By blocking the reuptake of

glutamate molecules back into
neurons, amyloid-β aggregation
leads to an excess of glutamate
that continually activates neuronal
glutamate receptors (Figure 3)
[19]. Overactivation of glutamate
receptors can lead to changes
in gene expression that impact
cell functioning and survival [19].
Glutamate regulating drugs designed to treat AD block neuronal
glutamate receptors, thus preventing the buildup of glutamate from
overactivating glutamate receptors [23]. Similar to cholinesterase
inhibitors, glutamate regulators
are capable of improving cognitive
and global functioning levels to a
limited extent in AD patients [23].
Glutamate regulators are often
prescribed in addition to cholinesterase inhibitors [23]. Simultaneous
treatment with both classes of
drugs may improve outcomes by
addressing the separate effects
of amyloid-β aggregation on two
different neurotransmitter systems.
The other drug category listed on the Alzheimer’s
Association website consists of
orexin antagonists. Orexin is a
neurotransmitter responsible for
keeping individuals awake and
alert [24]. Its role in AD is support-

“Brain Inflammation from Alzheimer’s Disease” by NIH Image Gallery. 2017. Flickr.
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ed by the fact that patients with
moderate to severe AD exhibit
increased orexin levels compared
to patients with mild AD [24].
Furthermore, AD patients often
exhibit abnormal sleep/wake
cycles, including insomnia: the
primary AD symptom that orexin
antagonists are designed to treat
[24]. Orexin dysregulation and
amyloid-β aggregation also appear
to be connected. Blocking orexin
activity reduces amyloid-β levels,
suggesting that orexin influences
amyloid-β dynamics, although the
precise nature of this relationship
remains unknown [24].
The current treatment
options available to AD patients
attempt to address the symptoms
of AD through a variety of pharmaceutical methods targeting different neurotransmitter networks.
While these treatments may have
positive impacts on the patient’s
cognitive and functional abilities,
or delay the patient’s entry into a
nursing home, they do not address the underlying causes of AD,
and therefore do not represent a
cure. The only drug that currently
targets the underlying biology of
AD is Aduhelm. However, even the
Alzheimer’s Association website
states that Aduhelm “may change
disease progression,” indicating
that a lot of uncertainty remains
regarding its efficacy. So how
exactly does Aduhelm work? And
in what ways is it different from the
current treatments available to AD
patients?

Aduhelm and
Donanemab
Instead of addressing
the adverse effects of amyloid-β
aggregation, Aduhelm and
Donanemab target amyloid-β
aggregation itself. Both Aduhelm
and Donanemab belong to a
class of pharmaceuticals known as
monoclonal antibodies [12], [14].
Antibodies are generated natu-
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rally by our immune system and
are used to identify and destroy
potentially harmful pathogens
[25]. In recent decades, antibody
production has been harnessed
by the biotechnology industry to
produce therapeutic monoclonal
antibodies. Biotechnology companies can design and produce
antibodies that target biological
threats of interest. The antibodies
are then administered to patients
to prompt the immune system to
mount an attack against the pathogen of interest. In addition to their
use in AD treatments, monoclonal
antibodies can be used to treat a
host of other disorders from asthma to leukemia, and have recently
demonstrated potential for treating COVID-19 [25], [26]. Currently
therapeutic antibody treatments
are one of the largest areas of biomedical research and account for
50% of biomedical sales revenue
[27].
Aduhelm and Donanemab
both attempt to treat the underlying biological cause of AD by
using monoclonal antibodies to
target and breakdown amyloid-β
plaques in AD patients [12], [14].
The main difference between the
two drugs is that Aduhelm targets
the entire amyloid-β sequence in
humans, while Donanemab recognizes a specific region of the amyloid-β protein [12], [14]. Because
of their slightly different targets,

Aduhelm and Donanemab have
differing abilities to bind soluble
and insoluble amyloid-β. Aduhelm
is capable of binding soluble
amyloid-β oligomers and insoluble amyloid-β plaques, whereas
Donanemab’s more targeted sequence means that it only binds to
insoluble amyloid-β plaques [12],
[28].
A phase 1 clinical trial found some evidence that
Aduhelm reduces amyloid-β
aggregation and slows the clinical
progression of AD [12]. However,
it is important to note that assessing the clinical symptoms of AD
was not the primary focus of this
study, and therefore these findings
remain promising but inconclusive [12]. Following administration
of Aduhelm, greater numbers of
microglia were identified in close
proximity to amyloid-β plaques,
suggesting that Aduhelm may induce microglial phagocytic activity
to facilitate amyloid-β clearance
[12]. Similarly, a phase 2 clinical trial identified cognitive and
functional benefits to Donanemab
treatment in AD patients, as well
as increased amyloid-β clearance
[14]. These initial results suggest
an incredibly promising future for
amyloid-β monoclonal antibody
treatments — so why is there such
controversy surrounding the FDA
approval process?

SCIENTIFIC KENYON

The Future of AD
Research and
Treatments
The FDA granted approval
of Aduhelm via the accelerated
approval pathway [29]. This pathway does not represent permanent approval, nor does it mean
that the FDA views Aduhelm as
a definitive cure for AD. What it
does mean is that the FDA believes it has strong evidence that
Aduhelm successfully targets an
underlying, physiological cause of
AD: in this case, amyloid-β plaques
[29]. Because there are no other
viable treatments targeting the
underlying cause of AD, the FDA
is allowing patients to start taking
Aduhelm based only on its success
in clearing amyloid-β [29]. What
remains to be seen is whether or
not its success in clearing amyloid-β translates into cognitive and
functional improvements in AD
patients. Biogen is currently con-

ducting experiments to determine
whether or not this is the case, and
if Aduhelm’s efficacy for treating
the clinical symptoms of AD remains unproven, the FDA may revoke its approval. The accelerated
approval pathway through which
Aduhelm was approved rests on
a basic assumption: ameliorating
the underlying source of a disease
will alleviate the associated clinical
symptoms as well. It is a relatively
valid assumption, although its accuracy likely varies based on how
many factors are involved in the
etiology of any given disease. AD
is an extremely complex disease
whose underpinnings remain incompletely understood after years
of research. While this article has
focused on the complexities associated with amyloid-β aggregation
and neuroinflammation, there are
other biological factors associated with AD including neurofibrillary tangles and loss of synaptic
connections, not to mention the
roles of genetics, environmental
conditions, comorbidities, gender,

nutrition, physical activity and so
much more [30].
So will the clearance of
amyloid-β plaques facilitated by
Aduhelm reduce the clinical symptoms of AD? The short answer
is maybe. Despite the extremely tangled web of contributing
factors, amyloid-β does seem to
play a large role in AD, and clearance of amyloid-β plaques may
prove effective at alleviating the
clinical symptoms of the disease.
However, as previously discussed,
amyloid-β plaques may be of secondary importance compared to
soluble amyloid-β oligomers when
it comes to AD onset and progression [18], [2]. It therefore remains
to be seen whether or not the
clearance of amyloid-β plaques will
prove sufficient for alleviating the
cognitive and functional symptoms
of AD. If so, treatments such as
Aduhelm and Donanemab would
represent a major step forward in
addressing one of the most pressing biomedical issues of our time.
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Your Mind’s Eye:
Metaphor or Reality?
An Exploration of the Varieties of Visual Imagery
By Alia Korot
31

I

f you are told to close
your eyes and picture an
apple, what do you see?
Do you actually see an apple?
What color is it? How detailed is
it? Can you taste it? Smell it? Hear
the crunch when you take a bite?
Most people can easily answer
these questions, and being told to
picture something in their mind’s
eye makes perfect sense. However, if you’re like me, you don’t see
anything when asked these questions. I know what an apple looks,
tastes, and smells like, but I do
not relive any of those sensations
when told to picture something.
For me, the mind’s eye has always
been a metaphor, and I only recently realized that my experience
differs from the majority of people.
Like myself, many people
are not even aware of their lack of
imagery, or that it is abnormal until
well into young adulthood. We
rarely describe the details of our
mental experience to others, and
instead assume that others think
and imagine in the same way we
do. With phrases like “picture this”
and “your mind’s eye” so wide-
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spread in our everyday language,
it is assumed that we all interpret
their meaning in the same way.
However, this is not the case, and
recognizing this can help us try to
understand the variety of ways that
people think, imagine, and experience the world around them.

Early Studies of
Aphantasia
The first recorded study of
variations in visual imagery was
conducted by Sir Francis Galton,
a notable 19th century scientist, in
1880, who recognized that some
individuals seemed to lack the
power to visualize. However, this
phenomenon has been mostly
ignored since then, and the term
to describe it was only coined in
2015 (1). This distinct experience
has now been labeled aphantasia,
which is defined as the absence of
voluntary mental imagery. Based
on what we know so far, aphantasia seems to be found in about
1-4% of people, but this number
will likely change as awareness of

the phenomenon grows (2).
The study that first defined
aphantasia was conducted by a
researcher named Rebecca Keogh and her colleagues (2). They
used a survey called the Vividness
of Visual Imagery Questionnaire
(VVIQ), which describes a variety of
situations and asks how clearly you
can visualize them on a scale from
seeing nothing to seeing something as detailed as real vision (this
survey is available to the public
online). The researchers gave this
survey to a group of people who
had self-reported a lifelong lack
of visual imagery. Interestingly,
around half the participants reported a dearth of all types of imagery,, but the majority still reported
experiencing involuntary imagery,
such as “flashes” while awake and
dreaming (1). Personally, I don’t
experience any type of sensory
imagery in my mind, whether that
be visual, auditory, or olfactory.
While I believe I do dream visually,
I rarely (if ever) remember those
dreams.
While this study provided
the first cohesive report of aphan-

The varieties of visual imagery. Image created by Alia Korot with BioRender.com
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tasia as a defined variation in
neuropsychological function, it still
relied on self-reports and observational rather than experimental
methods. This original reliance on
self-reports created some controversy in the scientific community
over whether anyone actually
lacked the ability to visualize, or if
they simply had poor metacognition– meaning they were unaware
of their own visualization. However, various other experiments have
supported that individuals with
aphantasia do indeed lack imagery
capabilities. A test called the binocular rivalry imagery experiment
is one empirical way to measure
the strength of visual imagery. Participants are told to visualize one
of two simple images, then are
very briefly presented with those
two images in a binocular rivalry
display (one image displayed to
each eye, for less than a second),
then asked which image they saw.
Individuals with aphantasia had
significantly lower priming scores,

meaning they were less likely to
preferentially identify the image
they had been previously told to
visualize (3). These results suggest
a much lower vividness and influence of visual imagery, and thus
support the presence of aphantasia.
Another empirical way to
measure visual imagery is through
physiological responses. The
pupillary light reflex is a normal
response in vision where your pupils constrict when you are seeing
something bright. Interestingly,
this reflex also occurs with mental
visual imagery–when imagining
a bright image, your pupils will
constrict. However, when individuals with aphantasia are told to
imagine images of differing brightness, there is no change in their
pupils (2). The normal pupillary
light reflex provides some insight
on the process of visual imagery
itself; namely, that it seems to
function through similar pathways
to normal visual perception. How-

ever, there remain many questions
about how exactly imagery is
formed in the brain.

Understanding
Mental Imagery
Using Brain Imaging
Techniques
Now that we know there
are differences in how well people
can visualize, let’s try to understand exactly what visual imagery is, and how it works. Visual
imagery is used by most people
in many of their day-to-day cognitive processes, such as memory,
planning, spatial navigation, and
reading comprehension. Visual
imagery can be voluntary, as in
many of the prior processes, or
involuntary, such as hallucinations
and intrusive images in disorders
like schizophrenia and PTSD. This
widespread relevance of visual imagery, as well as increasing aware-

Binocular rivalry experiment. Wilbertz G, van Slooten J and Sterzer P, CC BY 4.0 <https://creativecommons.
org/licenses/by/4.0>, via Wikimedia Commons
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ness of the variations in the ability to visualize, has led to recent
increased investigation into the
neuroscience behind mental imagery. Historically, it has been difficult
to study the neural basis of cognitive processes like mental imagery,
but the growth of functional brain
imaging has created new methods
that allow us to begin to see what
is happening in our brains when
we are told to visualize something.
The most important tool
that is used in this process is
functional magnetic resonance
imaging, or fMRI. This technique is
safe, noninvasive, and allows scientists and doctors to successfully
map and measure brain activity.
Magnetic resonance (MR) is the
emission or absorption of electromagnetic radiation by an atom in
response to a magnetic field. Conducting fMRI on humans involves
exposing them to a magnetic field,
and measuring MR signals from
their brain. Changes in MR signal
are indirectly related to changes in
blood flow, which reflect changes
in neural activity. Thus, when a part
of the brain is more active, there
is more oxygenated blood flow to
this region, so it produces a greater MR signal which can then be
mapped and imaged with fMRI (4).
With this technology, researchers
are able to ask patients to perform
certain cognitive tasks and can
observe the resulting neural activity. This enables us to understand
which parts of the brain are used
for different types of thinking and
tasks.
Through this use of brain
imaging, scientists have further
clarified which areas of the brain
are involved in voluntary visual
imagery. It seems to involve activation of a widespread network
in the brain including areas in
the prefrontal and visual cortices,
similar to those activated in normal visual perception. In vision,
visual information enters the brain

from the eyes, is relayed to the
visual cortex in the occipital lobe,
and then enters multiple streams
of processing and areas of higher-order functioning (that control
thinking, planning, and voluntary
behavior). Visual imagery, on the
other hand, seems to involve a
variety of processes that start at
the higher-order areas of the brain,
and move down to visual areas.
These include decision making,
attentional allocation, language
processing, and accessing longterm memory—all of which eventually lead to a quasi-visual experience (2). Thus, visual perception
and visual imagery seem to utilize
similar brain regions, but the flow
of activation occurs somewhat in
a reverse order, as a more “bottom-up” process for perception
versus a “top-down” process for
mental imagery. Meaning you
consider something in order to
perceive it rather than perceiving
something, and then considering
it.
Amazingly, some detailed
brain imaging studies have made
it possible to identify what someone is imagining based solely on
the pattern of brain activity in their
visual cortex! The level of activity

measured in the visual cortex also
seems to correlate with how vivid
someone reports their imagery to
be (2). These discoveries highlight
how accurately researchers have
been able to pinpoint the roles
of specific brain regions in visual
imagery, though much remains to
be discovered.
Now, with a good understanding of the neural activity
involved in visual imagery, the
next question is how functional
brain imaging can help explain the
differences in the ability to visualize found in aphantasia. The use
of resting state fMRI (in this case,
when the brain is not attempting
to conjure an image) has been
able to successfully elucidate some
of the differences in connectivity
of brain regions between those
with normal imagery, those with
hyperphantasia (ultra-vivid imagery), and those with aphantasia.
Hyperphantasic individuals show
stronger connections between the
visual-occipital network and several prefrontal regions compared to
those with aphantasia, whereas the
aphantasic group shows various
other areas of stronger connectivity. Interestingly, these differences
in connectivity are similar to those
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Neural activation pathways in visual perception vs visual imagery. (A.) depicts the neural activation for the visual
perception of an object out in the world, and (B.) depicts the neural activation for the visual imagination of an
object. Image created by Alia Korot with BioRender.com. Modified from Pearson, 2019 (11).
previously found in relation to
different types of autobiographical
memory. People with an episodic (and thus more visual) style of
memory show stronger resting
state connectivity between important memory regions of the brain
and visual areas, while those with
a more factual style of memory
show greater connectivity between
those memory regions and prefrontal regions (5). These findings
suggest that there are intrinsic differences in brain connectivity underlying variations in the ability to
visualize. There are also differences
in brain activity, as hyperphantasic
individuals show more activation in
certain brain areas when asked to
visualize something, in comparison
to those with aphantasia (5).
While there have only been
a few brain imaging studies on
aphantasia so far, the findings have
led to some hypotheses about
what causes a lack of imagery.
One suggested neural mechanism
is reduced connectivity between
cognitive control systems and
the visual areas of the brain. This
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hypothesis is supported by the fact
that many aphantasics still experience visual dreams, an experience
in which the imagery is involuntary,
suggesting the disconnect is in the
voluntary generation of imagery
and not the imagery itself (5). This
is further supported by individuals
with aphantasia not having any difficulty with visual perception; they
are simply unable to voluntarily
create mental images.

Further Defining
Aphantasia
While there is much more
to discover about the neural underpinnings of visual imagery and
aphantasia, it is also important to
further define this phenomenon
and its variations. Is it a disorder, a
defined and discrete condition? Or
just a variation of the human experience, as one extreme end of a
continuous spectrum of visual imagery? There is not yet a scientific
consensus on this question, and

perhaps the answer does not really
matter for our understanding of
the phenomenon. Definitions will
always change, and we can work
to understand aphantasia regardless of its classification. There have
been reports and previous studies
of individuals losing their ability
to visualize after injury or disease
(known as acquired or neurogenic
aphantasia), but individuals with
congenital aphantasia (which
present at birth), like myself, do
not recall ever having the ability to
form mental images.
Since congenic aphantasia is present from birth, we must
consider the role of genetics in
this phenomenon. First degree
relatives seem to share aphantasia
much more often than would be
expected by chance, suggesting heritability which suggests
a potential genetic component
(2). Around 20% of people with
aphantasia are confident they have
other family members affected,
while nearly 50% are simply unsure
(7). Many people simply are not
aware of or do not discuss their
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differences in mental imagery,
suggesting that the occurrence of
shared aphantasia among relatives
could be significantly higher than
currently reported. This certainly implies a genetic contribution
towards aphantasia, and potentially a strong one, but much more
research is required to clarify the
strength and details of these genetics.
Another remaining question is whether aphantasia has multiple subtypes,given that people
differ on which types of sensory
imagery they lack. Some aphantasics lack only visual mental imagery, while others lack all forms of
imagery, including auditory, gustatory, and olfactory. Some researchers have suggested a separate
name, dysikonesia, for impaired
or absent imagery across multiple
senses, while reserving aphantasia
for the sole lack of visual imagery
(6). It remains to be seen whether
this term will be more widely adopted, or if aphantasia will simply
be generalized to all forms of
impaired sensory imagery.

Aphantasia’s Impact
on Other Cognitive
Processes
For those without aphantasia, mental imagery plays a strong
role in a variety of cognitive processes. This raises the question of
how aphantasia affects other abilities such as memory. The answer
seems to be that there are differences in recall and memory, but it
depends on the type of memory.
Those with aphantasia have equal
ability to successfully complete
declarative memory tests or even
visual working memory tasks
(involving using visual information
to complete a task). To complete
these tasks with no impairments
in capacity or accuracy means that

aphantasics must rely on different strategies, such as semantic,
meaning-based labels and verbal
cues rather than visual representations to process visual information
(10). These strategies are likely developed throughout life, and perhaps are not developed by those
who rely upon mental images. This
suggests that visual imagery and
working memory are two separate
processes, and mental imagery is
simply one possible tool that can
be used for interpreting and using
visual information.
There are some memory
tasks that do demonstrate differences between those with and
without aphantasia. For example,
in one study researchers presented images of real-world scenes to
individuals with aphantasia and
control participants without aphantasia, and then asked them to draw
the scenes from memory. Aphantasic individuals remembered
fewer objects, drew with less color,
and relied more on symbolic and
verbal representations by labeling
more objects with words. In contrast, their spatial accuracy in placing objects from the scene was the
same as controls (8). These results
support the idea that there are
separate memory systems for object versus spatial information, and
spatial recall is unimpaired in those
with aphantasia. Additionally,
despite the aphantasic individuals
in this study struggling to illustrate
a scene from memory, aphantasia
certainly does not preclude artistry. There are many self-identified
aphantasic visual artists that seem
to use strategies that are slightly
different from other artists (2).
Autobiographical memory, the memory of your own
past, is another area of potential
difference. Normally, many people experience their memories of
the past through intense, vivid,
and movie-like imagery. However, those with aphantasia do not

experience their memories in this
way. This lack of movie-like imagery seems to translate to diminished autobiographical memory.
People with aphantasia report a
significantly lower ability to recall
specific life events and have very
little ability to produce sensory
details while remembering events
(9). This difference in the ability to
remember details of your own past
is perhaps the biggest impact of
aphantasia, and certainly seems
to be a source of distress for many
who are aware of it. However,
as with other forms of memory,
it seems possible for those with
aphantasia to learn to rely on other
strategies and develop ways to
supplement their own memories.
If you cannot visualize and relive
your life events through imagery in
your mind, you thankfully have the
ever-present technology of photos
and videos to supplement your
own memories. Thus, the consequences of aphantasia certainly
do not seem too dire and can
be overcome with the breadth of
other strategies the human imagination is capable of.
For most people, visual
imagination is a central part of
their lives and seems an intrinsic
part of their cognitive experience.
As I have discussed my aphantasia
with friends and family, I am often
met with the reaction that they
cannot imagine a mind without
imagery. They cannot comprehend
how I think and remember and experience the world. Many authors
and philosophers over the years
have discussed how our vision of
our lives, our ability to imagine,
and our ability to represent things
in their absence is crucial to our
human experience—and perhaps
what sets us apart as humans.
However, these abilities do not
rely solely on visual imagery. It was
only in the last few years, when
I began discussing my cognitive
experience with others, that I
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discovered that I lack this internal
experience that most people rely
on. I have certainly never felt that
I was missing some necessary part
of cognition, and there are many
methods of internal representation
besides the visual or sensory.  
Aristotle once wrote that
“the soul never thinks without a
phantasm,” and he was (and is) far
from alone in the assumption that
illusory representations and mental imagery are intrinsic to human
thought. However, it seems Aristotle was in fact incorrect. He fell
into the trap that befalls so many
and assumed that his own internal
experience resembles all others.
Let us not underestimate the many
incredible multi-representational
abilities of the brain or forget the
representational powers of language. Visual imagery is simply
one tool in the toolbox of the human brain and lacking it does not
prevent the human cognitive experience. I feel I can speak for all
those with aphantasia when I say
that lacking the ability to visualize
does not preclude any complexity
of thought or feeling. In this case,
I will confidently counter Aristotle
and say that my soul certainly does
think without a phantasm.
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I Feel Your
Pain, Do You
Feel Mine?
By Lucy Friedberg
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T

he experience of
emotion and pain
stem from our interactions with our environment,
peers, and selves, capturing the
essence of the complete human
experience. Our ability to verbally communicate our “feelings”
aids in fostering close bonds with
each other. The action of feeling
holds a double meaning. On one
hand, you can physically touch
something, experiencing a tactile sensation. While on the other
hand, you can also inwardly ‘feel’
intangible sentiments like emotion,
encapsulating our introspective
experience. Without being able
to communicate either physical or
internal feelings, our relationships
to each other would be completely different and unsustainable.
Throughout time, our frontal lobes
have evolved to reflect the developing complex social structures
and higher cognitive functioning
required to uphold it [1]. Expressing an emotion enacts both meanings of “feeling.” A physical stimulus triggers a cascading effect in
the brain to produce the conscious
thought that you feel “sad.” This
sequence inherently suggests that
there is an overlap in the emotion
and pain signaling networks of our
brain [2].

What is Emotion?
Movies, pictures, conversations, and almost every interaction
we have with our environment
elicit an “emotion.” Emotion is applicable to almost every individual.
Our emotional schema develops
throughout our entire lives, teaching us how to respond to certain
situations [2,3]. In a technical
sense, emotions are central brain
states that create a cause-andeffect interaction with other brain
structures stemming from stimuli
and behaviors. These brain states
arise from neurochemical interac-
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tions such as the release of neurotransmitters. Neurotransmitters
serve as chemical messengers between neurons, the brain’s foundation for transmitting sensory input
from the external world. Electrical
signals travel between neurons
along the axon and trigger the release of the neurotransmitter. One
commonly known neurotransmitter
is dopamine, which plays a crucial
role in the modulation of emotion
[4,5].
When defining emotion,
rather than thinking about neural connections or the release of
neurotransmitters, people utilize
adjectives such as happy, sad, or
mad. Emotions are states of being
produced by activation of certain areas in the brain such as the
amygdala or thalamus. A common
misconception is that one brain
area corresponds to one emotion.
Instead, the brain is a complex
network with communications between different structures. These
structures ultimately distribute
signals to the rest of our body to
produce behavior. The behavior or
actions produced is what people
think of when imagining emotion.
The amygdala isn’t where “fear” is
located, but rather, it is involved in
the evaluation of emotional importance of a stimulus, and is especially active in response to fear [6].
Earlier theories state that
the basic emotion and dimensional
models are two separate measures
of emotion. The discrete emotion
perspective states that we have
a propensity for certain emotions
such as happiness, anger, and disgust [7]. These exist as categorical,
basic, and specific emotions. The
dimensional perspective suggests
that emotions exist along a range
of dimensions based on valence
(positive vs. negative) and arousal
(activated vs. deactivated) [7]. The
dimensional spectrum of emotional experience is determined by
where valence and arousal land

within the range. Building on the
theory of an emotional spectrum,
recent models of emotions state
that emotions are learned from
previous experiences [7]. This suggests that emotions are derived
from the ability to recall and apply
conceptual knowledge to a situation and produce the appropriate
behavior (or emotion) [7]. These
models are important to understand because they establish the
basis of our emotional experience.
They also begin to distinguish
between states of being, and feeling, and provide theories for their
origin.

Where do we Feel
Emotion?
Attempting to decipher
emotions has been a prevalent
study across philosophical and
scientific disciplines throughout
all of history. Since the late 19th
century, there have been several
different theories as to how the
brain produces emotional states
that ultimately influenced the
modern idea of the limbic system
[8]. Dr. William James and Dr. Carl
Lange answered the question of
“After seeing a bear in the woods,
does our heart race because we
are afraid? Or are we afraid because our heart is racing?” by
stating that we are afraid due to
the physiological act of our hearts
racing [8]. The James-Lange Feedback Theory requires a prior set of
changes in the body to produce
emotion [8]. What these changes
are determine the following experience of emotion [2,8].
In the 1920s, Dr. Walter
B. Cannon and Phillip Bard disagreed with James-Lange. They
claimed that because humans
experience such a wide variety of
specific emotions, physiological
responses for a single emotion are
indistinguishable [8]. For example,
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Image created by Lucy Friedberg with BioRender.com

a multitude of scenarios can cause
a person’s skin to flush, such as
sexual arousal, anger, and embarrassment. In addition, Cannon
and Bard pointed to the fact that
you can encounter emotion prior
to any associated physiological
change [8]. Instead, Cannon and
Bard suggested that in the brain,
the thalamus directs information
to the cortex for the generation
of feelings (the emotional experience), and to the hypothalamus
for the generation of a bodily
response (expression of behavior
resulting from the emotional experience) [2].
A decade later, Dr. James
Papez proposed the Papez Circuit.
This circuit defined emotional processing as occurring in the medial
walls of the forebrain. Specifically,
the structures directly connected to the hypothalamus [2,31].
Building on this theory, Dr. Paul
Maclean’s developed the concept
of the Limbic System. From 1940-

1970, the control of emotional behavior was thought to require recognition of a significant stimulus
triggering subsequent activation
of a specific emotional response
[9]. Maclean believed it was the
hippocampus that identified
significant stimuli [2]. After 1970,
the ‘modern’ limbic system was
established [9]. Here, the amygdala is cited as the key proponent of
the limbic system. The amygdala
determines what a stimulus is, and
whether something needs to be
done about it. While not exclusive
to fear processing, the amygdala
plays a significant role in influencing approach or avoidance behavior in response to a frightening or
threatening stimulus [9].
Another part directly linked
to the limbic system is the insula
[34]. The insula filters all bodily information and integrates it to form
a representation of the state of our
body to our consciousness [34].
Alongside the insula during the
active experience of feelings is the

anterior cingulate cortex (ACC).
These two brain areas function to
project the experience of maternal and romantic love, anger, fear,
sadness, happiness, disgust, and
trust [1,2,21].

Why do we
Experience
Physical Pain?
Have you ever placed your
hand on a hot surface and swiftly pulled it back? Evolutionarily,
being able to perceive pain is
critical to human survival. Fight or
flight is a common adaptation that
is referred to when understanding
instinct and fitness. It is what tells
us to remove our hand from a hot
surface or to defend our territory.
Being able to distinguish these
signals is the job of the central
nervous system and pain receptors
called nociceptors. Nociception is
the process of detecting, experi-
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Highlight of the limbic system. Image created by Lucy Friedberg BioRender.com

encing and encoding harmful or
very unpleasant stimuli [11]. The
three types of stimuli nociceptors
are activated by are temperature
(thermal), mechanical (stretch/
strain) and chemical (inflammatory)
[11].
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processes are crucial to experiencing physical pain [6,11]. The ability
to process tactile stimuli is essential in understanding our relationship to the physical world.

What Hurts?

Don’t Get Your Wires
Crossed

Physical pain is typically
described as a part of the body
feeling discomfort. This can range
from slight, to extreme discomfort.
The direct pain matrix is made
up of the cingulate, insular, and
certain somatosensory areas. The
anterior cingulate cortex, parts of
the prefrontal cortex, and insula
have rich nociceptive and motor
receptor regions [32]. The interconnected nature of these brain
areas allow output of ACC pain
to influence immediate behavioral reactions [32]. So, if you put
your hand on something hot, the
nociceptors signal that there is
nociceptive pain, or acute tissue
pain, signaling the brain to remove
your hand from the hot surface to
prevent further injury. The involvement of the secondary somatosensory cortex and posterior insula

When people say as a
figure of speech, “love hurts” or
you have your “feelings hurt”, they
actually mean it. After examining
both emotional and pain processing, recent research supports the
idea that the two networks are
not separate [13]. While everyone
experiences emotional pain, it
can be harder to articulate since
it seems more abstract than physical pain. With physical pain, you
can usually point to a spot on the
body and where and why it hurts.
With emotional pain, if you say
your body aches because you’re
sad, people may sympathize, but
do not understand the extent that
your physiological state changes in
response to being sad.
If you have ever grabbed
your knee when seeing a basketball player fall hard on their

own knee, you are not alone. The
anterior cingulate cortex (ACC),
parts of the prefrontal cortex, and
insula are regions of the brain that
signal physical pain, but they are
also responsible for behaviors
stemming from our emotions as
well [13]. Part of the foundation
of this research is the finding that
the anterior insula (AIn) is activated not only when experiencing
displeasing stimuli that active
nociceptors, but also when viewing someone else experiencing a
displeasing stimuli (or even making
a displeased face) [13,26]. The
cingulate and insular regions are
activated when viewing someone
in pain, supporting the evidence of
emotional pain activating the same
brain regions as physical pain.
Particularly, researchers have been
able to link the nociception areas
and neural recruitment to insular
and cingulate regions, supporting
the theory of the same regions for
two types of pain [10,12,13,26].
Most people relate to the
common physical pain of scraping
your knee or stubbing your toe.
Remembering your own painful
experience may elicit a twinge
of pain. Empathy is the ability to
share and understand another’s
feelings. Being empathetic, for example, requires recalling how you
felt at a time when you scraped
your knee and relating to a person
in an appropriate emotional way
to comfort them. One study linked
the common painkiller Acetaminophen (Tylenol) to a reduction in
empathy [14]. As mentioned earlier, the ACC is activated when an
individual is experiencing distress
or when viewing someone else in
distress. The reduction of ability
to feel pain and consequently the
ability to empathize indicates a
certain degree of overlap between
areas in the brain that express
physical and emotional pain. Tylenol reduced both personal distress
when experiencing social pain
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(exclusion), but also when viewing
others in distress [14].

Emotional Pain
Being empathetic is crucial
to our social relationships because
it allows us to connect to, and
understand what other people
are expressing on a deeper level.
It helps us understand both the
negative and positive affects [15].
Negative affects include emotional
or psychological pain. Psychological pain is defined as an unpleasant feeling resulting from a negative experience that is caused by
an inability or deficiency of the self
[12,16]. This feeling is persistent,
but unsustainable. The need to
love, to be loved, and connect
with others are core psychological
needs that if not met can lead to
feeling unhappy or dissatisfied
[12,16]. Across several experiments
assessing psychological pain, the
ACC proved to be the most active
[10,12]. This extends the ACCs
involvement to the experience of
sadness, while the insular functions to a greater degree for both
negative affect and physical pain
[10,12].

Examining Our Social
Selves
Being able to perceive
social exclusion historically meant
a higher chance of survival since
in early times, those in groups
were more likely to live longer [17].
Feeling emotional and physical
pain similarly could be a function of evolution, given that an
emotional or social threat (being
alone) could result in a physical
one (dying). When examining our
social selves, the development of
self-esteem is frequently fixated
on, especially in adolescent aged
individuals. Self-esteem is feeling
good or bad about oneself which
subsequently affects our emotional state. It is an internal gauge
of social inclusion or exclusion in
relation to others [17,18]
A theory developed by
Leary et al. (1995) draws parallels
between social happiness and
self-esteem. Sociometer theory indicates that self-esteem fluctuates,
and is influenced by social experiences. Those who are socially rejected or deemed an outcast have
lower self-esteem than those who
perceive themselves as included or

well-liked. This theory involves our
“self” in a social context, providing a psychological framework for
our outward behaviors. In a study
done on social exclusion, researchers found that regardless of
whether a person knew the other
people, they exhibited distress at
being excluded from a game [27].
Since a sense of belonging is at
the forefront of satisfying our penchant for inclusion, studying social
exclusion in the context of pain
provides an objective perspective.
Theories such as sociometer theory and attachment style
provide social implications for the
connectivity of our brain structures. In a study done looking at
which brain areas are active during
social exclusion, researchers found
the ACC to be more active during
exclusion than inclusion. This
activation parallels studies done
looking at physical pain [27]. Understanding attachment is important in the context of social pain
because it provides an emotional
structure that forms a foundation
for baseline social interactions.
For example, it cues sensitivity to
exclusion which may correlate to
the activity or reactivity of the ACC
[10,12,13,22].
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Brain areas such as the
insular regions, medial prefrontal cortex, and anterior cingulate
cortex that have been identified
as being activated by emotional pain such as social exclusion.
In the context of empathy and
experiencing pain, their activation
provides support that these areas
are also activated by physical pain
[12,13,21,26]. These studies have
greater implications for biopsychological interventions and general
unification of understanding individual experiences. It also deepens
our understanding of empathy,
which is fundamental to our social
relationships and subsequently,
well-being [15,27,28].

Autism Spectrum
Disorder
Autism spectrum disorder
(ASD) presents several emotional
and sensory processing variances
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including both hypo and hypersensitivity to certain stimuli. Studying
the emotional and physical pain
processing in participants with
ASD presents the opportunity to
examine divergent neurological
functions. This would allow for
the development of a more comprehensive understanding of the
individual experience of pain [15].
Difficulty with perception and
processing the emotions of others
is commonly observed in ASD.
However, whether this difficulty
arises from a general struggle to
relate to emotional states, or from
struggling to perceive affective expressions is not fully understood. A
recent study used pain evaluation
in the self and others to link emotional and sensory perception in
individuals with ASD. The goal was
to distinguish whether these individuals have difficulty recognizing
other emotional states due to discrepancies in relating to emotional
experience (own or other) or if it is

specific to the perception of others
[15,19]. They found that participants with ASD demonstrated no
difference in evaluating intensity of
their own pain to participants without ASD. However, they also found
that participants with ASD exhibited more difficulty estimating the
pain intensity of others, specifically
when evaluating pain level based
on facial expressions. These results
contrast earlier findings of neurotypical brains showing activation
in insular and ACC regions when
viewing photographs of people
in pain. To support this, the researchers recorded a difference
in neural activation between ASD
participants identifying pain based
on context rather than bodily
expressions. Those with ASD had
reduced neural activation in response to higher social complexity
[19].
Not only did individuals
with ASD demonstrate decreased
neural activation in response to
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pain identification of others (reduced empathic ability), they also
had weaker brain activation in the
anterior insula and anterior cingulate cortex. This provides strong
evidence for the role of insular
and cingulate cortices in pain-related empathy, or the overlapping
of emotional and physical pain
processing [12,20,21,26]. Through
outlining how both neurodivergent and neurotypical individuals
experience pain, interpret social
stimuli, and process affect, a clear
relationship between the signaling
of physical and emotional pain
develops.

PTSD/Chronic Pain
Being able to understand
emotional processing has great implications for fields studying posttraumatic stress disorder (PTSD)
and chronic pain. Both PTSD and
chronic pain emanate from a biological, psychological, and social
field. Chronic pain and PTSD are
extremely prevalent across the
US and affect people’s day to day
lives. An incongruence between
emotional processing and the
experience of physical pain can
lead to chronic pain or even PTSD.
Chronic pain is the presence or
sensation of physical pain in the
absence of a clear source of pain
over an extended period [33].
People experiencing PTSD
often display intense negative
emotional reactions, higher reactivity to certain stimuli that may
trigger the traumatic experience,
avoidance of that stimuli, and
chronic overstimulation [24]. Generally, PTSD is classified as an anxiety disorder, and chronic pain is
often comorbid with PTSD. Using
brain imaging, researchers have
been able to establish a relationship between PTSD and increased
blood flow in the insular region
[23,24]. There is a distinction in
pain perception between people

with PTSD and those who experience isolated trauma. Those who
do not display PTSD symptoms
following a traumatic event tend to
have higher pain perception than
those with PTSD. Mickleborough
et al. (2014), associated this with
the changes to signaling between
the cortical and subcortical structures in the two different groups.
A common self-preservation response to trauma is dissociation. This entails both psychological and physiological responses.
People often report feeling “emotionally numb” to most stimuli. Research shows that there are neurological changes that occur that can
account for someone dissociating.
In the same study done by Mickleborough et al. (2014), they associated induced dissociative states
with more activation in the insula,
and a simultaneous reduced sensitivity to pain. The occurrence of
dissociation can account for the
increased pain threshold in those
experiencing PTSD compared to
those without PTSD symptoms

[23,24].
At rest, the brain demonstrates spatially and temporally distributed or synchronous
blood-oxygen level-dependent
(BOLD) variation [25]. In the brain
of chronic pain patients, there
is constant processing of “background” pain signaling. Spontaneous pain stemming from the
background pain conflicts with
both conscious and subconscious
processes [25]. This occurrence
contributes to fundamental neuronal plasticity in response to chronic
pain. The existence of background
pain is attributed to episodic
memory resulting in a constant
recall of the original pain or injury.
The persistent recall resulting in
the background pain is evident
by examining structural changes
to certain pain areas in the brain
such as insula, ACC, and Thalamus
regions [1,25]. PTSD emotional
responses and correlating them
to structural changes in the brain
draws a stronger connection between the experience and process-
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ing of emotional and physical pain.
Chronic perceived pain
conditions are often correlated
with response activation in the
thalamus. Thalamic activation is
connected to the time since onset
of the chronic pain, with differing
responses short-term to long-term
[29]. Hyper-perfusion occurs in
short-term pain, and hypoperfusion in long-term chronic pain,
demonstrating adaptive changes
during the development of chronic pain [29]. Operant theory of
chronic pain is the idea that there
are two distinct aspects of pain,
sensory and behavioral. Sensory
aspects of pain are essentially
unobservable while behavioral aspects are observable and measurable. These are categorized under
pain behaviors which are subject
to the influences of learning and
experience. Under this theory, pain
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can be reinforced via negative and
positive reinforcement causing
the occurrence of pain to linger
[11,29].
Similar to PTSD symptoms,
chronic pain creates neurological
changes in the brain that demonstrate and support the interconnected nature between emotional
and pain processing [29,30].
Several studies have shown a link
between chronic pain and mood
disorders such as depression and
anxiety leading researchers to
claim that psychosocial factors
affect pain perception [29]. This
model is referred to as the biopsychosocial model of pain. These
altered states of somatic awareness and pain catastrophizing
indicate changes to the peripheral
or central nervous system that are
crucial to signaling pain. This model has been extremely influential in

shaping new behavioral, psychosocial, and physical interventions
to pain management. It allows for
researchers and doctors to gain a
fuller image of individual differences in the experience of pain. It also
highlights the multidimensionality
to pain processing, both emotional
and physical [29,30].
Understanding why humans
feel emotions and pain separately
allows for a deeper understanding
of how the two sensations are related. People often assume physical pain is the only relevant pain to
our survival, but research consistently demonstrates that our social
needs and subsequent social pain
if these needs are not met can be
as painful. Comparative research
establishes the brain as an active,
interconnected entity with a strong
network to produce behavior.

SCIENTIFIC KENYON

48

SCIENTIFIC KENYON

References
1.

2.

3.

4.

5.

6.

7.

49

Semendeferi, K., Damasio, H.,
Frank, R., & Van Hoesen, G.
W. (1997). The evolution of the
frontal lobes: a volumetric analysis based on three-dimensional
reconstructions of magnetic resonance scans of human and ape
brains. Journal of human evolution, 32(4), 375–388. https://doi.
org/10.1006/jhev.1996.0099
Ward, J. (2015). The student’s
guide to cognitive neuroscience (3rd ed.). Psychology Press.
LeDoux, J., & Brown, R. (2017). A
higher-order theory of emotional
consciousness. Proceedings Of
The National Academy Of Sciences, 114(10), E2016-E2025. doi:
10.1073/pnas.1619316114
What are neurotransmitters?.
(2017). Retrieved 16 December
2021, from https://qbi.uq.edu.
au/brain/brain-physiology/
what-are-neurotransmitters
What is a neuron?. (2016).
Retrieved 16 December 2021,
from https://qbi.uq.edu.au/brain/
brain-anatomy/what-neuron
Meerwijk, E., Ford, J., & Weiss, S.
(2012). Brain regions associated
with psychological pain: implications for a neural network and
its relationship to physical pain.
Brain Imaging And Behavior, 7(1),
1-14. doi: 10.1007/s11682-0129179-y
Grootswagers, T., Kennedy, B.,
Most, S., & Carlson, T. (2020).
Neural signatures of dynamic
emotion constructs in the human
Implant
brain. Neuropsychologia, 145,

106535. doi: 10.1016/j.neuropsychologia.2017.10.016
8. Cannon, W. B. (1927). The
James-Lange theory of emotions: a critical examination
and an alternative theory. The
American Journal of Psychology, 39, 106–124. https://doi.
org/10.2307/1415404
9. Weisfeld, G., & Goetz, S. (2013).
Applying Evolutionary Thinking to
the Study of Emotion. Behavioral
Sciences, 3(3), 388–407. MDPI
AG. Retrieved from http://dx.doi.
org/10.3390/bs3030388
10. Bhattacharyya K. B. (2017).
James Wenceslaus Papez, His
Circuit, and Emotion. Annals
of Indian Academy of Neurology, 20(3), 207–210. https://doi.
org/10.4103/aian.AIAN_487_16
11. Loeser, John D.a,*; Treede,
Rolf-Detlef The Kyoto protocol
of IASP Basic Pain Terminology☆,
Pain: July 31, 2008 - Volume
137 - Issue 3 - p 473-477 doi:
10.1016/j.pain.2008.04.025
12. Corradi-Dell’Acqua, C., Hofstetter, C., & Vuilleumier, P. (2011).
Felt and Seen Pain Evoke the
Same Local Patterns of Cortical
Activity in Insular and Cingulate
Cortex. Journal Of Neuroscience, 31(49), 17996-18006. doi:
10.1523/jneurosci.2686-11.2011
13. Kross, E., Berman, M., Mischel,
W., Smith, E., & Wager, T. (2011).
Social rejection shares somatosensory representations with
physical pain. Proceedings Of
Arrays on
Cultocracy
The
National Academy Of Sci-

14.

15.

16.

17.

18.

19.

ences, 108(15), 6270-6275. doi:
10.1073/pnas.1102693108
Mischkowski, D., Crocker, J., &
Way, B. M. (2019). A Social Analgesic? Acetaminophen (Paracetamol) Reduces Positive Empathy. Frontiers in psychology, 10,
538. https://doi.org/10.3389/
fpsyg.2019.00538
Fitzgibbon, B., Segrave, R.,
Fitzgerald, P., & Enticott, P.
(2013). Can studies of pain help
to bridge the gap between
sensory and social impairments
in autism?. Frontiers In Human
Neuroscience, 7. doi: 10.3389/
fnhum.2013.00103
Meyer, M., Williams, K., &
Eisenberger, N. (2015). Why
Social Pain Can Live on: Different
Neural Mechanisms Are Associated with Reliving Social and
Physical Pain. PLOS ONE, 10(6),
e0128294. doi: 10.1371/journal.
pone.0128294
Leary, M. R. (2005). Sociometer
theory and the pursuit of relational value: Getting to the root of
self-esteem. European Review of
Social Psychology, 16, 75–111.
Leary, M. R., Tambor, E. S.,
Terdal, S. K., & Downs, D. L.
(1995). Self-esteem as an interpersonal monitor: The sociometer
hypothesis. Journal of Personality
and Social Psychology, 68(3),
518–530.
Thaler, H., Skewes, J. C., Gebauer, L., Christensen, P., Prkachin, K.
M., & Jegindø Elmholdt, E.-M.

SCIENTIFIC KENYON

(2018). Typical pain experience
but underestimation of others’
pain: Emotion perception in self
and others in autism
20. Bird G., Silani G., Brindley R.,
White S., Frith U., Singer T.,
Empathic brain responses in
insula are modulated by levels of
alexithymia but not autism, Brain,
Volume 133, Issue 5, May 2010,
Pages 1515–1525, https://doi.
org/10.1093/brain/awq060
21. Mani Pavuluri, Amber May. I Feel,
Therefore, I am: The Insula and
Its Role in Human Emotion, Cognition and the Sensory-Motor System AIMS Neuroscience, 2015,
2(1): 18-27. doi: 10.3934/Neuroscience.2015.1.18 http://www.
aimspress.com/article/10.3934/
Neuroscience.2015.1.18/fulltext.
html
22. Billeke P and Aboitiz F (2013)
Social cognition in schizophrenia:
from social stimuli processing
to social engagement. Front.
Psychiatry 4:4. doi: 10.3389/
fpsyt.2013.00004 http://journal.
frontiersin.org/article/10.3389/
fpsyt.2013.00004/full
23. Nicholson, A., Sapru, I., Densmore, M., Frewen, P., Neufeld,
R., & Théberge, J. et al. (2016).
Unique insula subregion resting-state functional connectivity
with amygdala complexes in
posttraumatic stress disorder and
its dissociative subtype. Psychiatry Research: Neuroimaging, 250,
61-72. doi: 10.1016/j.pscychresns.2016.02.002

24. Mickleborough, M. J., Daniels,
J. K., Coupland, N. J., Kao, R.,
Williamson, P. C., Lanius, U. F.,
Hegadoren, K., Schore, A., Densmore, M., Stevens, T., & Lanius,
R. A. (2011). Effects of trauma-related cues on pain processing
in posttraumatic stress disorder:
an fMRI investigation. Journal
of psychiatry & neuroscience :
JPN, 36(1), 6–14. https://doi.
org/10.1503/jpn.080188
25. Baliki MN, Mansour AR, Baria AT,
Apkarian AV (2014) Functional
Reorganization of the Default
Mode Network across Chronic
Pain Conditions. PLoS ONE 9(9):
e106133. doi:10.1371/journal.
pone.0106133
26. Botvinick, M., Jha, A., Bylsma,
L., Fabian, S., Solomon, P., &
Prkachin, K. (2005). Viewing facial
expressions of pain engages cortical areas involved in the direct
experience of pain. Neuroimage,
25(1), 312-319. doi: 10.1016/j.
neuroimage.2004.11.043
27. Eisenberger, N., Lieberman,
M., & Williams, K. (2003). Does
Rejection Hurt? An fMRI Study
of Social Exclusion. Science,
302(5643), 290-292. doi:
10.1126/science.1089134
28. Meyer, M., Williams, K., & Eisenberger, N. (2015). Why Social
Pain Can Live on: Different Neural
Mechanisms Are Associated with
Reliving Social and Physical Pain.
PLOS ONE, 10(6), e0128294. doi:
10.1371/journal.pone.0128294
29. Sharp, T., & Harvey, A. (2001).

30.

31.

32.

33.

34.

Chronic pain and posttraumatic
stress disorder: mutual maintenance?. Clinical Psychology
Review, 21(6), 857-877. doi:
10.1016/s0272-7358(00)00071-4
Edwards, R., Dworkin, R., Sullivan,
M., Turk, D., & Wasan, A. (2016).
The Role of Psychosocial Processes in the Development and
Maintenance of Chronic Pain. The
Journal Of Pain, 17(9), T70-T92.
doi: 10.1016/j.jpain.2016.01.001
Roxo, M. R., Franceschini, P.
R., Zubaran, C., Kleber, F. D., &
Sander, J. W. (2011). The limbic
system conception and its historical evolution. TheScientificWorldJournal, 11, 2428–2441. https://
doi.org/10.1100/2011/157150
Reddan, M. C., & Wager, T. D.
(2018). Modeling Pain Using
fMRI: From Regions to Biomarkers. Neuroscience bulletin,
34(1), 208–215. https://doi.
org/10.1007/s12264-017-0150-1
Chronic Pain. Hopkinsmedicine.org. (2022). Retrieved 18
April 2022, from https://www.
hopkinsmedicine.org/health/
conditions-and-diseases/chronic-pain#:~:text=Chronic%20
pain%20is%20long%20standing,physical%20activity%2C%20
or%20enjoy%20life.
Insula Cortex | What Is It?, Location, Function, Facts & Summary.
The Human Memory. (2022).
Retrieved 18 April 2022, from
https://human-memory.net/insula/.

50

SCIENTIFIC KENYON

High Performing Athletes
Does Cannabis Use Enhance Performance?
By Racine Ross
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Sha’Carri Richardson (far left) runs in the Women’s 100 Meter semifinal on day 2 of the 2020 U.S. Olympic Track and Field Team Trials at
Hayward Field on June 19, 2021 in Eugene, Ore. Image by jenaragon94 on Flickr. June 18, 2021.

June 19th, 2021

T

his was the day that
Sha’Carri Richardson’s
dream of going to
the 2021 Olympics was crushed.
Sha’Carri Richardson was predicted to be the big gun in the women’s 100-meter race after winning
with a time of 10.86 seconds in
the U.S. Olympic Track and Field
Trials. A turn of events occurred
when Richardson tested positive
for cannabis as a result of the
psychoactive component, THC.
Cannabis use, one of the numerous banned substances under the
United States Anti-Doping Agency
(USADA), results in a three-month
suspension if the athlete can
confirm that the substance use did
not occur within the competition
period and had no relation to their
sports performance. Additionally,
athletes can reduce their suspension to one month if they complete a substance abuse treatment
program with approval from the
USADA [1]. Insomuch as the Track
and Field Trials took place a mere
month before the start of the 2021

Olympics, Richardson had the
opportunity taken away from her
to represent the USA. Richardson
completed the counseling program as a result of her cannabis
use in response to cope with the
tragic news of her biological mother dying just weeks before the
start of the competition [2]. Athletes across the board have been
in situations like this, but as laws
are changing and research is being
conducted, the rules remain the
same for cannabis use in athletics.
Why is this the case?

Brief History Lesson
Cannabis has been present in this world since 4,000 B.C.E
originating in China. Its original
use was to treat ailments such as
gastrointestinal illnesses, seizures,
malaria, and pain associated with
childbirth. From that time, it made
its way through Asia, the Middle
East, and Africa. It did not appear
in America until 1545, though,
when the Spaniards brought the
hemp plant in hopes to make
good rope for the ships they were

building. Fast forward to the 19th
century, cannabis became more
popular and used for recreational purposes. Cannabis began
being used for numerous illnesses, plus drug companies began
constructing cannabis tinctures.
Subsequently, the Pure Food and
Drug Act of 1906 and the Harrison Narcotic Act of 1914 imposed
restrictions on alcohol which
indirectly increased recreational
use of cannabis. Harry Anslinger,
who was the first commissioner
of the Federal Narcotic Bureau
in 1930, attempted to eliminate
cannabis which led to the Marijuana Tax Act of 1937 [3]. This
tax act ensured that possession
of cannabis would result in legal
penalties which increased with the
implementation of the Boggs Act
of 1951 and the Narcotics Control
Act of 1956 [4] . Imposing a tax on
cannabis was declared illegal by
the Supreme Court in 1969 because imposing a tax on someone
who wants to possess an illegal
substance is considered a form of
self-incrimination. It was not until
1970 though when the Federal
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Drug Enforcement Agency (FDEA)
specified cannabis as a Schedule 1
drug, making medical and recreational use illegal [5]. As a schedule 1 controlled substance, cannabis has no accepted medicinal use,
high abuse potential, concerns for
dependence, and a lack of accepted safety for use under medical
supervision [4]. Despite this, in
1996 California enacted the Compassionate Use Act, which permits
legal access to and use of botanical cannabis for medicinal purposes under physician supervision.
This created a ripple effect in that
18 states have legalized cannabis
for recreational use, 38 states have
legalized cannabis for medical use,
and 32 states have decriminalized
cannabis and eliminated prohibition for the possession of small
amounts [6].

Protect and Serve
The justice system in the
United States was created to “protect and serve” its citizens, but it
does not do so equally. The “war
on drugs”, started by Richard Nixon in 1968, was created to reduce
the illegal drug trade in the United
States. Following this, our jails,
prisons, and courts experienced a
monstrous wave of rules and regulations while doing very little to
decrease the actual use of drugs
in communities. The United States
has seen a five-time increase in
incarcerations as compared to
1972, but there is no equivalent
decrease in drug use. Moreover,
discrepancies are found concerning the population that serves in
prison versus the rate and prevalence of drug use in the general
population. Rates of illicit drug use
are quite similar between Blacks
and Whites, with some lower numbers seen for Hispanics. Reporting
of drug use is commonly found in
communities of suburban, middle-class areas across the country.
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Marijuana plant and chemical structure of non-psychoactive compound: CBD.

Whites were 5 times more likely
to use cannabis than their Black
counterparts, but Black men are 13
times more likely to be admitted
to prison with similar drug charges
to White men and thus make up
60% of the prison population. In
some cases, there is a 26 to 27fold increase with this discrepancy.
This is not saying that Black men
are more likely to do drugs, just
that they are more likely to be
arrested and convicted. As a result
of these incarcerations, Blacks
have more difficulty finding work
as bosses are less likely to hire
people with previous track records.
Additionally, their social networks,
relationships, and families have all
suffered significantly. As demonstrated, the history of cannabis is
not only rooted in a plethora of
laws and regulations, but also a
severe discrepancy that disadvantages Blacks and Hispanics in an
already unequal society [7].

What is Cannabis?
Cannabis is a cannabinoid
that contains the psychoactive
compound delta-9-tetrahydrocan-

nabinol (THC) and non-psychoactive cannabidiol (CBD). The THC
in cannabis primarily acts on the
brain through the first cannabinoid
receptor (CB1) and the second
cannabinoid receptor (CB2). Each
of these receptors is a G-protein
coupled receptors (GPCRs) which
are a large number of receptors
that respond to various external
stimuli. Activating GPCRs causes the release of an intracellular
protein, known as a G protein,
which controls the activation of
an enzyme within the postsynaptic neuron. This activation then
communicates with the second
messenger, allowing the receptor
channel to open and potentially
affect additional processes in other
parts of the cell. CB1 receptors
have a high concentration in the
central nervous system (CNS) and
are the most common GPCRs
in the CNS 3. CB2 receptors are
primarily found in the tissues of
the immune system as well as the
heart. In 1964, the structure of the
main psychoactive compound,
now known as THC, was discovered by Mechoulam and Gaoni
[8]. Thus, this discovery allowed
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researchers to delve more deeply
into the world of cannabis.

The Ins and Outs
of THC
There are numerous neurotransmitters involved in the
mechanism of action for cannabis.
As illustrated in Figure 1, upon
inhaling a puff of cannabis containing THC, the CB1 receptors are
primarily activated. This activation
is dependent on two of the endogenous cannabinoids found in the
body which are anandamide (AEA)
and 2-arachidonoylglycerol (2-AG).
The cannabinoids inhibit the Ca2+
channels which in turn activate the
K+ channels, making the cell less
likely to release neurotransmitters.
As a result, there is an inhibitory
effect on the neurotransmitter
release of norepinephrine (NE),
dopamine (DA), gamma-aminobutyric acid (GABA), acetylcholine
(Ach), and glutamate (Glu). CB1
activation has been found to increase DA in the prefrontal cortex
(PFC), though, which is responsible for high cognitive functioning,
planning, and problem-solving. As
can be seen in Figure 2, there is a
disinhibition of pyramidal Glu neurons. The normal GABA release
onto these pyramidal Glu neurons
is now suppressed, allowing Glu
to be released onto the ventral
tegmental area (VTA) which plays a
role in drug addiction, behavioral
disorders, cognition, motivation,
and locomotor activity. The VTA
then projects onto the Nucleus Accumbens which then projects onto
the PFC and increases dopamine
in that region.

THC vs. CBD
CBD was first isolated from
cannabis in 1940 and its structure
was later reported in 1963. Unlike
THC, the most notable difference

Figure 1: The human endocannabinoids (AEA and 2-AG) can bind to the CB1 receptor as
well as THC molecules. Image created by Racine Ross with BioRender.com

for CBD is the fact that it is not a
psychoactive compound. In other
words, CBD has similar pharmacological effects to THC but does not
produce the high that you experience when consuming THC. CBD
does not have any impact on the
CB1 and CB2 receptors which typically produces the psychoactive
aspect, or high. CBD has increased
in popularity and is more heavily
studied with its possible health
benefits for the central nervous
system such as assisting with generalized anxiety, obsessive-compulsive disorder, panic disorder,
and psychosis [9]. Additionally,
CBD has been found to have
possible use as an antipsychotic,
anti-inflammatory, antiepileptic, as
well as for some neuroprotective
effects. Furthermore, some applications of CBD for medicinal use

have emerged such as in treating
pain (chronic and neuropathic), diabetes, cancer, and neurodegenerative diseases such as Huntington’s
disease [4].

Pharmacological
effects and Time
Course
Cannabis is known to have
psychotropic effects as well as
somatic effects such as analgesia,
antinociception (pain-blocking),
and orexigenia (appetite stimulant). When taken in low to moderate doses, pleasant side effects
can be seen such as euphoria,
elation, exhilaration, disinhibition,
hyperactivity, and an increase in
hunger. Additionally, users have
reported subjective effects includ-
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Figure 2. CB1 activation increases dopamine in the prefrontal cortex by allowing glutamate to be released onto the VTA as a result of
the inhibition of GABA on the glutamate neurons. The VTA acts on the NAcc which then acts on the PFC and increases dopamine in
that region. Image created with Biorender.com by Racine Ross.

ing feeling calm, relaxed, and in a
dream-like state. To boot, cannabis
is known to have anxiolytic effects,
so individuals may use it to aid in
relieving their stress and anxiety
[10]. On the contrary, when taken
in high doses, cannabis can induce
adverse effects such as anxiety,
tachycardia, and hypertension.
Cannabis has multiple
routes of administration but its
most effective and well-known is
smoking. When smoked cannabis
typically has peak plasma concentrations attained within 3-10
minutes [11]. Inhalation of cannabinoids bypasses the first-pass metabolism that usually takes place
when orally ingesting compounds.
First-pass metabolism occurs when
enzymes in the GI tract or liver can
significantly reduce the concentration of a drug that reaches the
bloodstream [3]. Cannabis rapidly
distributes into organs containing
high amounts of blood vessels
and then evening out into less
vascularized tissue. Much of the
THC absorbed is stored in body
fat where it is slowly released
from. Metabolism of THC takes
place by hepatic cytochrome P450
enzymes. In metabolizing THC,
its metabolites 11-hydroxy- THC
(11-OH-THC) and 11-carboxy-THC
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(11-COOH-THC) go through the
process of glucuronidation which
is excreted in feces and urine [11].
When identifying THC in urine
samples, the focus lies on identifying its inactive metabolite, 11-carboxy-THC. In compliance with the
World Anti-Doping Agency, testing
positive for cannabis is found when
the test detects 11-carboxy-THC
concentrations greater than 15
µg/L [13].
The amount of time it takes
for the plasma levels of THC to
fall to 50%, also known as a drug’s
half-life, varies depending on an
individual’s frequency of usage but
is typically around 20-30 hours.
Heavy users typically have a longer
half-life as a result of the slow
redistribution from fatty tissues.
In light users, who are individuals
that consume cannabis less than
twice per week, a positive urine
sample will occur for 1 to 3 days
after ceasing smoking. In regular smokers, who are individuals
that consume cannabis several
times per week, a positive urine
sample will occur for 7 to 21 days
after ceasing smoking. In chronic
smokers, who are individuals that
smoke daily for extended periods, a positive urine sample can
occur for 30 days or longer upon

ceasing smoking. Consequently,
testing positive does not technically mean that an individual has
recently smoked cannabis. There
is little to no correlation between
the presence of 11-carboxy-THC in
urine samples and the presence of
significant concentrations of THC
in the blood [3].

Do you use it too?
Cannabis is considered to be the
most commonly used federally illicit drug in the United States, with
about 18% of Americans using it
in 2019. Adolescent cannabis use
has varied since 1979 from 50%
to an all-time low of 22% and now
hovering around 36%. There also
appears to be a gender difference
among adolescents in which males
have a higher prevalence of daily
use of cannabis as compared to
females. Furthermore, daily use
is higher among Black and Hispanic adolescents as compared
to their White counterparts which
elucidates the racial stereotypes
associated with cannabis use in the
United States. These statistics are
found to be true for both adolescents and adults.
When looking at the young adult

SCIENTIFIC KENYON

age group, there were significantly
higher rates of increased pastyear cannabis use as compared
to those in the older age groups.
Contrary to the adolescent age
group, cannabis use declined
among men in the adult age group
while the use in women remained
fairly constant. This decline is
consistent with the narrowing of
the gender gap in the frequency of heavy drinking and alcohol
problems. In addition to the racial
and ethnic disparities, an individual’s income also plays a role in
cannabis use across the United
States. Individuals with the lowest
incomes had the highest risk and
substantial rates of increase in
past-year cannabis use as well as
cannabis use disorder. Moreover,
men in adult households making
less than $50,00 have increased
prevalence than women in the
same situation.
As it happens, cannabis use
among pregnant women is more
common than we would like to
admit. Past-month cannabis use
increased to 62% among pregnant
women and 47% among non-pregnant reproductive-age women [5].
Thus, we can see that cannabis use
is prevalent across all age groups,
genders, ethnicities, socioeconomic backgrounds, and reproductive
statuses.

Do athletes use it
too?
A recent study conducted
in 2019 found that cannabis use
runs in second place following alcohol use among athletes. A study
conducted in 2011 found that
one-third of male and one-quarter
of female student-athletes in their
NCAA Division 1 school reported
using cannabis in the past year
[12]. Additionally, a study conducted in 2020 found that 1 in 4 athletes (23.4%) used cannabis in the

past year but the scientists who
conducted this study believe this
number may be underrepresented
of the actual number since they relied on athletes self-reporting their
use. These numbers are slightly
lower than we see in students who
don’t participate in athletics, but
it is also thought to believe that
student-athletes underreport their
cannabis use [10].

Does Cannabis use
show evidence for
enhancing
performance?
Now that we’ve got the
nitty-gritty information out of the
way, we can talk about what we
came to talk about: does cannabis
use show evidence for enhancing
performance? Studies upon studies are conducted, indicating how
exercise is essential for remaining
healthy in life. As cannabis becomes increasingly popular and
laws are changing around its use,
scientists have begun studying
cannabis use and its effects on

physical exercise performance.
There is a lack of strong evidence
showing that there is a relationship
between cannabis use and athletic
performance. Conversely, there are
proven to be adverse effects from
short-term and long-term cannabis use. On the short-term side,
cannabis use has been found to
result in impaired short-term memory, impaired motor coordination,
altered judgment, and paranoia
or psychosis in high doses. On the
long-term side, significantly heavy
cannabis use has been found to
result in chronic bronchitis and
increased risk of chronic psychosis-related health illnesses such as
schizophrenia, myocardial infarction stroke, and transient ischemic
attack [4]. Moreover, research
has found that long-term effects
may result in immunosuppression,
bronchial irritation and inflammation, and even reducing sperm
count and viability in men.
Additionally, a review
study conducted in 2018 found
that there are results that indicate
cannabis use negatively affects
an athlete’s performance. Thus,
cannabis is considered an ergo-
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Figure 3. Reward pathway in the brain. Image created with Biorender.com by Racine Ross.

lytic substance as opposed to an
ergogenic one. That is, cannabis is
a substance that impairs exercise
capacity and athletic performance
instead of enhancing it [10].
Although there is no evidence on
physical performance enhancement, there is some evidence
that may suggest that athletes
use cannabis due to the euphoric
subjective experience. As mentioned earlier, THC has anxiolytic
effects at low doses which is why
some athletes may depend on the
substance to relieve any anxiety
before competitions. Additionally, athletes have reported other psychological improvements
such as an increase in relaxation,
pleasure, and an improvement in
sleep. These factors do not directly affect performance, but there
is the chance that they can positively impact an athlete’s mindset,
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therefore indirectly affecting their
performance. One thing to note
though is that these psychological
factors have all been subjective
self-reports. There is no concrete
evidence that shows a direct relationship between cannabis use
and its influences on the mental
state of an athlete concerning the
management of their anxiety [10,
12].
Throughout the sporting
world, there are no consistent
penalties found when testing
positive for THC. The NFL and
National Basketball Association
have clearly defined penalties,
but the National Hockey League
has minimal penalties for athletes
testing positive. Moreover, there
is no consistency in an acceptable
level of THC. The NCAA will not
permit THC levels at a threshold
greater than 1.5 µg/l while the

World Anti-Doping Agency (WADA)
will permit THC levels at a threshold of 15 µg/l. On top of this, the
NCAA does not allow cannabis use
at any point of the season, while the
WADA only bans the substance at
the time of competition.
With all the aforementioned evidence, my question then is, why
does our society continue to view
cannabis as an illicit substance with
no accepted medical use? Why
are there numerous discrepancies
between levels of accepted concentrations or times at which cannabis
use may be appropriate? As Bob
Marley once said concerning cannabis use, “Herb. Herb is a plant.
Herb so good for everything. Why,
these people who want to do so
much good for everyone – who call
themselves governments and this
and that – why them say you must
not use the herb?” [14]
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Why women are more
likely to develop migraines

SCIENTIFIC KENYON

Kayla’s Story*
The day Kayla found out she was pregnant, she was on cloud nine. Having grown up with siblings,
Kayla had always known she wanted a large family of her own. After getting married last year, she and her
husband, Adam, had immediately started trying for a baby. Nine months flew by, and they were soon parents to a beautiful baby girl named Hope. Although exhausting, the first few days with Hope were wonderful.
Then, Kayla started feeling sick.
She felt an intense pain on the left side of her head, had tunnel vision and often felt dizzy. She couldn’t stand
sunlight, and every time Hope cried, she almost threw up. When Kayla tried to explain her symptoms to
Adam, she stumbled over her words. Eventually, Kayla retreated alone to her bedroom, and slept for days.
In time, this wave of symptoms subsided, only to return again several days later. “What’s happening to me?”
Kayla cried on the phone to her mom. “I can’t take good care of Hope when I feel like this. I can’t even get
out of bed, or I’ll puke.” On the other line, her mom sighed. She explained that she hadn’t wanted to worry
her anxiety-prone daughter unnecessarily while she was pregnant, but that she knew the feeling Kayla was describing well. After giving birth to Kayla and her siblings, she too had struggled with severe migraines: “When
you feel better for a moment, why don’t you google migraine disorder, my love.”
*Kayla’s story is fictional and was written by the author

K

ayla’s story is not
uncommon; Kayla and
her mother are among
the nearly 20% of women who experience migraines [1]. But almost
everyone gets headaches throughout their lives, why was Kayla
struggling so much? Migraines are
different from everyday headaches
in several important ways (Figure 1).
First, headaches affect many more
people than migraines; over 96% of
people will experience a headache
in their lifetime compared to the
18% of people who experience a
migraine. Second, there are over
150 different kinds of headaches,
while there are only two kinds of
migraines, those with and without
aura. Third, the physical symptoms
of headaches and migraines are
distinct: headache pain is often
throbbing and not limited to one
area of the head; migraine pain is
usually dull and centralized to one
side of the head. The final most
important difference between
headaches and migraines is sever-

ity. Headaches are not pleasant by
any means, but they do not negatively impact daily life. The slew of
physical symptoms characteristic
of migraines, such as sensitivity to
light and sound, dizziness, vision
loss, changes in speech and vomiting, make it difficult for sufferers
to perform everyday tasks [2, 3]. In
Kayla’s case, she struggled to take
care of herself and her baby, Hope.
Now that we know the
differences between headaches
and migraines, let’s delve into the
two types of migraines mentioned
above — migraines with aura and
without aura. The Mayo Clinic
defines migraine with aura, also
known as classic migraine, as “a
recurring headache that strikes
after or at the same time as sensory disturbances called aura. Classic
migraines are the most common
form of migraines, and these
disturbances can include flashes of
light, blind spots, and other vision
changes or tingling and numbness
in your hand or face [4].” Aura is

thought to be caused by electrical
or chemical waves passing through
the cerebral cortex, a part of the
brain that contains regions responsible for sensory processing,
vision, speech and movement.
Kayla cried to her mom about
the aura she was experiencing
— she had changes in her vision
and difficulty speaking during her
migraines [5]. It is likely that Kayla
experienced these electrical waves
passing through her visual cortex,
the part of the brain that receives
and processes sensory input from
the eyes, and her Broca’s area, the
region of the brain responsible
for speech production. If you’ve
never had a migraine before, it
may be hard to visualize what aura
looks or feels like. Figure 2 provides two examples of visual aura:
blind or blurry spots and flashes of
light.
Many people who suffer
from migraines, also known as
migraineurs, learn to tell when a
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Figure 1. Differences between headaches and migraines. Image created with Biorender.com by Karoline Edlund.

migraine is coming by the appearance of this aura. The onset of migraines without aura is not marked
by the same “warning sign,” although, after onset, the two types
of migraines are characterized by
the same physical symptoms.
So, what causes people
like Kayla and her mom to have
migraines? While the etiology of
migraines is not entirely understood, researchers have identified
three main factors that contribute
to the development of a migraine
attack: 1) genetics, 2) the environment and 3) hormones (Figure 3).
Unfortunately for Kayla, she was at
risk of developing migraines in all
three of these groups. Her story
does, however, serve as a useful
tool with which to better understand migraine development.

Genetics
“Genetics” refers to the
study of how traits are passed
intergenerationally, in a process
called heredity. To understand
heredity, we first need to understand how Deoxyribonucleic acid
(DNA) molecules function in the
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body. Contained within chromosomes, some sections of DNA are
called genes, which are the foundational units of heredity. Genes
make proteins, which work to allow
our bodies to function. Other
sections of DNA are thought to
act like on/off switches for nearby
genes. Mutations in the genetic
sequence can also impact gene
expression. What’s most important
to understand, is that different
genes are responsible for different
traits — for example, my neighbor
has brown eyes because specific
genes in his chromosomal instruction manual were turned on or
off. Because he has the genetic
instructions for brown eyes, his
son, who received half his chromosomes from his father, is likely to
have brown eyes too.
You may recall that, like
Kayla, Kayla’s mom suffered from
migraines. Researchers Russel et
al. (1996) found that first-degree
relatives of people with migraines
with aura are four times as likely to
suffer from the same type of migraines themselves. This hereditary
pattern in migraine development
suggests a genetic component

to the disorder. But what specific
genes have been linked to migraines?
Recent studies on the genetic etiology of migraine attacks
have identified several potential
genetic markers of the disorder.
Focusing primarily on migraines
with aura, researchers discovered
an overexpression of a C677T
gene mutation in migraineurs
with aura [7]. One specific type of
migraine with aura that affects a
single side of the body — hemiplegic migraines — have been
linked to mutations in three more
genes that contain the instructions
for ion channels and transport
proteins: CACNA1A, ATP1A2 and
SCN1A.
An ion channel is like a cat
door, it allows ions (in this analogy
the cat) to move between sides of
the bigger door (the cellular membrane). Different cat doors open in
different ways — some allow the
cat to move back and forth across
the larger door, others only allow
the cat to cross the door in one
direction and still other cat doors
can be closed for periods of time
to ensure that the cat stays on one

SCIENTIFIC KENYON

Figure 2. Examples of Visual Aura. Images adapted from Cincinatto (2015) (6).

side of the door. Sometimes, a cat
(ion) needs a little help getting
through the cat door (ion channel) or moving around the house
(cell) — transport proteins, in our
analogy cat owners, can help carry
their cats around the house and
coax them through the cat door,
although this does take some energy on the owner’s part (Figure 4).
When mutations in the
genetic sequences that encode
for ion channels and transport
proteins occur, as in the case of
hemiplegic migraines, neurotransmitters and ions are unable to
pass through channels or travel
between cells, and cortical depression is likely to ensue. Cortical
depression is characterized by a
wave of depolarization followed by
activity suppression in a region of
the brain. This decreased function
greatly impacts neural and vascular functioning and, as discussed
above, may be the mechanism
underlying migraine aura [8].
Through the identification
of mutations in these four genes,
we see how genetics play an
integral role in the development
and heritability of migraines with
aura. Research done on twins tells
us that mutations in these migraine-associated genes have an
overall heritability of nearly 50%,
so it is likely that Kayla’s mom

Figure 3. Contributing factors of migraine development. Image created with Biorender.
com by Karolina Edlund.

passed one or all of these mutations down to her daughter, resulting in the two women’s shared
struggles with migraines [9].

The Enviornment
In addition to genetic
predisposition, many migraineurs
report that environmental factors
trigger their attacks. Three of the
most common of these triggers

include changes in weather, odor
and stress. While the majority
of studies on the impact of the
environment on migraine development have relied on self-reported
data, the consistency of responses
across the globe suggests their
validity.
Weather has been one of
the most extensively studied triggers of migraines and, although
the findings have been controver-
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Figure 3. How ion channels and transport proteins function in the brain. Image created with Biorender.com by Karolina Edlund.

sial, 45.5% of migraineurs report
their migraines and headaches
often occur before changes in
barometric pressure followed by
rain, bright sunshine, humidity and
wind [10]. However, the pathophysiology of migraine is complicated, and the physical reasons for
why this environmental factor may
trigger a migraine attack require
more research. More than 40% of
migraineurs report odors as triggers and many people experience
sensitivity to smell during a migraine attack. One possible explanation for this osmophobia was
put forward by researchers Meggs
(1993) and Bernstein (2005), who
suggested that chemical sensitivity
is propagated by neurogenic inflammation in neurons located on
the outer protective layers of the
central nervous system [11, 12].
There are also several interesting
historical hypotheses to support
the evolutionary usefulness of
these triggers. Many migraineurs
claim to be able to predict the
weather based on their symptoms,
which may have allowed early humans to better prepare for storms.
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Sensitivity to odor may also have
been an evolutionary advantage,
as migraineurs may be better able
to identify and warn against environmental toxins [10].
For most migraineurs,
stress is a major trigger of migraine
attacks. Stress may be thought of
as the human response to suboptimal conditions in the surrounding
environment. Again, the pathophysiological mechanisms underlying the relationship between stress
and migraines are poorly understood, but it has been suggested
that stress triggers migraines by
inducing biological changes that
lower a migraineur’s susceptibility
to an attack [13]. Unfortunately,
the connection between migraines
and stress is cyclical in nature
— stress triggers migraines and
migraines increase stress.
While Kayla did not track
the weather or the odors around
her at the beginning of her migraine journey, it is certain that she
was under a lot of stress. As a new
mother her body was physically
healing and she was learning how
to take care of a baby for the first

time. Lack of sleep has also been
strongly linked to increased maternal stress and Kayla, like many
new parents, was certainly not
getting enough sleep [14]. While
some triggers are not within a migraineur’s control, like the weather,
other triggers may be avoided or
managed through lifestyle changes. At the end of this article, we
will see how Kayla learned to track,
identify and avoid as many of her
triggers as possible, particularly through lifestyle changes she
made to reduce her stress.

Hormones
Women, both adolescent
and adult, are three times as
likely to suffer from migraines as
men [14]. Oftentimes, women
develop their first migraine after
first menstruation, pregnancy or
menopause; this pattern suggests
the role of female sex hormones in
migraine etiology.
Hormones are chemical
messages that are released via
our bodies’ endocrine system and
circulate throughout our blood-
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Figure 5. Fluctuations in female sex hormones throught the reproductive cycle. Figure adapted from Glover et. al. (2013) (16).

stream. These chemical messages
control numerous bodily processes, including growth, appetite
and sleep cycles. Sex hormones
in particular, however, control
processes related to sexual maturation and reproduction. In women, the two main sex hormones
are estrogen and progesterone.
Largely produced in the ovaries,
adrenal glands and fat cells,
estrogen helps to regulate a
woman’s reproductive cycle and
is important for cognitive function
and bone health. Progesterone is
secreted by a type of endocrine
gland found in the ovaries called
the corpus luteum; it triggers the
thickening of the uterine lining
to prepare for the potential of
fertilization.
During the female reproductive cycle, hormones fluctuate wildly (Figure 4). Amid the
follicular phase of menstruation,

estrogen and progesterone levels rise in the female body. If an
egg is fertilized, the hormones
move to support pregnancy, but if
pregnancy is not conceived during
ovulation then both hormones
dramatically fall, causing a woman
to shed her uterine lining through
menstruation.
These fluctuations in
estrogen levels have been shown
to trigger migraine attacks, particularly right before menses
when estrogen levels are rapidly
decreasing in the body. In accord
with these findings, many women
on hormonal birth control report
migraine attacks during their placebo weeks, when they experience
estrogen withdrawal.
Pregnancy is also characterized by widespread hormonal
changes. Researchers have observed a worsening of migraine
attacks during the first trimester,
and many women may experience

migraines for the first time during
pregnancy. The postpartum time
period represents another vulnerable time for women, as the
dramatic decrease in estrogen
levels following childbirth often
leads to intense migraines with
aura. But why do hormonal changes seem to lead to migraines?
Some professionals suggest that
decreased estrogen levels may
influence blood vessel contractions
in the brain. Others believe that
low estrogen increases facial and
scalp nerve sensitivity. Still others
have pointed to the relationship
between estrogen and serotonin,
a neurotransmitter important for
mood stabilization and nerve cell
communication. These scientists
also suggest that changes in levels
of serotonin in the brain may cause
the narrowing of blood vessels
which, in turn, cause migraines
[17].
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Kayla experienced her first
migraine with aura after the birth
of her daughter, Hope. Her development of the disorder was likely
in part due to the rapid decrease
of estrogen women experience
after giving birth. While hormonal
birth control has been known to
trigger migraines in some women,
in others, particularly postpartum
women, it has been used to stabilize levels of estrogen in the body
as well as to avoid drops in estrogen by skipping periods. Another
class of drugs, called Triptans,
have also been used to treat the
disorder. Triptans work by behaving like serotonin in the brain to
calm down overactive pain nerves
and, as we will see shortly, Kayla
found a combination of the birth
control and Triptan medications
helpful in managing her migraines
[18].
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Kayla’s Solution
Kayla had been dealt a bad
hand. She was at high risk of migraines in all three of the etiologic categories associated with migraine development: 1) her family
had a history of migraines, 2) as a
new mother, she was under an immense amount of stress, which was
compounded with a lack of sleep
and loud environment, and 3) following the birth of her daughter,
she was also experiencing dramatic
hormonal changes. What I failed to
mention at the beginning of this article, however, was that Kayla was a
trained neuroscientist. Having dedicated her life to learning about the
brain, Kayla was determined not
to let this neurological condition
affect her quality of life. Soon after
being diagnosed with a migraine
disorder, she scoured many of the
scientific articles cited above and

scheduled countless doctor’s appointments. As her list of migraine
resources grew, Kayla and her clinical team developed a plan to avoid
and manage her migraines.
Kayla could not change
her genetics. Neither could her
mother. While Kayla found comfort
in knowing that mutations in her
C677T, CACNA1A, ATP1A2 and
SCN1A genes were likely to blame
for her and her mother’s migraines,
she worried that Hope would inherit these mutations and thus the
disorder, as well. Much of Kayla’s
distress at the start of her migraine
journey came from the confusion
of what was happening to her, so
she swore not to make her mother’s
mistake. She would be open with
her daughter about her struggles
with migraines and would explain
the heritable nature of the condition to Hope early on. She would
make sure her daughter was prepared and supported if she were to
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ever develop migraines.
Kayla soon accepted that
her environment and emotional
stress greatly triggered her migraines. While she could not control the weather, she learned to
check the weather app on her
phone in order to prepare herself
for the possibility of a migraine
attack. As strong odors often triggered her attacks, Kayla stopped
wearing strong perfumes and always opened a window when she
knew she or her husband, Adam,
were going to be cooking something smelly. While these lifestyle
changes were simple life, managing stress as a young mother is anything but easy. It was in this regard
that her husband, Adam, became
her biggest supporter — aware
that sleep greatly affects maternal
stress, he took to comforting Hope
throughout the night so that Kayla
could get a good night’s rest. Kayla began meditating, journaling
and seeing a therapist, as well. After hearing that she had struggled
with anxiety for much of her life,
her therapist suggested she look
into starting anti-anxiety medication. Selective serotonin reuptake
inhibitors (SSRIs) are the most commonly prescribed antidepressant

medication in the United States today, and Kayla read that SSRIs work
by increasing available serotonin
in the brain. They do this through
the inhibition of serotonin reuptake
by neurons, allowing serotonin to
stay active in the brain at higher
levels for longer periods of time.
SSRIs are highly effective in treating mood disorders like anxiety
and depression [19]. Convinced,
Kayla soon began taking an SSRI
pill every night before bed and, in
combination with her other lifestyle
changes, her stress levels soon decreased.
Lastly, while Kayla knew that
it was only a matter of time before
her hormones returned to what
they had been before her pregnancy and the birth of her daughter,
she was desperate for instant relief.
In order to stabilize her hormones
fast, Kayla began taking a combination contraceptive pill, which
contained both synthetic estrogen
and progesterone. This pill helped
to regulate her hormones throughout the month, as well as allowing
her to skip her period in order to
avoid sudden drops in her estrogen
levels. As mentioned above, if she
were to feel a migraine coming on,
Kayla also found it helpful to take

a dose of her Triptan medication in
order to quickly stop the migraine
from progressing.
Kayla’s story is not uncommon. Nearly 20% of women experience migraines throughout their
lifetime, a statistic which underscores the importance of increased
awareness about the disorder [1].
What sets Kayla apart from the rest
is her determination to understand
the condition and her willingness
to try things to manage and reduce
the frequency of her migraine attacks. She learned about the heritable nature of her disorder, and
the environmental triggers of her
attacks. She also learned the importance of hormones to female
health. Kayla’s training as a neuroscientist undoubtedly helped her
understand her condition, which
brings us to the point of this article.
It is my hope that this article will serve as a resource for other
women struggling with migraines; a
reminder that you are not alone. As
Kayla learned, there are biological
and environmental reasons for the
pain you are feeling, and through
an exploration of these triggering
factors, this article aims to provide
clarity about and tools with which
to manage this disorder.
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Short Term Cravings,
Long Term Effects
A Call for More Comprehensive
Alcohol Education
By Madde Hyland
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I

f you were watching television in the early 2010s,
you likely saw commercials of people with breathing stomas and robotic sounding voices
on nearly every channel. Many
companies and non-profit organizations were hoping to use scare
tactics in a desperate attempt to
stop the devastating effects of
a nationwide nicotine addiction.
Other campaigns, mainly targeted
at younger generations, focused
on having a smoke free country
and aimed to have the upcoming
generation be the one to end
smoking. Anti-smoking ads have
been produced and consumed
for decades. In fact, Britain’s
Health Education Council created
a Superman comic in which the
superhero fights a new villain: Nick
O’Teen (1). In the comic, Superman highlights the dangers of
smoking, and encourages children to join the fight against Nick
O’Teen by saying no to ever smok-
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ing cigarettes. The comic even
featured a certificate for children
who wished to sign on to fight
Nick O’Teen with Superman.
Ads and campaigns like
Britain’s Health Education Council
Superman comic have become
a norm in society because the
negative effects of nicotine, tobacco, and cigarettes have become
common knowledge to the general public. There are long term
effects of smoking cigarettes not
only on the person who decides to
smoke, but also on those around
them. Most people know that
secondhand smoke is just as bad
for a person as smoking cigarettes
themselves, and policies have
been put in place to prevent people from unwillingly experiencing
secondhand smoke. Additionally,
the individual long-term health
effects of smoking, such as the
development of high blood pressure and lung cancer, can pass on
a genetic risk of disease to unborn

A pin depicting anti-smoking ads geared towards younger audiences. “Crush the Evil
Nick O’Teen” by Leo Reynolds is licensed under CC BY-NC-SA 2.0. (https://www.flickr.
com/photos/49968232@N00/4123836129).

children.
All of this information
allows for consumers to become
informed about the risks of smoking before they decide to pick up
the addicting habit. Specifically,
this information puts a sense of
responsibility on both smokers and
non-smokers to be mindful of the
potentially devastating repercussions of smoking on themselves,
those around them, and their
future children. Because of all of
this well-advertised and well-researched information, smoking is
no longer seen as ‘the cool thing
to do’. In fact, many people will
get disgusted looks from others
if they are smoking in a public
space. This can even be seen in
popular culture, where it is no
longer common to see individuals
smoking in movies, whereas that
was the cultural norm several years
ago.
Now imagine yourself in
college on a weekend with your
friends. You’re getting ready to
go out and unwind after a stressful week of classes. What’s the
first thing that you do? Your likely move is going to be drinking
some alcohol to ‘loosen up’ before going out on the town. From
getting drunk at parties, to having
a few beers with your coworkers at
a bar after work, social drinking is
considered an acceptable way to
spend time with friends, unwind,
and meet new people. In fact,
drinking is so ingrained into American societal norms that nearly 30%
of young adults 18 and older in
the United States reported binge
drinking while about 7% reported heavy alcohol use in 2019 (2).
While these numbers already seem
large, they are very likely to be an
underestimate.
According to the United
States Department of Health,
alcohol consumption is considered binge drinking when a person’s blood alcohol levels reaches
0.08%. A person is thought to
have heavy alcohol use if this happens at least five times per month
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The social acceptance of smoking and drinking in America. Original image by Madde Hyland. Created in BioRender.

(3). Many college students go out
to parties, bars, and other social
events one or two times per weekend (roughly four times a month)
and often become intoxicated
beyond the requirements for binge
drinking. Additionally, it is unlikely
that most people will self-report
binge drinking and heavy alcohol
use for a multitude of reasons, all
of which lead to the same result:
underestimates of the true amount
of people who frequently drink
heavily. This means that almost
certainly more than 30% of young
adults have indulged in binge
drinking. The individual long-term
effects of alcohol are well-known:
excessive alcohol use can lead to
severe health effects such as high
blood pressure, heart disease,
learning and memory problems,
risk of addiction, and mental
health problems (4).
Think back to the anti-tobacco campaigns that were mentioned earlier. Can you name an
alcohol ad that is similar to any of
those? The answer is likely no. It is
currently not normal to talk about
alcohol consumption in the way
that we now talk about cigarettes,
nicotine, and tobacco. Other than
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the occasional ‘Don’t Drink and
Drive’ commercial or billboard as
the holiday season approaches,
there are very rarely discussions
about the consequences of drinking alcohol in today’s society. We
know the long-term effects of
heavy alcohol consumption, so
what is the major difference between alcohol and tobacco that
allows for drinking to be socially
acceptable while smoking is not?
The answer is likely that the general public believes that they can
partake in these activities without
affecting others. As long as people
are not drinking and driving, many
people view drinking as a relatively
harmless activity. To compare this
to smoking, the general public
understands – and has received
an abundance of media teaching
them – that anyone who smokes
can negatively affect those around
them, as well as risk the health of
their unborn children. However,
people seem to believe that when
it comes to drinking, everyone is
seemingly off the hook, making it
socially acceptable to drink alcohol
as much as they would like. That is,
unless you are a pregnant woman.

Fetal Alcohol
Spectrum Disorders
and the Weight of
Drinking for Two
In Ancient Greek and Roman cultures, the risks of drinking
during pregnancy were constantly
acknowledged. In fact, women
were told to not drink on their
wedding night in order to avoid
birthing children with developmental defects (5). Although this cautionary tale was passed on through
generations, it somehow found its
way into the world of mythology.
Therefore, many people took it as
just that: a myth. The identification of the relationship between
alcohol and severe birth defects
was widely ignored until the late
20th century. For many years it was
believed that low levels of drinking
were acceptable during certain
stages of pregnancy without causing any harm to the unborn child.
However, doctors continued to
see babies born with severe birth
defects, and began to suspect that
alcohol may be involved.
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As more scientific research was
done on the effects of gestational
alcohol consumption, it became
apparent that there was no safe
amount of alcohol that a woman could drink while pregnant. It
appeared that all levels of alcohol
consumption could risk leaving
a developing fetus with serious
health defects. As knowledge of
this phenomenon grew, the terms
‘Fetal Alcohol Syndrome’ and
‘Fetal Alcohol Spectrum Disorder’
became buzz words as scientists
uncovered all of the potential
effects of drinking alcohol during
pregnancy (6).
Fetal Alcohol Spectrum
Disorders, which may occur when
an expecting mother consumes
alcohol during pregnancy, result in
a multitude of physical, behavioral,
and learning problems throughout
development, many of which can
persist into adulthood (6). Symptoms associated with Fetal Alcohol
Spectrum Disorders include the
following: low body weight, poor
memory, intellectual disability,
vision problems, heart problems,
shorter than normal height, small
head size, and abnormal facial
features (6). These symptoms are
often striking and devastating to
new parents. Because many of
these symptoms do not go unnoticed, babies are able to be diag-

nosed with Fetal Alcohol Spectrum
Disorders at birth or in early stages
of childhood. The growing prevalence of these disorders after their
discovery required some sort of
action on behalf of public health
officials. The public needed to
be informed of the dangers of
drinking alcohol during pregnancy.
Beginning in 1988, the Surgeon
General required that every alcoholic beverage must have the
following warning on the outside
of the container (7):
“GOVERNMENT WARNING:
(1) According to the Surgeon
General, women should
not drink alcoholic beverages
during pregnancy because of the
risk of birth defects.”
As people became more aware of
the risks of drinking alcohol while
pregnant, the pressure was placed
on pregnant women to avoid alcohol at all costs. Unborn fetuses live
in a mother’s womb and survive using the nutrients that they get from
their mother. It seems logical that,
since the fetus and mother share
blood (and therefore blood alcohol
content), this is how the negative
effects of alcohol are passed down
through generations. Pregnant
women were — and still are — advised to break societal norms and

stop drinking with their friends or
unwinding with a glass of wine at
night after a long day at work. This
responsibility was placed on them
alone to make sure that their children were not negatively impacted
by alcohol. However, is it really
only up to pregnant women?

Changing the
Narrative: Everyone’s
Drinking Habits
Affect Everyone
For a long time, it seemed
unlikely that there were any risks to
someone’s future children posed
by alcohol outside of gestational
alcohol consumption given that
moms are the only people who
have contact with a fetus before
it enters the world. However, this
frame of thinking ignores the developmental biology of a growing
fetus, specifically where it gets the
basic genetic information necessary to create human life. DNA
from both the mother and father
are passed onto the fetus, and
therefore mom and dad both have
the ability to pass traits on to their
children. This leads to a very pressing question: does alcohol affect
our DNA? If so, how?

Drinking while pregnant can cause severe developmental effects for new babies. Original image by Madde Hyland. Created in
BioRender
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In the last 20 years, research has been done to investigate these exact questions. When
a question is asked about how a
certain behavior affects our DNA,
the field of epigenetics is often a
topic of discussion. Epigenetics
involve changes to the DNA that,
although they do not affect the genetic code itself, can affect the way
the certain genes are expressed
throughout the body (8). Epigenetic changes can do several things,
including turning genes on and off
at points when they would usually
not be. This can potentially lead to
an imbalance of proteins and hormones that regulate bodily func-

tions and behaviors. Researchers
have found that certain behaviors
lead to specific epigenetic changes to the DNA. Since epigenetic
research seeks to explore how a
person’s behavior can impact their
genetic makeup, scientists set off
to explore the impacts of heavy
drinking on the expression of specific genes related to learning and
memory, as well as addiction.
Mouse models are often used to
study epigenetics because epigenetics work similarly in humans
and mice. Therefore, researchers
used mouse models of binge
drinking and chronic alcohol
consumption to investigate how

Heavy drinking can lead
to heritable epigenetic
changes to the DNA. Me3
is a type of epigenetic
change to the DNA.
Original image by Madde Hyland. Created in
BioRender
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this can affect gene expression
and epigenetics. Studies have
shown that alcohol consumption
can actually epigenetically modify
a person’s DNA. These changes
can result in a multitude of behavioral changes, including making
an individual more susceptible to
the rewarding effects of alcohol
and therefore more likely to develop a dependence or addiction
(9). Scientists have also demonstrated that high levels of alcohol
consumption in mice, similar to
heavy alcohol use in humans, can
lead to an increased preference
for alcohol, and a decrease in
working memory – the capability
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to remember information for small
amounts of time (10).
Scientists have used mouse
models of alcohol consumption to
show that these behavioral changes are linked to the differential
regulation of particular genes, and
that this differential genetic regulation can be passed down to the
next generation of mice (10). One
specific study investigated the role
of alcohol consumption on working memory in the next generation.11 This study found that the
offspring of mice who were subjected to heavy alcohol consumption had a downregulation in dopamine transporter proteins, which
are crucial for memory and the
formation of new neurons in the
brain.12 These molecular changes
in the brain resulted in a deficit
in spatial memory, and the mice
whose parents had consumed
large amounts of alcohol were
unable to remember locations that
they had previously visited (11).
A separate study showed that
heavy alcohol consumption can
lead to the upregulation of the
SIRT1 gene, which plays a role in
the rewarding effects of alcohol (9,
13). An increase in the rewarding
effects of a drug of abuse can result in a higher risk of developing
an addiction to the drug. Therefore, the upregulation of the SIRT1
gene is a potentially dangerous
result of long term alcohol use.
Unfortunately, it has been suggested that the upregulation of this
gene may be passed onto future
generations, which can increase
the risk of offspring developing
addiction later in life (13). Studies
have demonstrated that some
of these epigenetic changes can
even persist into a second generation of offspring (13). This means
that your alcohol consumption
can not only affect you, but your
children and grandchildren as well.
Put simply, anyone who drinks
heavily can pass down negative
traits to their future children, and
can even increase their susceptibility to addiction.

Potential labels warning consumers of the negative consequences of heavy drinking.
Original image by Madde Hyland. Created in BioRender.

While these studies uncover the impacts that alcohol consumption can have on your children even prior to conception, it
also highlights that both sexes are
capable of passing these negative
traits on to the next generation
(10, 11, 14). These research findings, while grim, may be seen as
somewhat of a relief for expecting
mothers: the idea that they are
the only ones responsible for the
health of their unborn children has
now been debunked. The responsibility is no longer only on them,
but rather on everyone to drink
responsibly.

It’s About Access to
Information
The research papers discussed in this article are often
hard to read for an undergraduate science student, let alone
someone with little to no scientific
background. Many forms of scientific research are inaccessible
to the general public due to the
heavy use of scientific jargon. This
leads to a delay in the spread of
new and important information
and can often lead to a disconnect
between the scientific community
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and the rest of the world. New
commercials, advertisements,
campaigns, and warning labels
all do one thing: they give the
general public access to information that allows them to make an
informed decision before partaking in potentially harmful activities.
As information about the harmful
effects of smoking became public
knowledge, less people made the
decision to smoke. Once people
learned that secondhand smoke
could affect other people, policies
were enacted to give people the
choice to be smoke-free. Now
that it is known that heavy alcohol
consumption can affect people’s
future children, it is likely that the
incidence of heavy drinking, along
with its negative effects, will decrease if this knowledge is transferred from the scientific community to the rest of the world.

Taking Action:
Changes in Policy
It has now been established that heavy alcohol consumption and binge drinking can
in fact affect those around you,
specifically when thinking about
your future children. Now that we
know this, what is the next step?
We can actually use the lessons
learned from cigarette and tobacco prevention strategies and apply
similar tactics to heavy drinking.
The very first step is to educate
the general public about the
long-lasting and hereditary effects
of drinking to an unhealthy extent.
This can be done by commercials that target all generations. A
short commercial using a simple
splitscreen to demonstrate the
difference between the life of a
heavy drinker and their family
compared to a responsible drinker
could prove to be an effective way
to portray this information to older
audiences. For younger audiences
such as school-age children, education on the long-term effects of
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heavy drinking can be implemented into preexisting “Don’t Drink
and Drive” education campaigns.
Additionally, a spin-off of the Nick
O’Teen character in the Superman
comic could spread awareness to
yet another audience. The main focus of these proposed campaigns
is simple: make the long term
negative effects of alcohol public
knowledge, just like we’ve done
with tobacco.
While educating the general
public will be a long and tedious
process, there are also immediate
changes that can be made to the
way that alcohol is advertised and
distributed across the country. As
mentioned earlier, the only warnings currently displayed on alcohol bottles are ones that warn of
gestational alcohol consumption
and a warning to not drink and
drive. Alcohol companies are not
required to warn consumers about
the risk of addiction or any other
potential effects of alcohol consumption (7).
This has been a very recent
point of discussion in the tobacco
industry, and in March of 2020 the
FDA officially required cigarette
companies to add warning labels
to their packaging and in their
advertisements (15). These new
warning labels are required to
demonstrate some of the less wellknown, but still devastating health

risks of smoking cigarettes in vivid
detail, including imagery of lung
disease, cancer, and even a small
child on oxygen. These regulations
are set to take effect in October
of 2022 (15). These now complex
and informative labels on cigarette packs are meant to inform
consumers about the dangers of
their purchase and the potential
choice to smoke cigarettes. Given
that alcohol also has widely unknown long-term effects, it is of
the utmost importance that the
warning labels on alcohol containers also change. The addition of a
simple image and text box explaining how alcohol can not only affect
the consumer, but also their future
children, would help to diminish the
risk of alcohol addiction and cognitive defects in future generations.
It is important to note that the
overall goal of this proposed
alcohol education is not to scare
people away from drinking. Alcohol consumption is ingrained in
our society. People enjoy wine with
their meal and cracking open a
beer while watching football, and
these norms will likely remain for
the foreseeable future. Rather, the
purpose of more comprehensive
alcohol education is to inform the
public of the potential long term
dangers of misusing alcohol, and
to encourage them to think before
they drink.
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Exercise Can Give Us
Brain-Boosting Superpowers?
By Selam Habtemariam
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ith the snap of
your fingers, what
if it was possible
to boost brain power, longevity,
and function against the strains
of time? What if we could slow
the brain’s process of aging? For
centuries, questions of maintaining the brain’s youth and boosting
its power have been grappled
with by scientists and nonscientists alike. Legends of fountains of
youth have been an alluring topic
of many stories throughout pop
culture along with similar myths
of immortality. Many superheroes in our favorite movies often
have these gifts of immortality,
extraordinary physical capabilities, sharp instincts, and highspeed problem-solving abilities.
Such fantasies of having these
superpowers, of course, do not
exist to our knowledge. However,
the incorporation of a particular
lifestyle change has been found
to be responsible for extending
life expectancy and brain power:
staying physically active. In many
ways, exercise may be one of the
closest things we have to our very
own semi-instant power boost for

the brain. It does not sound as
enthralling as the subject of many
expeditions in search of immortality, or having the power to levitate
objects with our mind. However,
when incorporated into one’s
lifestyle, exercise has tremendous
influences on the brain that you
may not expect.
Regular exercise is widely
known for its physical benefits
from maintaining a healthy weight,
to supporting our heart health, to
heightening endurance, to building strength in muscles and bones
(1). Though it is not a muscle, the
brain also becomes stronger when
exercise is incorporated correctly.
In fact, physical activity can help to
slow the typical aging processes
of the brain, along with boosting
brain health and function. Many
of these aging processes involve
neurodegeneration, processes
by which neurons lose function,
resulting in the deterioration of
memory, motor abilities, cognitive
function, and many other capacities (2). It is known that exercise
is important for brain health,
but what specific pathways does
it work through? Research has
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revealed that numerous neurophysiological and neurochemical
pathways are altered with physical
activity that produce long-term
effects, as described previously
with neurodegeneration prevention, but also valuable short-term
effects (2). Chances are, you have
also experienced some of these
short-term effects after completing a long or intense workout.
Picture this: as you wrap up
a workout, you reach your last rep
of burpees. Your body is aching,
and you feel like you can’t finish.
Your hands hit the ground and you
propel yourself upward with a feeling of fulfillment and elation washing over you. Chances are you feel
more exhilarated at the end of the
work out than before you began
from that boost of adrenaline. This
is due to modulation of pathways
responsible for elevating your
mood.
Together, we will continue
to explore new strategies that you
can incorporate into your own
workout routines to maximize
both short term and long-term
benefits to your health based on
emerging research.

“A happy young woman holding two pink weights” by Nenad Stojkovic. June 6, 2022 on Flickr is licensed under CC BY 2.0.
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Acute vs. Long-Term
Exercise: What’s the
Difference?
Before we get into the details of how exercise can influence
the brain long-term, it is valuable
to understand the benefits of a
single bout of exercise — clinically
referred to as acute exercise. We
have discussed some brain benefits from short-term exercise, but
interestingly, there are more benefits than just mood. How do these
acute brain benefits of exercise
compare to long-term brain benefits? Many clinical trial studies have
been conducted trying to answer
this question.
Studies on acute exercise
explain that performing approximately a half-hour of aerobic
exercise has benefits linked to
motor learning, characterized by
both the excitation and inhibition
of the motor cortex observed with
transcranial magnetic stimulation
(TMS) measurements (2). These
measurements provide evidence
of motor learning improvements
and the potential for enhanced
cortical plasticity, or the brain’s
extraordinary ability to form new

connections between neurons
based on lifestyle choices or
experiences (2). Intriguingly, this
indicates that simply performing
a single round of exercise for a
short amount of time does so
much more than elevating the
heart rate and mood. It sparks
the performance and adaption of
new motor skills, particularly when
there is repetition. Acute exercise
also introduces the potential for
making more neural connections
throughout the brain. It was additionally found that acute exercise performed at a large range
of intensities, from low to high,
improved the following aspects
of executive function for up to
two hours: attention, problem
solving, decision making, verbal
fluency, cognitive flexibility, and
even working memory (2). Though
one may expect that these brain
boosts after physical activity occur
from activities performed over a
longer amount of time, these effects were seen in as little as thirty
minutes of aerobic exercise! This
is significant because it illustrates
that no matter how little exercise
is performed, almost any form
of exercise performed for some
amount of time is great for brain
health. As you may guess, if the

brain begins to develop stronger
motor skills within the span of
thirty minutes, the influences of
the same exercise over a longer
period must hold even more opportunities for levels of neuronal
plasticity, learning, memory, and
many other benefits.
Researchers have found
that compared to short-term exercise, exercise consistently practiced over a long period of time
results in many more enhancements and protective mechanisms
being activated in the brain. In
fact, the long-term benefits of
physical activity on the brain are
so vast, they have been incorporated into treatment programs
for patients with various mental
disorders. For example, a previous
clinical study worked with middle-aged patients suffering from
stress-related exhaustion with
exercise incorporated into their
treatment. Patients were given
physical activity recommendations
with comprehensive instructions
as a part of a multifaceted treatment program for 18 months. It
was found that though all of the
patients experienced some level
of improvement from burnout, depression, and anxiety, strong and
mild compliers to physical activity

Neuroplasticity by CogniFit.com, illustrating neural networks before stimulation (1), after two weeks of stimulation (2), and after
two months of brain stimulation (3).
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Figure 1. Long-term vs. short-term influences of exercise on cognition, mood, and behavior. Image created with Biorender by Selam
Habtemariam.

recommendations reported significantly less burnout compared
to non-compliers at the end of the
18-month period (3). This study
revealed that long-term exercise
helps with treating chronic stress
and improving mental health, and
can be incorporated into current
treatment plans. Compliance with
these recommendations is important in maximizing enhancement
of brain health. Now that we have
looked at long term brain benefits
of physical activity in middle-aged
people, let’s consider these effects
on young adults.
Another study with young
adult women, ages eighteen to
twenty-five years, with moderate
levels of depression were also
enrolled in an exercise program.
The program lasted eight weeks
in which researchers found that
when students performed aerobic
exercises with 60-65% maximum
heart rate, levels of depression
were reported to significantly
decrease over the course of the

eight-week period (4). Of course,
it would be too ambitious to
assume from these results that
curing depression through sport
or other forms of physical activity are possible. After all, crucial
sessions of psychotherapy, compliance to particular prescription
medications, self-soothing techniques, and many other forms of
treatment suggested by doctors
for depression may be necessary
to see substantial improvements in
mood. But what other neural circuits do incorporations of regular
aerobic exercise work through?
If you guessed that long-term
aerobic exercise improves brain
function in more long-lasting ways
than mood and stress deficits, you
are absolutely right.
Incorporation of long-term
exercise into your lifestyle can
reduce the risks of developing
detrimental effects of aging on the
brain, or neurodegeneration (2, 5).
Neurodegeneration is a process
that occurs in many cognitive dis-

eases such as Alzheimer’s, Parkinson’s, and Huntington’s disease.
How does the brain assemble such
a strong protection against these
deadly brain diseases? The brain
does this through heightening
brain plasticity and neurogenesis,
or the generation of new neurons
in the brain (2, 5). Brain plasticity,
or neuroplasticity, is responsible for the brain’s extraordinary
ability to adapt from experience
through growth and reorganization of neural networks. As
long-term exercise is performed,
neurogenesis facilitates the brain’s
powerful ability to adapt through
the generation and integration of
new neurons. As you go for your
next routine jog, think of how
transformative exercise can be in
strengthening these neural connections and protecting you not
only from cardiovascular disease,
but also many neurodegenerative
and behavioral disorders!

80

SCIENTIFIC KENYON

Aerobic vs. Mindful
Exercise: What’s the
Difference?

Have you ever tried running up a steep hill as fast as you
could without stopping? Each step
hiking upward to the top seems
to make your steps and chest feel
heavier, and you begin to pant
heavily. Maybe you have been late
to class or work. With the elevator
taking too long, you grudgingly
decide to take the stairs to class
as fast as you can, feeling your
heart rate increase and gasping
for air when you finally get there.
Or maybe you remember jumping
rope with your friends when you
were younger. Swinging the rope
as fast as you could, you may have
tried to see who could jump rope
fastest or for the longest amount
of time. What do all of these
periods of physical activity have
in common? Commonly known
as “cardio,” these are all forms of
aerobic exercise. Aerobic exercise
is characterized by physical activity that produces increased heart
rate and increases the body’s use
of oxygen. Oftentimes, these are
exercises of high intensity, though
there are some lower impact
aerobic exercises such as walking. However, benefits exist for
both moderate and high intensity
aerobic exercise. Moderate-intensity aerobic exercise is particularly

81

helpful in improving executive
functions, such as working memory. High-intensity exercises, on the
other hand, boost information processing (2). Each of these benefits
may be something you would like
to keep in mind as you think of
what aerobic exercises you would
like to get into. We now know
that intensity matters, but all we
have discussed are heart pumping
exercises. Let’s slow our pace and
investigate another exercise.
Stretch your arms up,
take a deep breath in, and slowly
pull your arms down by your sides,
breathing out. When done with
the correct intention and focus,
you should be engaging muscles
up through the torso with the
rising and falling of your breath
with this stretch. In fact, you have

performed the first step of a new
range of brain-boosting exercises: mindful exercises. You may be
wondering how these soothing
exercises may compare to aerobic
exercise. Scientists have made
these comparisons in participants
of two mindful, low exertion
exercises, Feldenkrais, and yoga.
These exercises were compared
to a computer class that served as
a control, and two aerobic classes: an aerobic dance class, and a
swimming class (8). Yoga, Feldenkrais, and swimming were all found
to improve subjective well-being,
anxiety, and general mood (8).
On the other hand, participants’
mood did not improve in the
control computer class or aerobic
dance groups. Interestingly, it was
suggested that swimming has
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components of both mindful and
aerobic exercise. The rapid, rhythmic, and repetitive nature of the
movements in conjunction with
controlled breathing awareness
may produce particularly heightened benefits in decreasing anxiety and improving general mood
(8). This suggests that finding an
exercise routine that incorporates
both mindful and aerobic qualities
can maximize the benefits of physical activity on brain health.

Is there such a thing
as too much
exercise?
We have explored the vastness of benefits that exercise has
on the brain along with the diverse
modes of exercise that have been
studied to maximize these benefits. Taking all of this into consideration, is there a limit to how much
we should exercise to reap these
benefits? More importantly, how
does excessive exercise influence
brain functionality? As you may
have guessed, too much of anything often leads to more harm
than good for the body.
In many of our favorite
athletes, we likely have seen the
influence of over-training on the
physical body. Some of the injuries that result may cause physical
burnout, temporary inability to
compete, end careers completely,
or may even cause life-threaten-

Figure 2. Aerobic, mindful, and combination exercises to boost brain health. Created by
Selam Habtemariam. Image created with Biorender by Selam Habtemariam.

ing complications. Unfortunately,
overtraining or excessive exercise
may cause the brain to burnout as
well. For this reason, it is vital to
understand the limitations of how
much physical activity we should
incorporate in our daily lives.
We have previously discussed
the necessity of compliance with
suggested physical activities given

by medical providers, and studies
have also explored the negative
influences of overexertion of the
body on the brain (3). Studies have
shown that excessive training,
particularly through aerobic exercises, causes cognitive fatigue,
reduced activity in the prefrontal
cortex, and increased impulsive
behaviors (9). Cognitive control is
required for goal setting behavior. Goal setting behavior helps
prevent impulsive behavior, such
as not stopping physical exertion
of the body when it hurts. These
results may seemingly conflict with
our general findings on aerobic
exercise benefits, but they actually
describe how the cognitive effects of burnout can persist if not
attended to. For this reason, it is
important to be mindful of what
should and should not be incorporated into your exercise routines.

82

SCIENTIFIC KENYON

Tips for Creating
your Brain-boosting
Exercise Routine
Many people likely have
a new year’s resolution of staying
active to improve their health.
We have explored the specifics
of the influence of exercise, so
now is a good time to get up, do
some stretches, and start warming up before we secure a solid
routine! Nevertheless, it can be
really intimidating to know where
to begin. With time constraints of
classes, work schedules, and an
even longer list of commitments, it
can also be difficult to set a routine that works effectively for one’s
individual needs. The main objective is to incorporate exercise into
a long-term plan to improve brain
function more effectively. It likely
will take some time to explore
what modes and levels of exercise
work best for you.
While these may all be
healthy ways to boost brain
health, always consult your doctor
before preparing lifestyle changes. If other health complications
may get in the way of remaining
physically active, this is particularly important. Moreover, here are
some suggested tips before you
make your own routine:
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Suggested Tips:
1. Oftentimes, exercises that improve heart health aid in brain
health as well.

2. Practicing exercises regularly is crucial to reaping benefits in

brain health, longevity of cognitive function, and production
of long term changes in brain plasticity.

3. Know the limits of both what your brain and body can handle.
4. Try and craft an exercise routine that incorporates all the ben

efits of exercise. This likely will mean you may want to try
out a mix of aerobic exercise, mindful exercise, high-intensity
exercise, moderate intensity exercise, etc. We have discussed
that swimming is a mode of exercise that thoughtfully
engages in many of these aspects, making it a great option
for enhancing your brain health.

5. Know what your brain needs. This will likely mean you will

want to work with a professional and do your research before
you dive in.

“Exercise is really for the brain, not the body. It affects
mood, vitality, alertness, and feelings of wellbeing. Exercise is the single best thing you can do for your brain in
terms of mood, memory, and learning.”
John Joseph Ratey, M.D., clinical professor of Psychiatry at
Harvard Medical School.

As you engage your body in some healthy physical exercise, think
of all these lasting benefits and hopefully they will motivate you to
fulfill your goal of elevating the power of your brain.
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In 500 Feet,
Turn Right Onto
Memory Lane
How Our Brains Create
Maps of Our Memories
By Sofia Alonso
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Figure 1. Simple illustration of a memory palace. Image created with Biorender.com by Sofia Alonso.

W

e as humans have
an incredibly
refined understanding of the physical world.
Remembering in detail specific
landmarks and spaces in our everyday lives comes with very little
effort. Evolutionarily speaking,
this innate ability was crucial in
ensuring our survival during a time
where maps had yet to make their
debut. It isn’t surprising that our
strongest memories are significantly linked to the spatial information
associated with its consolidation.
Giving physical context to our
memories can help to lock them in
and improve our ability to retrieve
those memories when necessary.
An ancient form of this technique
is used by the well-known fictional
detective Sherlock Holmes in the
form of a “memory palace,” also
known as the method of loci. According to myth, the invention of
this technique is said to have come
from the Greek poet Simonides of

Ceos who invented it after attending a banquet that ended terribly.
Simonides is said to have stepped
outside during this banquet. Upon
arriving outside, the banquet hall
collapsed in his absence. Simonides was able to identify his fellow
banqueters, despite their bodies
being crushed and disfigured.
He did so by putting a name to
each body in relation to where
they had been sitting before the
hall collapsed. The technique was
further adopted by the Greeks and
Romans, such as the orator Cicero.
During a time where writing was
an expensive luxury few had, he
would utilize a memory palace to
help memorize his speeches (1).
This memory strategy is
a mnemonic device that helps to
memorize information by positioning a visual cue or item at a specific point along an imaginary journey of your choice. Typically, this
journey must be at a familiar location with a well-known route. This

could be your house, high school,
or a familiar stretch of road whose
layout you know how to navigate
like the back of your hand. To
satisfy the conditions of a memory
palace, you would have to create
a mental journey through your
chosen geographical entity composed of numerous discrete loci.
If you are imagining your home,
these loci could be your bedroom,
staircase, kitchen, backyard, and
many other locations specific to
your house. To then embed information into your memory palace
for later recall, one is advised to
travel through the mental journey
and commit imagery of the information you would like to memorize to any locus of your choice.
When the time comes that you
wish to retrieve the information, all
you must do is walk through your
memory palace and come upon
the loci associated with each piece
of information, activating it into
your memory. Let’s try it out! Here’s
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a list of 10 random words that I
would like for you to try to remember using a memory palace:
Ice, Telephone, Birthday Cake,
Toilet Paper, Strawberry, Mouse,
Witch, Carrot, Hairbrush, Golf ball.
Now, walk through your memory
palace and begin to place these
items in any locus of your choice.
Again, if you are traveling through
your home, you could place the
telephone in the kitchen sink and
the witch on your staircase. Have
fun with it! The more absurd the
locations of your items are the easier it will be to remember later.

Let’s Go Back in
Time!
Henry Molaison, also
known as Patient H.M., was a
27-year-old epileptic patient in
1953 when he experienced severe
memory impairment following an
experimental brain procedure.
Surgeons removed a thumb-sized
piece of tissue from each side
of Molaison’s hippocampal formation and surrounding medial
temporal lobe areas of his brain
in hopes that it would help relieve
the severe seizures he had been
suffering for 10 years. Although
the seizures subsided following
the surgery, Molaison experienced
severe memory loss and was not
able to form new memories, leaving him with permanent amnesia.
This tragic event for Molaison became a significant turning point for
the field of neuroscience, letting us
know that each cortical region of
the brain may be associated with
a specific mental function such as
learning or memory. Memory was
now considered separate from other cognitive functions of the brain
and was specifically attributed to
the medial temporal lobe, which
includes the hippocampus, amygdala, and parahippocampal regions. Research inspired by Patient
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H.M. focused on replicating similar
memory impairments in laboratory
animals which led the animals to
display memory deficits as well.
It was also established that the
hippocampus played an important
role in declarative memories —
memories of facts and events that
can be consciously recalled or “declared” in humans (2). Researchers were still left wondering what
underlying neuronal mechanisms
are involved in storing information
as memories.
The term cognitive map —
a mental image that provides the
layout, or map, of a space — came
about when American psychologist
Edward Tolman tested the concept
of latent learning. At the time it
was widely accepted in the field
of behaviorism that learning only
took place when the individual was
conditioned to a specific stimulus
or reinforcement. Tolman tested
three groups of food-deprived
rats and observed their ability
to transverse a maze all the way
to its end. One group had food
rewards at the end of the maze,
the second group had none, and
the third group had no food for

the first ten days, but on the 11th
day, food was placed at the maze’s
exit. Interestingly, after the 11th day
when rats in the third group found
the food at the end of the maze,
subsequent maze trials immediately showed that the same rats were
able to quickly and efficiently find
their way out of the maze, similar
to the rats who were always fed.
Tolman’s experiment showed that
the rats developed a cognitive
map and learned the layout of the
maze despite the lack of any reinforcement, disproving accepted
theories of learning at the time (3).

Palace Cells
Some things remained unclear following Tolman’s discovery.
O’Keefe and Lynn Nadel tested
and proved their belief that a
population of neurons exists in the
hippocampus that holds the ability
to encode the position of the
mammal within its spatial environment. These neurons were given
the name place cells. Recordings
of these place cells in the hippocampus of rats showed that when

”John O’Keefe” by NTNIU, Faculty of Natural Sciences is licensed under CC by 2.0. Flickr.
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Figure 2. When a mouse finds itself at a specific location in its cage, unique place cells will fire at each spot. Left image: Singular place
cells firing at location A, B, and C as the mouse moves through its environment. Right image: Multiple place cells firing along the red
dotted path depicting mouse’s movement. Image created with Biorender.com by Sofia Alonso.

the rats would enter a particular location in their environment (cage)
place cells specifically associated
with that location would fire (4). If
we take for example yourself navigating through your kitchen, some
place cells will become activated
as you hover your hand over your
collection of holiday-themed mugs
trying to find your favorite mug.
Other place cells will fire as you try
to navigate your kitchen through
the dark attempting to find the
refrigerator door handle. Place
cells are responsible for our sense
of place. Once you have explored
your environment and place cells
have anchored themselves to particular places, they accumulate and
create a mental map of the space.
These cells are subject to change,
remapping to different landmarks
as the location of the subject
changes and so does the environment (4). When you walk from your
kitchen upstairs to your room, it
may be that the place cells that
were once firing when you approached your kitchen cabinets are
now firing when you come upon
your bed.
They discovered that the
hippocampus not only has an important role in declarative memory

but is also primarily involved in
spatial interpretation and navigation. Given that both memory and
space appeared to function within
the same brain region, researchers
were challenged to account for
both and better understand how
they work together. A linkage between space and memory became
apparent in some early studies of
place cells where they were able
to express past experiences in
mice. It was discovered that place
cells are not just markers of an
animal’s instantaneous location,
but they also represent locations
in the environment that the animal
experiences in the past, present,
and future. Mice placed through
maze tasks showed place cells
that fired when the animals went
the wrong direction, or when they
made errors trying to navigate out
of the arena, showing that these
neurons have stored information
of these spaces into memory (5). In
a separate study, similar place-cell
activity in rats persisted through
multiple “morphed” environments,
exhibiting the brain’s ability to
reactivate previous representations
of the external world that seem to
be retrieved from memories (6).
Place cell firing sequences that

were activated during spatial behavioral tasks in mice were found
to “replay” or “reactivate” during
sleep episodes, showing that
these sequences were also saved
into memory (7).

Grid Cells
Given the flexible nature
of place cells, researchers were
not sure whether they were entirely responsible for the spatial
blueprint we use to fabricate how
we perceive and experience our
surroundings. These uncertainties
eventually led to the discovery of
grid cells by the wife and husband
duo, scientists May-Britt Moser
and Edvard Moser, and their students at the Norwegian University
of Science and Technology. These
types of neurons are located in
the entorhinal cortex — the hippocampus’ very talkative, next-door
neighbor. The entorhinal cortex is
a flood gate for information leaving and entering the hippocampus. Grid cells are specialized cells
of the brain that, unlike place cells,
do not represent specific locations,
rather they internally create a coordinate system that allows us to
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navigate our external world. They
do not require sensory information
from the environment, such as
sounds, textures, and visuals, to
form this spatial framework. Each
grid cell will fire at various locations that are at a consistent distance from each other, forming a
grid-like hexagonal pattern across
the space (8). An easy way to picture this is if you position yourself
in a small room and imagine the
floor is made up of large, hexagon-shaped tiles. Now imagine dividing each one of those hexagons
into six equilateral triangles and
assigning a specific color to each.
A unique grid cell will fire every
time you step on a certain colored
triangle. Let’s say you move to the

corner of the room and step on a
red tile, grid cell #1 will fire. Then
you move to another red triangle
at the other corner of the room
and grid cell #1 fires again. Finally, you move to a green triangle
in the middle of the room and
grid cell #2 fires up. These grids
can overlap and can have various
orientations or different hexagonal
sizes. When you take them all into
consideration, they all add up in a
way that maps out the exact spatial structure of our world. Specific
locations in your home, whether
that be the corner of your hallway
that you must turn to enter your
room or that one creaky step in
your staircase, are represented by
a special sequence of grid cells.

“Grid cell firing pattern.” Action potentials are shown in black superimposed on movement path shown in gray. Adapted from Stensola et al. (2012). Nature, licensed under CC
by 2.5.
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Your brain will understand where
your body is positioned in relation
to space when multiple grid cells
that overlap at a specific location
are firing at once, almost like when
your GPS tells you your exact
location relative to a map. Together place cells and grid cells work
somewhat like Google Maps. Place
cells establish the presence of
landmarks and important locations
in your cognitive map. Grid cells
are responsible for the coordinate
system, fragmenting your environment into latitudinal and longitudinal points that track direction and
distance.
It is believed that the
grid code which underlies how
grid cells communicate structural information of space to your
brain, could also be responsible
for representing other types of
information. There is reason to
speculate that grid cells can also
represent the structure of conceptual knowledge and abstract
thought. Mapping not only our
physical world but our internal
world as well. It has been hypothesized that we humans can process
conceptual information in the
same manner that we approach
navigating space. It was speculated that the hexagonally symmetric
grid-code produced by grid cells
during spatial navigation may also
be activated during the storage of
conceptual knowledge. Timothy
Behrens and his team of researchers at the University of Oxford
tested this hypothesis by having
human subjects navigate two-dimensional knowledge. Subjects
were instructed to watch a video
where the black outline of a bird
continuously morphed as the leg
and neck lengths were shortened
and elongated. They found in their
data the presence of a hexagonal
grid code that changed and varied
as if the subjects were navigating
their way through a “two-dimensional conceptual bird space”
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Figure 3. Grid cells will record and track the mouse’s location through an overlapping hexagonal coordinate system. Left image: Singular grid cells firing at locations A, B, and C as the mouse moves through its environment. Right image: Multiple, overlapping grid cells
firing along the red dotted path depicting mouse’s movement. Image created with Biorender.com by Sofia Alonso.

— the two dimensions being the
bird’s neck length and leg length.
Their results suggest that this code
is used in both the navigation of
physical space as well as non-spatial conceptual information (9). As
of recently, many neuroscientists
have sought to propose the idea
that the hippocampal-entorhinal
region provides a universal geometric code that maps out all
types of knowledge — experiences, memories, and ideas — within
cognitive spaces in the brain.

Memories Are Not
Forever
Most memories are not
permanent as you may have come
to realize yourself. Many of the
things we have learned or studied in school do not stick with us
forever. Although we have spent
a significant amount of effort
attempting to store this information long-term, it is impossible to
remember everything we have
experienced. According to Ebbinghaus’s forgetting curve, most of our
memories of learned knowledge
will tend to fade over time, unless
this knowledge is attended to with

repetitive review across a long period of time (10). Despite the effort
it might take to store most information into long-term memory,
some meaningful memories can be
permanently retained. Considering
this observation, Kentros and his
colleagues investigated the longterm stability of place cell firing
fields when paired with attentional
demands to specific spatial cues.
Mice were trained in a cylindrical
arena to locate a goal location
while their hippocampal place
cells were being recorded. Other
mice were allowed to freely roam
through the arena with no specific
goal location or task to complete.
They found that place cell stability,
which is when the same place cell
can maintain a consistent firing
field across multiple exposures to
the same environment, is strongest
when the mouse was encouraged
to pay attention to spatial cues to
complete the task at hand. Essentially pointing to the notion that
when spatial cues are attributed to
memories, whether that be facts or
experiences, the retainment of the
information is strongest and most
consistent (11).
Therefore, you may have
noticed that most of your episodic

memories are the easiest to recall.
Episodic memories are those of
autobiographical events that we
have experienced. These types of
memories allow us to “re-experience” the events as if we were
actors in a mini movie playing in
our heads. They can be engraved
in our minds as they are strongly
characterized by multiple cues
such as location, time, and sensations. Take, for example, a significant event in your life whether that
be the death of a loved one or the
day you won a grand prize from a
contest you decided to randomly
enter. If you try to re-experience
this moment it would probably not
be difficult to see all the details
that made up your environment
the day you received the news.
The strong association
between memory and spatial cues
can be attributed to place-cell
activity in the hippocampus. The
possibility that spatial characteristics of our episodic memories are
encoded by our place cells was
tested on patients awaiting surgery for their epilepsy. The subjects had electrodes placed in their
medial temporal lobes while they
were asked to navigate a virtual
town and deliver items to one of
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”Machine Learning & Artificial Intelligence” is licensed under CC by 2.0. Flickr.

the stores. The recordings showed
that place cells, once active at the
locations where each item was delivered, were also activated when
the subjects were asked to recall
each item. The findings suggest
that when attempting to recall an
event, place cell activity during this
recall will bring into consciousness
the spatial context that the event
or item took place in (12). Similar
to how a memory palace associates imaginary spatial cues that
give spatial context with objects
or facts. Time is also a crucial
element of information regarding
experiences and events in our
lives that are stored as episodic
memory. A study led by Kraus and
a team of researchers discovered
that grid cell activity in rats running
on a treadmill was able to track not
only spatial features but temporal
features as well. Their findings supported the notion that a common
circuitry is present between the
computation of spatial mappings
in our brain as well as the temporal
organization of episodic memories
(15).
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Now What?
How can we utilize the grid
code and use it to answer some of
the problems and questions that
come up in our everyday lives? Researchers are looking into how the
grid code can be applied to social
relationships and hierarchies.
There is a spatial component to
our perception of the social world
around us. When we consider social status and hierarchies, sometimes we group certain individuals
as having a “higher” or “lower”
social standing. A study conducted
in 2015 observed the social brain
by tracking its hippocampal activity in response to changes in social
relationships. The participants
were asked to play a computer
game where they navigated a
virtual world in which they interacted with cartoon characters and
worked to increase their social
status by finding a new home and
job. They were able to find that
the hippocampus of the participants navigated the social space
of the game in two dimensions,

that being affiliation and power
(14). Researchers are hoping to utilize the concept of encoding social
information into a social cognitive
map to examine social deficits
present in clinical disorders like
autism spectrum disorder (15).
Additionally, studying place
and grid cells in these new contexts has propelled researchers to
study their connection to diseases associated with age. A paper
published by Stangl and his colleagues looked into the progressive loss of navigational abilities
that come about with old age.
They hypothesized that since the
entorhinal cortex is predisposed to
neurodegeneration during aging
and Alzheimer’s disease, grid cell
functioning should be significantly reduced in these individuals
causing navigational decline. They
were able to find exactly that. The
older subjects were less successful
in keeping track of their position
when attempting to navigate a
course with curved paths while
their vision was impaired. The
researchers believe that taking into
consideration grid code stability
could be a potential early measure
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for Alzheimer’s and other neurodegenerative disorders. Since the
spatial grid code system also provides a neuronal basis for non-spatial domains such as conceptual
knowledge and memories, broadening our understanding of how
this system may be destabilized in
the brain could help us to comprehend how our memories and other
cognitive domains are affected
with time (16).

Coding the Future
Researchers within this
specialized field are just beginning to expand on the concept
of place and grid cells in a variety
of different ways. They speculate
that there is a slew of intricacies
that may link memory and spatial navigation within our brains,
inspiring research that approaches
this potential unity from different
directions. Many theories and
claims on this notion remain unexplored, with some claims being
more striking than others. A team
of researchers led by Jeff Hawkins
are looking to expand our understanding of the grid code beyond
memory and the hippocampal-entorhinal region of the brain. They
hypothesized that grid-cell-like
neurons are present throughout
the entirety of the neocortex rather
than at just one localized area.
Similar to how grid cells in the
hippocampal-entorhinal complex
can process and store spatial information, the neocortex also utilizes
such cells to learn the structure of
objects that one touches or looks
at, as well as to learn higher-level cognitive tasks. According to
Hawkins, if you were to hold a pen
in your hand, each sensor patch
of your skin, like sections of your
hand’s palm or your fingertips, will
be associated with grid cells in
your neocortex that will process
each patch’s location relative to
the pen. Your neocortex will add

up all the information generated
by each sensor patch and create
an expansive internal map of the
object’s features, helping your
brain recognize that the object
you are holding is a pen (17). The
“neocortex” model has been met
with controversy as some researchers believe grid cells may not be
present in other areas of the brain
beyond the hippocampus and entorhinal cortex. If this model were
to be proven true, it could pave
the way for the incorporation of a
universal grid-code system into the
world of artificial intelligence.
And so we ask: Can this
universal grid framework help
create machines that better mirror the human brain and its abstract qualities? Neuroscientists
at University College London and
AI researchers at DeepMind may
have just launched us in the right
direction. Using a deep learning
AI technique inspired by brain
structures, they were able to train
a rat-like computer simulation to
keep track of its position as it navigated a virtual maze. Surprisingly,

the simulation program created
activity fields of hexagonal patterns similar to the hexagonal grid
code generated by grid cells in
mammals. The simulation was then
able to utilize the grid code to
learn and navigate its way through
the maze.18 It almost seems impossible to imagine what more
we could discover about how we
store and navigate knowledge and
memories with the help of AI and
a universal grid-code. The possibilities seem endless!
Now that you know more
about the memory palace and the
neuroscience behind this technique, let’s put it to the test! Go
back to the memory palace you
created and retrace the route you
took when placing the ten items
on our list. Grab a sheet of paper
and jot down the items you see
in your route and in the order you
come across them. See if you can
match your list with the one I provided above. Feel free to continue
expanding your memory palace.
I’ll leave it up to you and your
imagination to “map” out your
memories however you see fit!
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Are You Depressed?
Or are you just on birth control…
By Olive Cowan
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S

ixty-five percent of
women of reproductive age in th United
Stated take birth control pills. It
is likely therefore, that if you are
an American woman reading this
article, you have used some form
of birth control in your lifetime.
Societal standards have deemed
women responsible for carrying
the burden of birth control. However, the first clinical trials for birth
control were actually conducted
on men; they consisted of two injections of two different hormones
and were found to be 96% effective. However, the trials were terminated when men reported side
effects such as acne and mood
swings (2). Researchers replaced
women as the subjects because it
seemed easier to block the release
of one egg a month as opposed
to millions of sperm. In the U.S.,
hormonal contraceptives such as
IUD or combination pills are most
commonly used for women — because who wouldn’t opt for 99%
efficacy?
Across cultures, the implications of birth control vary immensely. Many religions advocate
against birth control or abortion
because they believe one should
not alter the innately biological
processes of reproduction. In
underdeveloped countries, it can
even be difficult to gain access to
birth control. Additionally, birth
control can be viewed negatively
because of its association with sex,
and subsequently female pleasure (another taboo topic in many
societies). However, hormonal
contraceptives are not just used to
prevent pregnancy; many women are prescribed birth control to
treat common reproductive disorders that affect the ovaries such
as polycystic ovarian syndrome
(PCOS) and endometriosis. When
I was 16, I was diagnosed with
PCOS and prescribed birth control
as a medication to treat it. I was
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relieved to know that there was a
medication that could help, but
overwhelmed by the list of side
effects associated with taking birth
control.
If you have used hormonal
contraceptives before, you have
probably experienced a moment
of shock when you learn all the
possible side effects and risks..
Even though they tend to be rare,
side effects range from common/
minor effects such as changes
in bleeding, headaches, weight
fluctuation, facial acne, nausea
or cramping, to serious/rare side
effects such as blood clots, ovarian cancer, or vaginal infections.
They are rare, and if caught early
they can be treated. The important
factor is knowing side effects are
a possibility so that if you experience them, you can recognize
them and tell your doctor. Another
side effect listed under the rare
section is depression/mood changes. However 2.2 out of 100 women
who are taking hormonal birth
control developed depression
compared to 1.7 out of 100 women who did not use hormonal birth
control (29). Indicating that if you
are taking hormonal birth control,
you are potentially at a higher risk
for developing depression or other
mood disorders. Additionally, this
number is likely underestimated

because many individuals do not
report their mood changes as a
side effect of birth control, instead
they view them as independent
issues. After I started birth control,
I was one of the unlucky few who
experienced these mood related side effects. For a while, I too
believed they were independent,
but now I’m not so sure. A few
months ago I stumbled upon an
article titled “Can hormonal birth
control trigger depression?”, and
what I learned was shocking. If you
have ever experienced something
similar, or relate to what I have
already said, I suggest you continue reading. Before we begin, a
solid understanding of menstruation, hormones and birth control
is necessary to understand the
implications of the aforementioned
article.

What is
Menstruation?
Menstruation begins when
a woman goes through puberty.
Her hormone levels fluctuate and
she becomes fertile. The menstrual
cycle has a few stages, first, menstruation where the uterus releases
its inner tissue lining through a
“period”. In the Follicular phase,
the uterine lining begins to build
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up again to prepare to release an
egg from the ovaries in the Ovulation phase. The Luteal phase
completes the menstrual cycle by
building up the uterine lining and
preparing for menstruation again.
During the 30-day cycle of menstruation, hormone levels fluctuate
dramatically (17).

Hormones and
Birth Control
Hormones are responsible
for regulating a number of different biological processes mostly
within the endocrine system (a
network of glands that dictate
the functioning of cells and organs). The endocrine system is
made up of regions of the brain
(hypothalamus, pineal and pituitary gland), thyroid/parathyroid
gland, adrenal gland, pancreas,
ovaries, and/or testes (20). This
system is responsible for essential biological processes such as
homeostasis, metabolism, phys-

ical/mental growth, energy, fear,
and reproduction. The endocrine
system interacts with the HPA axis
(hypothalamic-pituitary-adrenal
axis), a network of communication
and feedback within the hypothalamus, pituitary gland and adrenal
gland that dictates our body’s
stress response. The pituitary and
pineal glands release stress hormones called cortisol, which signal
to the hypothalamus and other
brain regions to go into fight or
flight mode. Hormone fluctuations
can have effects throughout the
whole body because hormones
interact with many different physiological processes. You might be
wondering what this has to do with
periods and birth control; birth
control manipulates this pathway
by altering levels of the female sex
hormone (estrogen) to interrupt
the menstrual cycle.
Estrogen has three major
endogenous forms: estriol, estradiol and estrone (17). β- estradiol
is the most abundant form of
estrogen produced naturally in the
body (3). Scientists spent years

researching these hormones in order to generate synthetic versions
that act in a similar manner. The
primary goals for using synthetic
hormones were hormone therapy and hormonal contraceptives.
Supplemental synthetic estrogens
increase estrogen levels which can
stop periods, and prevent ovulation. Increased estrogen levels
signal via the endocrine system to
the brain and the ovaries that the
body is pregnant (even though
it isn’t actually). When the body
thinks it is pregnant, it does not
ovulate (release eggs) and therefore cannot become pregnant.
Hormonal contraceptives can
be administered in several ways.
Some work through a daily pill
which releases hormones into
the bloodstream. Hormones can
also be administered through an
intrauterine device (IUD). This is
placed in the uterus and slowly
releases small doses of hormones
over time to the localized area.
These hormones do not interact
with the brain or the bloodstream,
however similar changes still occur
in the uterus. The hormones in the
IUD cause the tissue lining of the
uterus to become thinner which
results in lighter/less frequent periods. The IUD prevents pregnancy
by triggering swelling and mucus
generation in the uterus so that
it is inhospitable to sperm (34).
These hormonal contraceptives are
composed of synthetic hormones
such as ethinylestradiol (the most
commonly used hormone in oral
contraceptives) or levonorgestrel
(a synthetic hormone similar to
progesterone used in an IUD) (10,
34).

Treating Other
Disorders
Hormone therapy is often
used to treat disorders that impact the endocrine system. These
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disorders impact processes such
as reproduction, growth/development, mood, and hormone
regulation. Endometriosis is an
endocrine disorder that affects
the growth/development of the
uterus by overproducing endometrial/uterine tissues that begin
to grow on the outside of other
organs. When the uterine lining is
shed during a period, it can cause
small lacerations on other organs
which can be very painful and lead
to infertility (19). Polycystic ovarian syndrome (PCOS) is another
endocrine disorder that affects the
uterus. It is caused by the overproduction of androgens (a male sex
hormone found in low concentrations in women) that leads to cysts
(small fluid filled sacs) on the ovaries. The hormone imbalance can
prevent some women from menstruating. Menstruating with PCOS
can be very painful and also poses
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health risks by increasing your risk
of having a cyst burst (19). Hormonal birth control as a form of
treatment has a positive impact
on the severity of both PCOS and
endometriosis symptoms. Supplementation of synthetic progesterone and/or estrogen decreases
menstruation by thinning the
uterine lining which makes periods less painful and decreases the
risk for lesions or burst cysts (36).
Medications used to treat endocrine disorders such as hormonal
contraceptives have widespread
effects due to the diffuse nature of
the endocrine system.

The Emotional Side
of Things
While the physiological
side effects of birth control have
been widely studied, the emo-

tional effects have not been given
much attention. As mentioned previously, between 4 and 10 percent
of women experience emotional
changes after taking oral contraceptives (15). These effects range
from mood swings to diagnosis of
mood disorders, and are impacted
by the type of hormonal contraceptive, age of first exposure, and
duration of use. Different brands
of hormonal birth control have different concentrations and ratios of
progesterone and estrogen, which
makes choosing a birth control
very hard. A general rule of thumb
is to use the lowest dose possible
to remain effective because higher
doses increase the risk of serious
side effects (30). Additionally, progesterone-only forms of hormonal contraceptives have a higher
association with depression (29).
Women who are first exposed to
birth control during adolescence
as opposed to adulthood are 1.7
to 3 times more likely to develop
depression or other mood disorders later in life (2). Researchers
speculate that the significant brain
changes that occur during adolescence are altered by the ways in
which supplemental sex hormones
interact with the brain and other
parts of the endocrine system. If
the body gets used to receiving
estrogen from birth control it may
not learn to produce it on its own.
In a similar manner, prolonged use
of birth control can have similar
neurological effects.
Some brain regions have
stronger associations with the
overall mood and depression due
to their interaction with estrogen.
Estrogen receptors can be found
in the digestive system, bone
tissue, reproductive system and
nervous system (6). They are also
highly concentrated in areas of
the brain associated with mood
regulation such as the hippocampus, hypothalamus, raphe
nucleus, and cerebellum. ERs are
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specific estrogen receptors used
by synthetic and natural forms of
estrogen. Estrogen receptors are
nuclear receptors, a special kind
of receptor that is able to interact
with DNA and regulate gene transcription. Transcription impacts a
wide range of biological processes
such as reproductive organ development, bone density, and brain
functioning (27). Alterations in
brain functioning due to transcriptional changes is a potential route
in which depressive symptoms can
emerge. Fluctuations in estrogen
levels caused by the menstrual
cycle have been shown to cause
structural changes in the brain
such as decreased overall volume,
in addition to decreased volume
in specific regions associated with
depression/mood such as the
hippocampus, amygdala, temporal
and parietal regions (24).
Another possible mech-

anism by which estrogen can
impact mood is through estrogen
receptors abundance in areas of
the brain responsible for serotonin
regulation and usage. Serotonin
is a neurotransmitter associated
with mood regulation. When serotonin levels are low, individuals
experience symptoms of anxiety
or depression. It is not clear how
serotonin levels get depleted, but
scientists have speculated that
early life stressors, persistent trauma, or lack of gut microbiota can
all impact serotonin levels (13, 38).

You May be Moody
Or It Could be Your
Birth Control
Women are often ridiculed for being moody or asked
“are you on your period?” when

they are irritable. This is a normal
response to hormone fluctuation
and should not be criticized by
others. The drastic changes in hormones during the menstrual cycle
can cause moodiness or irritability
which can be worsened by life
changes or new stressors. Supplemental hormones in birth control
can often intensify these effects
and in some cases lead to different
mood disorders. When doctors
prescribe birth control, they rarely
go into detail about the potential
severity of mood effects.
The statistics on prevalence of mood related side effects
and hormonal birth control are
shocking. 47% of women who
began taking birth control terminated their use within the first six
months due to adverse effects.
These women tend to switch forms
of birth control or discontinue
use permanently (26). Due to the
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recent evidence supporting an association between mood disorders
and use of hormonal birth control,
scientists have begun researching
ways in which this could occur.
The route is not completely clear,
however based on the information
discussed above, there are a few
mechanisms by which these mood
changes are possible. Estrogen
may interact directly with the
endocrine system and produce
effects in areas of the body such as
the brain and reproductive organs.
It is possible that the supplemental
synthetic hormones disrupt proper
cognitive functioning and lead to
mood changes. Another possible
mechanism is through gene transcription caused by the estrogen
receptors. Scientists do not know
which genes the hormones turn on
or off. It’s possible based on the
fact that estrogen receptors are
highly concentrated in regions of
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the brain that produce serotonin,
that the synthetic hormones turn
off genes that produce serotonin,
and decrease serotonin levels.

Back to The Article
That Started it All
Now that you understand
the background information about
hormones, birth control, and their
effects on mood, we can begin
to explore why this is applicable
to you and a large portion of the
population. After reading “Can
hormonal birth control trigger
depression?” I googled some
key words and the results of my
search were astounding. I knew
that moodiness or irritability were
among the other potential side effects on the generous list. However, I was unaware of how direct the
correlation between depression

and hormonal birth control is.
A study tracking women
taking birth control found that
47% of women taking an oral
contraceptive discontinued it, and
14% changed to a different type
of pill within the first 6 months of
starting (26). One of the leading
causes of these changes was their
awareness of worsening mental/
emotional wellbeing. Various experiments have shown that women
taking hormonal birth control pills
experience higher scores of depressed mood, mood swings, and
fatigue than individuals receiving a
placebo treatment (14).
Even when the hormone
release is localized to the uterus, such as an IUD, women have
reported experiencing depressed
mood or anxiety. A population
study in females with an IUD detected a decrease in psychological
well being, an increase in anxiety
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and impaired stress recovery (5).
A diminished response indicates
an inability to cope and deal with
stress, one of the principal contributors to mental disorders. This
blunting effect commonly found
in disorders such as anxiety and
depression is also seen in women
on the birth control pill.

Necessary Societal
Changes

about health, and an increase in
alcohol dependence (32). This particular study ran statistical analyses
to determine if the contraceptives,
or a different variable, were contributing to the issue. The correlational analysis determined that the
use of hormonal contraceptives
was contributing most heavily to
the psychological effects. Another
population study done in Denmark
revealed that adolescents with
IUD’s were more likely to subsequently be prescribed antidepressants than adolescents who did
not take birth control (28). These
women were 50% more likely to
be diagnosed with depression
within six months of starting birth
control than individuals who were
not taking any hormonal contraceptives. These same researchers
did another study, using a simi-

lar sample, but this time looking
at women with IUD’s risk of attempted or completed suicide.
Shockingly, they found that these
women, about 21 years old with
no previous psychiatric diagnosis,
antidepressant use or hormonal
contraceptive use before the age
of 15, were two times more likely
to attempt suicide than those who
did not use hormonal contraceptives during these years [28]. Unfortunately, the risk of completed
suicide was even higher; women
using hormonal contraceptives
were three times more likely to
commit suicide.
Remember the HPA axis?
It’s responsible for our stress
response. Patients with depression have been shown to have a
blunting effect, in which patients
have a diminished stress response

These statistics are disturbing and indicate that significant
changes need to be made in regards to the way in which women
are informed about mood effects
and the use of hormonal birth control in general. Mood effects are
not usually discussed in detail as a
side effect of birth control use. In
order to decrease the prevalence
of mood effects, doctors need to
inform women taking birth control of the increased risk for mood
effects. This way, they can look out
for them and make the association
between mood changes and birth
control rather than viewing them
as independent issues. Potential
interventions could be changing
dosages or forms of birth control
to decrease the mood effects.
Some individuals may be more
sensitive to oral contraceptives because they are absorbed into the
bloodstream, but not as sensitive
to an IUD which releases hormones to a localized region of the
uterus. Determining which method
is safest for you is imperative to
your emotional wellbeing.

The Bright Side
While these statistics are
grim and you are probably feeling
like getting your IUD taken out or
stopping your birth control, that
isn’t the first step and there are
other options. While there is a
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risk for developing depression or
mood disorders, not all women
do. Some women benefit greatly
from hormone therapies. Women
using hormones to treat endometriosis or PCOS experience
significant reductions in pain and
dangerous physical impacts. Additionally, some studies show that
hormone therapies can actually
have positive impacts on mood for
women with severe premenstrual
syndrome (PMS) or post menapause (7).
If you are worried that
your birth control may be contributing to a depressed or anxious
mood, you can talk to your doctor
to discuss maybe switching the
concentration of your hormones,
or changing to a different form of
birth control. These small changes
can make a big difference. Factors such as personal/familial past
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medical history of mental illness
or mood related side effects from
hormonal contraceptives can have
a significant impact on your sensitivity to synthetic hormones (15,
12). In addition, the use of progesterone only pills or multiphasic pills
(hormone dose increases over the
course of your cycle rather than
remaining constant) can increase
your likelihood of the development of negative mood effects
(31). Lastly, starting birth control
at a young age increases your risk;
the less developed your mind is,
the more likely you are to experience these mood related side
effects (28). Therefore, it may be
best to consider starting hormonal
birth control as late as possible.
In light of these concerns
for women’s mental health, scientists have gone back to the lab
in search of non-hormonal birth

control options. The FDA has
approved a number of different
products, however none are as
effective as their hormonal counterparts. One of the most promising new options is a non hormonal
gel used before sex called Phexxi.
It works by altering the vaginal pH
to be inhospitable to sperm. This
birth control was shown to be 93%
effective in clinical trials, making
it relatively competitive with other
forms of hormonal birth control.
This birth control is now on the
market, but it requires a prescription from a doctor to ensure it is
a safe option for you. However,
this is made easy with telehealth
appointments on phexxi.com.
Some doctors recommend progestin-only birth controls to alleviate
the emotional side effects; however, literature has shown similar
negative emotional effects with
these pills (31). The overall trend
is ambiguous and requires more
research to make any conclusions.
Additionally, researchers
are working hard to generate an
effective birth control pill for men.
One drug called “11 βmethyl nortestosterone dodecyl carbonate”
has moved into phase one of its
clinical trial (28). It works by supressing testosterone and another
male sex hormone essential for
sperm production. It is unclear if
these will be viable options, but
if they are safe and effective, this
medication may prevent many
women from suffering mood
related side effects. Regardless
of the scientific limitations, there
are societal stigmas surrounding
men and infertility which makes
implementing male birth control
difficult. Reproduction is biological
and innate; any deficiencies in this
domain are frowned upon. There
needs to be both societal and scientific growth in order for change
to occur and the norms of birth
control to shift.
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Consciousness

Our most basic state is more complicated than you think!
By Alyssa Dowling
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Rude Awakenings

I

n 1998, Carol Weiher awoke to
the sound of disco music—and, if
that wasn’t bad enough, the next
thing she heard was “cut deeper,
pull harder.” Carol was having
her right eye surgically removed
and the muscle relaxants she was
administered prevented her from
alerting anyone that she was still
conscious and in pain (1).
“I was doing a combination of praying and pleading
and cursing and screaming and
trying anything I could do but I
knew that nothing was working,”
said Weiher. Weiher is one of a
relatively small group of people
who have experienced anesthesia awareness, a phenomenon in
which anesthesia does not render
the patient properly unconscious.
In the worst scenarios, the patient
wakes to tremendous pain without
any means of communicating; they
must simply bear the physical and
psychological consequences of
this deeply traumatic experience.
Still, though one or two people
out of every thousand who go
under anesthesia experience some
degree of awareness during their
procedure, only an unlucky few
can feel pain (1).
Experiences like Carol’s
highlight our tenuous understanding of consciousness and the
dangers of not researching the
subject further. Through the study
of comas, anesthesia, and artificial
intelligence, scientists and philosophers alike have realized that our
ability to understand and scientifically define consciousness is crucial.
Even so, a precise scientific definition of consciousness is extremely
difficult to establish, in part because we use the word in so many
ways. We are conscious, but we can
lose consciousness while sleeping,
under anesthesia, or from a brain
injury. I can also say that I am conscious of something to indicate that

Patient undergoing eye surgery by Sasint on Pixabay.

I am aware of it, a definition that
has little to do with consciousness
in reference to the self.
Consciousness is a problem
so nebulous that it is often difficult
to know what questions to ask or if
science will even be able to provide greater insight. It is a subject
that some think is an illusion and
others consider the essential question of neuroscience. Some believe it is irreducible, while others
want to study it at the molecular
level. Still, to productively discuss
consciousness, we must have a
generally agreed-upon definition.
Though the scientifically accepted
definition of consciousness will
change over time, it is possible to
combine several popular definitions to make the concept more
accessible. Broadly, consciousness
refers to the ability to experience
one’s existence rather than simply recording and responding to
it as a computer program might.
Consciousness consists of inner,
qualitative, subjective states and
processes of sentience or awareness (2). Though a robot may
detect the world around it, it is
not consciousness because this
requires a qualitative feeling along
with those inputs in conjunction
with communication, thought,

and reflection (2). Consciousness
can be divided into two functional components: wakefulness and
awareness. While wakefulness refers to arousal, awareness refers to
how we process the content of our
consciousness. Put simply, wakefulness is required to perceive a
tree or experience happiness, but
demonstrating wakefulness does
not guarantee awareness—both
are necessary for consciousness
(3).

The History of
the Study of
Consciousness
In the seventeenth century,
after the Renaissance, the Greek
concept of a “theory” was combined with systematic observation
and experimentation (2). However,
at this same time, conflict between
science and the Church raged,
and scientists and philosophers
adjusted their teachings to protect themselves and their field of
study. To separate science away
from the church and thus protect
it, Descartes argued that reality
has a strict and abiding cleavage between the mental and the
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physical, a designation that was
long accepted. Given this reasoning, Descartes was able to create
a separation between religion and
science of sorts, with a degree of
success. At the time, this was a
decent compromise—the church
had uncontested domain over the
mind and soul, and scientists were
relatively free to study the material
world. Although this distinction
was useful at the time, it has persisted much longer than its utility.
Consequently, for reasons ranging
from ease to convention, science
has been considered a strictly
objective, third-person endeavor.
This leaves scientists little agency
to provide insight on first-person
subjective experiences—especially
not one as abstract as consciousness. After all, to study consciousness is to examine our very conception of the human soul (2).
This history meant that it
wasn’t until the 1990s that neuroscientists began to regard consciousness as a legitimate area
of study in the natural sciences.
The Merriam-Webster dictionary
defines neuroscience as “a branch
(such as neurophysiology) of the
life sciences that deals with the
anatomy, physiology, biochemistry, or molecular biology of nerves
and nervous tissue and especially
with their relation to behavior and
learning.” Simply put, it is the
study of the brain. It is thus puzzling that we do not study a fundamental function of the brain—
consciousness. Studying the brain
without studying how the brain
causes and sustains conscious
states is like studying the lungs
without studying how they allow
us to breathe. Though consciousness admittedly involves more
philosophical, spiritual, and ethical
considerations and is certainly
more complex than breathing, the
logic stands. Further, the study of
consciousness should be driven by
many of the same medical consid-
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erations that would drive the study
of any other major physiological
process. Even if neuroscience will
never be able to fully explain consciousness, and I suspect its study
will provide useful insights into
comas, anesthesia, and perhaps
our very personhood.

The Neuroanatomical Basis of
Consciousness
The study of the neuroanatomical basis of consciousness is still
in its nascent stages. There are
many different theories, but it is
important to understand some of
them and how they are derived to
understand the ways in which neuroscientists are making progress in
their study of consciousness. The
traditional viewpoint is that consciousness essentially arises from
interacting neurons in the midline
of the brain, the cerebral cortex
(associated with attention, awareness, etc.), and the reticular activation system (regulating alertness
and wakefulness) (4). At the same
time, contemporary research suggests that consciousness originates
in the frontal region of the brain,

while others maintain that it comes
from the hindbrain. In studying
the material basis of consciousness, researchers must address the
external sensory network and the
internal self-conscious network,
making consciousness a uniquely
complex function. There may be
many theories of consciousness
simply because so many parts of
the brain are involved.
One way that neuroscientists attempt to simplify the
physical study of consciousness is
through the study of neural correlates of consciousness (NCC).
Because these “signatures of
consciousness” are not necessarily
causal, they are much easier to
study and identify (if slightly less
illuminating). Stanislas Dehaene,
a neuroscientist at Collège de
France, has identified four “signatures of consciousness (5).” Of
those, the P3 wave in the dorsolateral cortex (behind the top of your
forehead) correlates most reliably
with normal conscious states (5).
Physicians have successfully used
measurements of these “signatures of consciousness” in coma
patients to predict which individuals are most likely to regain consciousness. Neuroscience jargon
aside, our understanding of neural
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was moderately correlated with
the duration of consciousness
loss following brain damage. The
study of the claustrum as a neural
correlate of consciousness demonstrates major issues with the study
of NCCs in general. For one, the
structure is thin and in close proximity to a variety of other brain
structures, making it challenging
to study using neuroimaging (3).
Additionally, though scientists like
Crick and Koch proposed that the
claustrum plays a crucial role in
consciousness due to its structure
and connectivity, more recent
research does not support this
same hypothesis. Instead, results
suggest that several neural networks combine to generate and
maintain consciousness, although
some, such as the claustrum, may
be more involved than others (3).

Forms of Consciousness. Original image by Alyssa Dowling. Created in Biorender.

correlates of consciousness is
proving to be an essential part of
developing more accurate prognoses for individuals in unconscious
states.

Curious Case of
the Claustrum—
A Promising NCC
The claustrum is a thin
sheet of neurons attached to the
bottom of the neocortex in the
middle of the brain (6). Relatively
little is known about the function of the claustrum, but we do
know it provides functional links
between the frontal cortices and
the association cortices in the
brain. These linkages suggest that
the claustrum plays a role in how
perceptual information interacts
with the arousal (alertness) system,
and thus is involved in the generation of consciousness. In 2014,

Koubeissi et al., in the pursuit of a
cure for epilepsy, implanted electrodes deep in a woman’s brain in
an attempt to record signals from
different brain regions during seizures (7). When an electrode next
to the claustrum was stimulated,
the woman lost consciousness.
When the stimulus stopped, she
immediately regained consciousness without recollection of the
incident. Other wider-scale studies have found that the degree
of claustrum damage affects the
duration of consciousness loss,
suggesting that the claustrum
plays a role in the restoration of
consciousness,but not maintenance (3). One study looked at
Vietnam veterans with traumatic
brain injuries that were limited to
one brain region, and impacted
the claustrum. Researchers defined
traumatic brain injuries as injuries
that caused at least 24 hours of
loss of consciousness. They found
that damage to the claustrum

Theories of
Consciousness
While research of the neurobiological basis of consciousness
expands this field of study, a more
holistic approach is to perhaps
examine the experience of consciousness. Instead of trying to
reduce consciousness into biological parts, theories of consciousness
attempt to give a more systemic
explanation. The first, the global
workspace theory of consciousness
(GW), was proposed in 1998 (14).
This idea is essentially that a single
brain region is incapable of generating consciousness. Instead, consciousness requires the coordination of many different parts of the
cerebrum—an idea that encourages researchers to explore the brain
as a whole (8). Interestingly, this
theory (along with some related
ones) posits that computers will
one day gain consciousness. Critics of this theory say that it fails to
explore what consciousness is and
instead only provides a vague call
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Global Workspace Theory of Consciousness (GW). Original image by Alyssa Dowling. Created in BioRender.

to consider the entire brain in the
production of consciousness.
The integrated information theory, on the other hand,
conjectures that consciousness is
simply “the capacity of a system to
integrate information,” and provides a mathematical framework
for evaluating the magnitude and
quality of consciousness (9). This
theory, while helpful for measuring
consciousness on a clinical level,
provides conditions that are necessary, but not sufficient on their own
to produce consciousness.
More metaphysical theories of consciousness exist, with
two being the most prominent.
Some think that consciousness is
a fundamental building block of
the universe in the way that physicists think of space and time and
mass (13). According to this theory,
there are fundamental laws that
govern these building blocks, but
they cannot be understood and
explained in more basic terms.
Others still think that consciousness could be universal and that
every system can possess some
degree of consciousness. This
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idea is called panpsychism and
suggests that everything, from a
human to a photon, has some element of subjective feeling, some
primordial precursor to consciousness as a human experience. This
idea does not assert that everything is intelligent or thinking, but
rather that everything has some
aspect of “universal” conception
of consciousness. While this idea
is somewhat incomprehensible in
Western, monotheistic culture, it is
seen as a more intuitive explanation in cultures that see the human
mind as continuous with the rest of
nature.
The idea that consciousness is both fundamental and
universal has been taken up by
a neuroscientist by the name of
Giulio Tononi, who has rigorously
developed the idea via mathematical theory (13, 9). This mathematical theory is centered around the
idea of phi, which is a measure of
the amount of information integrated in the system, and thought
to be related to consciousness.
Therefore, the human brain, with
its large degree of information

integration, has the highest degree
of consciousness. Everything else,
down to a microbe, has a non-zero
degree of consciousness. In the
science of consciousness, this is
one of the leading theories, and
it has the potential via ethical and
social implications to transform
how we relate to nature. On the
other hand, this theory could apply
to non-organic systems like computers, which, according to the
pan-psychic view, have the capacity to be completely conscious. This
is a view that many neuroscientists,
philosophers, and religious leaders
would take major issue with. On
the topic of computers especially,
leading neuroscientists have taken
the stance that consciousness has
much more to do with our nature
as living and breathing organisms
than with pure intelligence, and
thus would reject Tononi’s hypothesis (12). It perhaps follows that the
“pan-psychic” view would need to
only apply to living things, at least
for the time being, to properly
mesh with other neuroscientific
conceptions of consciousness.
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Philosophy of
Consciousness and
the Limits of
Consciousness
There is tension between
neurological and philosophical
theories and conceptions of consciousness. Although to be human
we must have a brain in relative
working order, some philosophers
believe that there is confusion between the necessary and sufficient
conditions for consciousness. Thus,
when thinking about neuroscience,
it is important to not lose sight of
that fundamental mind-brain problem. Most neuroscientists do not
think that the mind is the brain,
but some neuroscientists seem to
get lost in chemical and anatomical explanations of consciousness
and risk losing sight of the forest
in their study of the trees. There is
a legitimate fear that an overly reductionist approach to conscious-

ness will lead to purely chemical
explanations of behavior. For instance, there is a quoted instance
in which Patricia Churchland, a
so-called neuro-philosopher, came
home after a difficult day at work
as told her husband, “Paul, don’t
speak to me, my serotonin levels
have hit bottom, my brain is awash
in glucocorticoids, my blood
vessels are full of adrenaline, and
if it weren’t for my endogenous
opiates I’d have driven the car
into a tree on the way home. My
dopamine levels need lifting. Pour
me a Chardonnay, and I’ll be down
in a minute (10).” It is hard to say
how seriously these sorts of sentiments are taken, but at the very
least I think it is easy to understand
how such statements would alarm
those who take a more holistic
approach to human consciousness and behavior. Further, such
explanations do not yet provide a
particularly convincing explanation
for consciousness, and cannot be
taken entirely seriously.

Covert
Consciousness
Severe brain injuries often
lead to a loss of consciousness
for weeks or even longer. In such
unresponsive states, it is difficult
to determine to what degree the
patient is aware or conscious. Fifty
years ago, these patients probably would not have survived their
injury, but as life support technology has improved and such patients
can be sustained for longer periods, doctors and neuroscientists
have identified a newfound demand for more robust techniques
for determining the degree of
a patient’s consciousness. Many
patients who are unable to give
muscular or behavioral indications of consciousness have been
shown, through brain imaging,
to have some degree of covert
consciousness (11). These findings
have many clinical applications
and can be used to give more
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accurate treatments and diagnoses
to unconscious patients. This can
also contribute to more accurate
prognoses—that is, brain imaging that discovers some degree
of covert consciousness can help
provide more accurate predictions
as to whether or not a patient will
regain consciousness. Patients who
exhibit some degree of subjective
experience as discovered by brain
imaging are substantially more
likely to recover from their injuries.
When we discuss impairments of consciousness, it is
essential to distinguish between
the different states that are possible and the spectrum on which
they exist. Although there are
ideal types, each unconscious
state is different from the next,
and a person’s level of consciousness exists at different degrees of
several different axes. The coma is
the most referenced impairment
of consciousness and can basically be understood as a very deep
sleep that you cannot awake from.
In the “ideal type” of coma there
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is little to no movement, the eyes
are closed, and the patient has
little to no awareness or processing of their surroundings. The
opposite of a coma is understood
to be full consciousness in which
you have total awareness, normal
processing, and physical ability to
respond to the environment. Still,
there are types of consciousness
impairments that fall into other
categories, such as the vegetative
state, during which a person can
open their eyes and there is some
level of alertness, but they do
not exhibit full consciousness. An
individual in a vegetative state is
sort of a physical shell of a person
in that they lack consciousness,
but display some movement and
the theoretical ability to use their
body (if their brain could utilize
that ability) (11). Opposite from a
vegetative state is a person who is
“locked-in.” These patients are fully conscious but have limited to no
ability to express their consciousness, often due to an injury to the
pons, a part of the brain which

plays a large role in transmitting
and receiving motor information.
This is a condition in which it is
particularly vital to discover covert
consciousness since it is distinctly
inhumane to mistake a fully conscious (though immobile) person
for someone in a vegetative state.
Consider, for example, instances
in which fully conscious patients
overheard family members saying
that it would be better if they were
dead, or adult individuals who
were stuck in front of a TV playing Barney for several months (7).
Indeed, when locked-in patients
recover or find ways to communicate, they generally have suffered
trauma from having been treated
as an object during the time in
which their degree of consciousness was misunderstood. At the
very least, discussions of covert
consciousness should include the
vital importance of what physicians
have been taught for decades)—
medical professionals and family
alike must treat seemingly unconscious individuals as if they can
understand and respond to everything that is said and done around
them.
Considering that there is
no direct test for consciousness,
the study of covert consciousness is intimately connected to
the technologies which detect it
(11). While behavioral and muscular indications of consciousness
are undeniably central to our
understanding of the concept,
brain imaging has demonstrated
how limiting and unsatisfactory
such markers are. Functional MRI
scans have drastically changed
the quality of life for seemingly
unconscious patients and have
helped identify a need for further
therapeutic strategies. Still, these
scans always require transporting
the patients, which can be costly
and dangerous. The scan itself is
expensive and logistically difficult
since there must be physicians,
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nurses, and respiratory technologists present to safely perform an
MRI on a patient who may be on
some degree of life support (11).
Additionally, consciousness generally fluctuates during recovery, and
so a patient that starts out unconscious may become increasingly
conscious without any behavioral
change. However, repeated MRI
scans may not be logistically or
financially possible. Luckily, many
new promising technologies are
being researched that could be
used more consistently. One major
study used EEGs and found that
around 15% of patients in an
“unconscious” state demonstrated
some degree of covert consciousness. Other studies have put the
number at closer to 30, or even 40
percent (11).

Conclusions
Pinning down a definition
of consciousness demonstrates
how nebulous the concept can
be. At the same time, however,
the clinical advantages of better
understanding consciousness are
evident. Providing more suitable
treatment plans and prognoses for
unconscious patients, preventing
anesthesia awareness, and finding
a more connected way of thinking
about our place in the world are all
reasons the study of consciousness
is essential. While there is certainly
some validity to complaints of the
inscrutable nature of consciousness, it is not an area of neuroscience that we can afford to ignore
because it is too complicated or
because of the possibility that we
might never understand it. All we
need to know is that the journey
toward a better understanding of
consciousness will improve clinical
outcomes, our understanding of
ourselves, and perhaps even our
understanding of our place in the
world.
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Deputy Civil Rights/Title IX
Coordinator - Retired Professor
Emerita of Psychology

Becky Gallagher
Animal Caretaker and Laboratory
Technician

Harry Itagaki
Retired Professor Emeritus of Biology

Joel Richeimer
Professor of Philosophy

Areas of Expertise: Neurobiology,
mechanisms of perception and
reaction to stimuli, physiological and
anatomical bases of gustation in
insects, metabolic physiology.

Areas of Expertise: Philosophy of
perception, philosophy of science,
epistemology, ancient philosophy.

Chris Gillen
Professor of Biology

Hewlet G. McFarlane, Chair
Professor of Neuroscience

Areas of Expertise: Animal physiology,
salt and water balance physiology.

Areas of Expertise: Neuroscience,
relationship between brain chemistry
and behavior, autism, schizophrenia/
depression.

Andrea White
Visiting Assistant Professor of
Psychology and Neuroscience

Shanon Hashman
Administrative Assistant in the Academic Division Psychology, Chemistry,
and Neuroscience

Tabitha Payne
Associate Professor of Psychology

Bruce Hardy
John B. McCoy Bank One
Distinguised Teaching Professor of
Anthropology

Sarah Petersen
Ashby Denoon Assistant Professor of
Neuroscience and Biology

Areas of Expertise: Paleoanthropology (early hominids and
Neandertals), Human ecology

Areas of Expertise: Adult
development and aging, health
psychology, identity development.

Areas of Expertise: Cognitive
psychology, methods in cognitive
psychology.

Areas of Expertise:
Neurodevelopment and genetics,
synaptic remodeling, myelinating
glia.

Neuroscience Majors & Concentrators, Class of 2022: Sofia Alonso, Olive Cowan, Alyssa Dowling, Karolina Edlund,
Lucy Friedberg, Alia Korot, Selam Habtemariam, Madde Hyland, Lauren Limbach, Hailey Napier, Racine Ross, Sierra Smith
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